Category Archives: Industry Insights / 行业洞察

Hainan’s Island-Wide Customs Closure: How Bonded Cargo Moves Between the First and Second Lines

  • Hainan issued Qiong Cai Shui [2026] No. 986 on 2 November 2026, effective on publication, to settle how goods move between areas inside the island once the island-wide closure is in operation.
    海南省三部门于 2026 年 11 月 2 日联合印发琼财税〔2026〕986 号,自公布之日起实施,用于明确全岛封关运作后货物在岛内不同区域之间流转的管理口径。
  • Bonded cargo held in a customs special supervision area, a bonded logistics centre or a bonded warehouse may move into other parts of the island by reference to first-line import, provided no operation has changed the state of the goods.
    存放于海关特殊监管区域、保税物流中心或保税仓库的保税货物,在未发生改变货物状态情形的前提下进入自贸港其他区域,可以参照”一线”进口办理。
  • Circulation, processing, testing, repair and blending are named as the operations that break the chain, and the list is deliberately open-ended.
    流转、加工、检测、维修、混兑被点名为会打断这条链条的操作,且该列举本身留有兜底空间。
  • Quarantine, inspection and licence verification already completed are not carried out a second time when the cargo moves on.
    此前已经完成的检疫、检验、许可证件核验等管理措施,货物继续流转时不再重复实施。
  • Goods made by encouraged-category enterprises in the port from imported inputs, with value-added processing of 30 per cent or more, follow the second-line processing value-added rules when sold on the island.
    自贸港内鼓励类产业企业使用进口料件生产、加工增值达到或超过百分之三十的货物,在岛内销售的,参照经”二线”进入内地的加工增值政策执行。
  • The notice introduces no new tariff schedule and no new list; it points operators back to closure policy documents that already exist.
    这份通知没有新增税则,也没有新增清单,它的作用是把经营者指回已经生效的封关政策文件。
  • Delivery sits with provincial departments and with municipal finance, development and reform, and commerce bureaux, under a standing risk-screening and reporting duty.
    落实责任落在省直单位与市县财政、发改、商务部门身上,并配有常态化的风险排查与上报机制。

Hainan’s Island-Wide Customs Closure: How Bonded Cargo Moves Between the First and Second Lines | 海南全岛封关:保税货物如何在”一线”与”二线”之间流转

Why this notice matters

On 2 November 2026 the Hainan Provincial Department of Finance, the Hainan Provincial Development and Reform Commission and the Hainan Provincial Department of Commerce jointly issued the Notice on Management Matters Concerning the Island-Wide Customs Closure Operation of the Hainan Free Trade Port, numbered Qiong Cai Shui [2026] No. 986. It took effect on the day it was published, which is to say there was no transition period and no separate implementing circular to wait for.

The notice rests on a working arrangement issued by the General Office of the National Development and Reform Commission together with other bodies, numbered Fa Gai Ban Qu Yu [2026] No. 754. That document set the task; this one discharges it for a specific and rather narrow set of movements. Nothing in the text creates a new tax instrument, a new catalogue of goods or a new eligibility test for investors. What it does is decide which existing rule applies when cargo crosses an internal boundary.

That is a smaller question than it sounds, and a more consequential one. An island-wide closure turns Hainan into a territory that is treated separately from the mainland customs territory for a defined set of purposes. Once that is true, every movement of goods acquires a direction: in from overseas, out to the mainland, or across from one part of the island to another. The first two directions were addressed when the closure framework was published. The third — internal movement — is what this notice settles.

For a foreign group running a bonded warehouse, a regional distribution centre or a light processing line on the island, the internal boundary is not an abstraction. Goods arrive from overseas and sit in bond. Some of them are later sold or transferred to a buyer elsewhere on the island: a hotel group, a retailer, a construction contractor, a manufacturer. Before this notice, an operator had to reason by analogy about whether that transfer counted as a fresh import, with all the documentary consequences that follow. The notice replaces analogy with a rule.

The document contains two substantive provisions and two housekeeping ones. The first substantive provision covers bonded goods leaving a bonded premises for another part of the island. The second covers goods manufactured on the island and sold on the island. The housekeeping provisions assign implementation duties and set out a risk-control mechanism. Everything else in this article follows from those four elements.

Because the notice is administrative rather than fiscal, it is easy to skip. There is no headline rate in it, no new list of eligible activities, nothing that would appear in an investment pitch. That is precisely why it repays a careful read. A group that has already decided to use Hainan as a staging point for regional distribution has, in practice, already accepted the fiscal framework; what it now needs is to know how goods move, and by what paperwork. Those are the questions this notice answers, and they are the questions that determine whether a warehouse runs smoothly or spends its days explaining itself.

What “first line” means for bonded cargo

The closure framework uses two directional terms. The first line is the boundary between overseas and the island. The second line is the boundary between the island and the mainland. Duty, licence and inspection questions cluster at those two lines, because that is where a customs territory begins or ends.

The notice’s first provision deals with a movement that crosses neither line. Goods come in from overseas and are placed in bonded storage inside one of three types of premises: a customs special supervision area, a bonded logistics centre or a bonded warehouse. Later, instead of being exported or sent to the mainland, they move to another area of the island. On the face of it, that is a domestic movement inside a single customs territory. But because the island has its own closure arrangements, the destination area may be governed by closure policy documents that assume goods have just arrived from overseas.

The notice resolves this by directing that such goods, when they enter other areas of the port, are handled by reference to first-line import and apply the requirements of the closure policy documents. The operative phrase is “by reference to” rather than “deemed to be”. The drafters are not reclassifying the goods or creating a legal fiction that they never entered. They are telling the operator and the local customs office which set of documents to work from.

The provision then closes the door on any wider reading. Goods other than those described continue to be managed under the rules currently in force. So the notice is not a general liberalisation of internal movement. It is a targeted answer for bonded cargo that has not been touched since it was stored.

It is worth pausing on the fact that all three premises types are named together. A customs special supervision area, a bonded logistics centre and a bonded warehouse occupy different positions in the supervision architecture, and an operator familiar with one does not automatically understand the others. By listing all three in a single clause, the notice signals that the operative test is bonded status rather than the shape of the enclosure. That is a useful signal for a group deciding where to site a new facility: the notice does not push the decision toward one form over another, and the choice can be made on commercial and logistics grounds.

There is a practical reason the answer had to be given in this form. Bonded storage exists precisely so that goods can be held without duty being settled, and the commercial logic of a distribution hub depends on being able to move stock to where the buyer is. If every internal transfer required the goods to be treated as a fresh import, the bonded model on the island would lose much of its point. If every internal transfer were simply waved through, the closure arrangements would be undermined. The notice picks a middle course: honour the bonded status, but only while the goods remain in the condition in which they were stored.

The three conditions that must all hold

The provision is written as a single sentence with three cumulative conditions. All three must be satisfied. Fail any one and the goods fall back into the ordinary rules.

The first condition concerns where the goods are. They must be held in bonded storage inside a customs special supervision area, a bonded logistics centre or a bonded warehouse. These are the three named premises types. A yard, a general warehouse outside supervision, or a factory store is not on the list. The condition is about the legal status of the storage location, not about the physical security of the site.

The second condition concerns what has happened to the goods. There must have been no circulation, processing, testing, repair, blending or any other circumstance that changes the state of the goods. The list is illustrative rather than exhaustive — the closing words “and other circumstances of any kind that change the state of the goods” make that explicit. So the test is functional: has the goods’ condition altered since it was stored? An operation that leaves the goods exactly as they were does not break the chain. An operation that changes them does, whether or not it appears in the list.

The third condition concerns where the goods are going. The destination must be another area of the free trade port. Movement to the mainland is not covered here; that is a second-line question governed by a different set of documents. Movement back overseas is an export. The notice is only about the internal leg.

Read together, the three conditions describe a fairly narrow corridor. Cargo enters from overseas, goes into bond in a recognised premises, is not touched, and is then transferred to another point on the island. That is the case the notice was written for. Anything more elaborate — a blend, a test, a repair, a repack that changes the goods — steps outside it and the operator must look to the general rules and to whatever specific policy covers the operation in question.

Operators should also note what the notice does not say. It does not require the goods to be sold, nor does it require a buyer to be identified in advance. It does not impose a time limit on how long the goods may sit in bond before the transfer. Those matters, if they are regulated at all, are regulated elsewhere.

Where the corridor ends: three situations

Abstract conditions become easier to apply when they are run against concrete operations. Three recur often enough in bonded practice to be worth spelling out. In each, the question is the same — has the goods’ state changed — but the answer is not always intuitive.

The first is blending. Liquid bulk, agricultural commodities and some chemical inputs are frequently stored in bond precisely so that different parcels can be combined to meet a buyer’s specification. Blending is named in the notice as a state-changing operation, and it is easy to see why: after blending, the consignment is no longer the consignment that entered. The customs identity of the goods has been altered, and the record that travelled with the original parcels no longer describes what is in the tank. An operator who blends in bond and then moves the result to another part of the island is outside the corridor, however clean the original clearance was.

The second is repair and testing. A bonded maintenance or quality-control operation takes goods that entered in one condition and returns them in another, or at least establishes something about them that was not established before. Both are named. This is the case that most often surprises operators, because repair and testing are services rather than manufacturing, and the commercial logic feels like an extension of storage. The notice does not draw that distinction. What matters is the effect on the goods, not the label on the contract.

The third is the consignment that is split. Here the answer depends on what splitting involves. If a pallet is broken down into cases and the cases are the same goods in the same condition, with only the handling unit changed, the argument that nothing has changed is available. If the split involves repacking into retail packaging, relabelling that alters the declared description, or any process that touches the goods themselves, the argument becomes much harder. The dividing line is the condition of the goods, and a pack that changes them falls on the far side.

There is a fourth situation that is not really an exception but is often confused with one: the goods leave the island for the mainland. That is a second-line movement, governed by the second-line documents, and the first provision of this notice has nothing to say about it. An operator who assumes that a clean bonded file automatically carries a consignment across the second line is reading the notice for more than it says.

What “no repeated inspection” saves

The second sentence of the first provision is short and, in day-to-day terms, probably the most valuable: where quarantine, inspection and verification of licence documents have already been completed, they are not carried out again.

Consider what that means for a consignment that entered Hainan from overseas, cleared quarantine and inspection at the first line, had its permits checked, and went into bond. When it later moves to another area of the island, the receiving end would ordinarily want to satisfy itself that the regulatory formalities had been met. Under the notice, it does not repeat them. The file travels with the goods.

The saving is measured in three currencies. Time is the obvious one: a second round of inspection means a second appointment, a second queue, a second release. Cost is the second: inspection fees where they apply, but more often demurrage, storage beyond the free period, and the labour of handling the consignment twice. The third is condition. Every additional handling event is a chance for damage, and for temperature-controlled cargo it is a chance for a break in the cold chain.

The wording matters as much as the benefit. The notice says the measures are not repeated; it does not say the goods are exempt. A measure that was never carried out in the first place is not covered, and a measure that was carried out incompletely is not cured. The relief assumes a clean file. Where the original clearance was partial, or where a permit was issued subject to a condition that has not yet been discharged, the operator should expect the gap to be closed rather than overlooked.

For that reason the operational discipline the notice implies is documentary. The relief is available to the operator who can show what was already done. Certificates, inspection records, release notices and permit numbers should travel with the consignment or be retrievable at short notice, and the internal transfer record should cross-reference them. A warehouse that cannot produce the first-line paperwork will find that the second-line or internal checkpoint simply starts again from the beginning.

The record that makes the rule work

Both substantive provisions in the notice are conditional, and both conditions are proved by documents. That is not an accident of drafting. A rule that grants a benefit on the basis that something has not happened, or that something has already been done, can only be administered against a file.

Three records carry most of the weight. The first is the bonded entry record: what entered, when, from where, in what quantity, under which declaration, and with which permits. This is the document that establishes the starting condition against which everything later is measured. The second is the state log: an internal record, kept by the operator, of everything done to the consignment while it was in bond. Its value is that it is contemporaneous. A log written at the end of the storage period, reconstructing what happened, is worth much less than one written as events occurred. The third is the transfer note: the document that links the origin premises to the destination area, names the date, and cross-references the first two.

Where the notice’s relief depends on prior measures having been completed, the entry record and the permits it cites do the work. Where the relief depends on nothing having been done, the state log does it, supported by the absence of any processing, testing or repair instruction in the operator’s own systems. Both are more persuasive when they were created before anyone asked.

There is a further, quieter benefit to keeping these records well. The risk-screening mechanism described in the notice draws on information shared across departments. A consignment whose bonded record, state log and transfer note agree is easy to clear and uninteresting to a risk model. A consignment where one of the three is missing or inconsistent invites a question, and a question at the point of movement is exactly what the notice is designed to avoid.

The second-line rule for island sales

The notice’s second substantive provision moves from storage to manufacturing. Where an encouraged-category industrial enterprise in the port produces goods that contain imported materials and components, and where processing on the island has raised the value-added by 30 per cent or more, those goods, when sold within the island, are handled by reference to the processing value-added policy documents that apply to second-line entry into the mainland.

Three elements have to be present. The producer must be an enterprise in an encouraged industry — the classification that determines whether the closure’s industrial preferences apply at all. The goods must contain imported materials or components; entirely domestic input does not engage the rule. And the value added by processing on the island must reach or exceed 30 per cent. That threshold is the same one used for second-line entry to the mainland, and the notice borrows the machinery rather than inventing a parallel test.

What changes is the destination. Until now, the processing value-added rule was associated with goods leaving the island for the mainland. The notice extends the same reference point to goods that stay: a sale to a buyer on the island is now handled as though the goods had gone through the second line, for the purposes of the processing value-added policy documents. For a manufacturer whose customers are Hainan hotels, retailers, builders or public projects, that removes a gap between the export-facing and domestic-facing sides of the business.

The provision is drafted as a reference, not a grant. It says the processing value-added policy documents apply by reference; it does not restate the treatment those documents provide, and it does not create an independent entitlement. An operator who wants to know the actual fiscal outcome of an island sale must therefore read the underlying processing value-added documents, and must be able to substantiate the 30 per cent calculation in the way those documents require.

The first of the three elements deserves separate attention, because it is the one most often assumed rather than checked. Encouraged-category status is a classification of the enterprise’s business, not a description of what it makes on any given day. A company that sits inside the catalogue for one product line may find that a second line falls outside it. The notice does not extend the reference to island sales to enterprises that are not in the encouraged category, and it does not extend it to goods that contain no imported materials at all. Both points should be settled before a pricing decision is built on the assumption that the rule applies.

The commercial consequence of the reference is easiest to see at the invoicing stage. A sale to a buyer on the island that relies on the notice should be able to point to the calculation behind it — the imported input values, the processing costs incurred on the island, and the resulting proportion — in a form that a reviewer can follow without reconstructing the business. Where the same product is also sold to the mainland, keeping one methodology across both channels is simpler than maintaining two, and it reduces the risk of the two sets of figures drifting apart.

That calculation is where most of the work sits. Value-added is not a matter of assertion; it is a computation over input values, processing costs and output values, and it has to survive scrutiny. Enterprises that already run the calculation for mainland-bound sales will have the methodology in place and can extend it to island sales. Enterprises that have never had to compute it should build the model before, not after, the first island invoice is issued.

Who implements, who supervises

The notice divides implementation between two levels. Provincial departments carry out their parts according to their assigned responsibilities. Below them, the finance, development and reform, and commerce departments of the cities and counties exercise territorial duties: interpreting the policy, publicising it, and providing service support to enterprises in their area.

That division matters for anyone seeking guidance. The provincial text is short and leaves the operational detail to the levels that deal with individual consignments and individual enterprises. A question about whether a particular warehouse qualifies, or how a particular transfer should be documented, is most likely to be answered by the municipal or county bureau rather than by the provincial drafters.

Alongside implementation sits a risk-control mechanism with three layers. The first is routine screening: risks are to be identified and assessed on an ongoing basis rather than in response to incidents. The second is analysis, judgement and early warning — the machinery for spotting a pattern before it becomes a loss. The third is prevention and handling, which is where an identified risk is actually dealt with.

The notice also requires information sharing and coordinated action across departments, which is the practical precondition for any of the above. A closure regime that depends on knowing what is in bond, where it came from and where it went cannot function if each department holds a fragment of the picture. And where a major risk or hidden danger is identified, it must be reported immediately through the prescribed procedures and channels. The emphasis on immediacy, and on using the established channels rather than ad hoc ones, is worth noting: it signals that escalation is expected to be fast but orderly.

For operators, the supervisory architecture has a straightforward implication. The reliefs in the notice are premised on the goods being what the file says they are. A risk-screening system that works across departments will notice a consignment whose bonded record and internal transfer record do not match. The compliance posture that makes the notice useful is therefore the same posture that makes an operator uninteresting to a risk model: complete records, consistent declarations, and no gaps between what was stored and what moved.

The two-level split also has a timing consequence worth planning around. Provincial documents arrive first and set the principle; local practice develops afterwards, city by city. A group with facilities in more than one city should expect that the same transfer may be handled with slightly different expectations about paperwork in each place, at least in the early period, and should build its internal standard to the more demanding of the two rather than to the more convenient. Where a group runs a single hub, the relevant standard is the one applied where that hub sits, and it is worth confirming in writing before the first transfer rather than after.

What to ask the local bureau

Because the notice is short and the implementing levels are close to the cargo, most of the practical work happens in a conversation rather than in a reading of the text. Five questions are worth putting in writing, early, to the finance, development and reform, or commerce bureau of the city or county where the premises sit.

First, confirm the classification of the premises. The notice names three types, and the treatment of a transfer depends on which one the goods are in. A warehouse that has been described loosely in internal documents should be re-checked against its formal status before a transfer is planned around it.

Second, describe the intended operation and ask whether it is regarded as changing the state of the goods. This is the question on which most cases turn, and it is better asked in advance, with the process flow attached, than discovered at the point of movement. A written answer, even an informal one, is worth keeping.

Third, ask what documentation the local level expects for an internal transfer. The notice sets a principle; the form of the transfer note, the evidence expected for the state log, and the way prior inspection results should be referenced are matters that will be settled locally.

Fourth, ask whether the destination area has requirements of its own. The notice governs the movement by reference to first-line import and the closure policy documents; the area receiving the goods may have its own operational expectations, and a transfer that satisfies the origin may still need something at the destination.

Fifth, ask how a discrepancy should be handled. If the file and the cargo do not match — a missing permit, an unrecorded handling operation — the useful thing to know in advance is whether the matter can be regularised and how, rather than discovering the answer while the consignment is standing still.

None of these questions has a single national answer. They are local questions about a local notice, and the operators who get the most out of it will be the ones who asked them before the first movement rather than after.

Practical checklist for bonded operators

  • Confirm which of the three premises types your goods actually sit in, and keep the documentary proof of that status. A bonded warehouse, a bonded logistics centre and a customs special supervision area are distinct, and the notice names all three but does not treat them as interchangeable in every other respect.
  • Map the movement before it happens. Identify the origin premises, the destination area and the route, and record the date. The notice governs a movement to another area of the port, so a movement to the mainland or back overseas needs a different file.
  • Keep a state-of-goods log. If nothing has been done to the consignment since storage, say so in writing and be able to show it. If something has been done, classify it against the list in the notice — circulation, processing, testing, repair, blending, or anything else that changes the goods — and assume the exception applies until you have confirmed otherwise.
  • Pull the first-line file forward. Quarantine records, inspection results and licence verification should be indexed and linked to the internal transfer, because the “no repetition” benefit depends on being able to prove what was already done.
  • For island sales, build the value-added model early. Confirm encouraged-industry status, isolate the imported content, and document the calculation that takes you to 30 per cent or above, in the format the processing value-added documents expect.
  • Read the underlying closure documents rather than the notice alone. The notice is a pointer; the treatment it points to lives in the policy documents it references.
  • Watch for follow-up guidance from provincial and municipal departments, particularly on documentation standards for internal transfers. The notice sets the principle; the forms will come from the implementing levels.

None of this requires a new business model. It requires that the file matches the cargo, and that the operator knows in advance which of the notice’s corridors a given movement falls into. For a distribution hub, that is a modest administrative discipline in exchange for a rule that no longer has to be inferred.

It is also worth reading the notice for what it reveals about how the closure will be administered. A framework that is willing to answer a narrow question precisely, by reference to documents already in force rather than by inventing a parallel regime, suggests that subsequent questions will be handled the same way: one movement type at a time, in short documents, with the operational detail left to the levels that see the cargo. Operators who keep their files in order and their questions specific will find that pattern easier to work with than one that produces a single comprehensive code and then amends it.

Sources

  • 海南省人民政府,《关于海南自由贸易港全岛封关运作有关管理事项的通知》(琼财税〔2026〕986 号),2026-11-02。https://www.hainan.gov.cn/hainan/0101/202611/926377e2319c47eb8ff62e034689d5a0.shtml
  • 海南省人民政府,《海南自由贸易港全岛封关运作有关管理事项政策解读》,2026-11。https://www.hainan.gov.cn/hainan/tingju/202611/9a26d8be2ecf4cada93fd4ea210a6809.shtml
  • 三亚市中级人民法院(转载),《海南自由贸易港全岛封关运作有关管理事项通知及政策解读》,2026-11。https://syzy.hicourt.gov.cn/article/detail/2026/11/id/9560564.shtml
  • 中国经济网,《海南明确全岛封关运作有关管理事项》,2026-11-03。https://www.ce.cn/xwzx/gnsz//gdxw/202611/t20261103_3281236.shtml

海南全岛封关:保税货物如何在”一线”与”二线”之间流转

这份通知为什么值得看

2026 年 11 月 2 日,海南省财政厅、海南省发展和改革委员会、海南省商务厅联合印发《关于海南自由贸易港全岛封关运作有关管理事项的通知》,文号为琼财税〔2026〕986 号。通知自公布之日起实施,没有过渡期,也没有另一份实施口径需要等待。

这份通知的依据,是国家发展改革委办公厅等部门印发的《关于做好海南自由贸易港全岛封关运作有关工作的通知》,文号为发改办区域〔2026〕754 号。后者布置任务,前者就一组相当具体的货物流转作出交代。通知全文没有创设新的税种、新的商品目录,也没有为投资者设置新的资格条件。它做的是一件很窄的事:当货物跨越岛内的一条内部边界时,决定适用哪一套现成规则。

这个问题听起来不大,实际分量不轻。全岛封关之后,海南在一组被明确界定的用途上,被当作与内地关境相区别的区域对待。一旦如此,货物的每一次移动都有了方向:从境外进来、往内地出去,或者在岛内从一个区域转到另一个区域。前两个方向在封关制度框架公布时已有交代,第三个方向——岛内流转——正是这份通知落笔的地方。

对在岛上经营保税仓库、区域分拨中心或轻加工线的外资集团来说,这条内部边界不是抽象概念。货物从境外运来,存放在保税状态;其中一部分后来卖给或转给岛内其他区域的买方:酒店集团、零售商、施工承包商、制造商。在通知出台之前,经营者只能靠类推去判断这次转移算不算一次新的进口,以及随之而来的单证后果。通知用一条规则替换了类推。

文件包含两条实体规定和两条事务性规定。第一条实体规定管的是保税货物离开保税场所、进入岛内其他区域。第二条管的是在岛上生产、在岛上销售。事务性规定一条分配落实责任,一条布置风险防控机制。本文余下的内容,都从这四个要素展开。

正因为这份通知是管理性的、而非财税性的,它很容易被跳过。里面没有醒目的税率,没有新的可享受优惠的业务目录,也没有哪句话能写进招商材料。恰恰因为如此,它值得细读。一个已经决定把海南当作区域分拨中转点的集团,实际上已经接受了那套财税框架;它此刻需要知道的,是货怎么走、凭哪些单证走。这些问题正是通知回答的问题,也正是决定一间仓库是顺畅运转、还是整天忙于解释自己的问题。

“一线”对保税货物意味着什么

封关制度使用两个方向性概念。”一线”是境外与海南之间的边界,”二线”是海南与内地之间的边界。关税、许可证件、检验检疫的问题都聚拢在这两条线上,因为关税区的起点与终点在那里。

通知的第一条实体规定,处理的却是一次两条线都不跨越的移动。货物从境外进来,存入三类场所之一并处于保税状态:海关特殊监管区域、保税物流中心、保税仓库。此后,它既没有复运出境,也没有进入内地,而是转到岛内另一个区域。表面看,这是同一关税区内的国内移动;但由于全岛封关有自己的制度安排,目的地所在区域可能适用那些”假定货物刚从境外抵达”的封关政策文件。

通知的解法是:这类货物后续进入自贸港其他区域的,参照”一线”进口办理,适用封关政策文件的要求。要害在”参照”二字,而不在”视同”。起草者没有给货物重新定性,也没有拟制一个”从未入境”的法律事实;他们只是告诉经营者和属地海关,该按哪一套文件办。

紧接着,通知把口子收住:上述情形以外的货物,继续按现行规定管理。所以这不是对岛内流转的普遍放开,而是针对”入区后未被触动过的保税货物”给出的一条定向答案。

三类场所被并列写进同一句,这一点值得停一下。海关特殊监管区域、保税物流中心、保税仓库在监管架构里所处的位置并不相同,熟悉其中一类,并不等于自动理解另外两类。通知把三者一并列出,等于说明:起作用的判断标准是保税状态本身,而不是围栏长什么样。对一个正在决定把新设施设在哪里的集团来说,这是个有用的信号——通知并不把选址往某一种形态上推,选择可以按商业与物流的需要来做。

答案必须写成这个样子,有它的现实原因。保税仓储存在的意义,本就是让货物在不结税的状态下被持有;分拨中心的商业逻辑,也依赖于能把库存挪到买方所在之处。如果每一次岛内转移都要当作一次全新进口,岛上的保税模式就失去了大半意义;如果每一次岛内转移都直接放行,封关安排又会被架空。通知走的是中间路线:承认保税状态,但只在这批货物仍保持入库时状态的前提下承认。

必须同时成立的三项条件

这条规定写成一个长句,里面叠着三项条件,三者必须同时满足。任何一项不成立,货物就回到一般规则里去。

第一项条件关乎货物在哪里。它必须存放在海关特殊监管区域、保税物流中心或者保税仓库,处于保税仓储状态。这是被点名的三类场所。堆场、监管区之外的一般仓库、工厂的自用料仓,都不在名单上。这项条件看的是存放场所的法律属性,不是场地的物理安保水平。

第二项条件关乎货物经历过什么。不得发生流转,也不得发生加工、检测、维修、混兑等各类改变货物状态的情形。这份列举是示例性的,收尾的”等各类改变货物状态情形”把话说明白了。所以判断标准是功能性的:入库之后,货物的状态有没有被改变?没有改变状态的操作,不打断这条链条;改变了状态的操作,无论是否出现在列举里,都会打断它。

第三项条件关乎货物去哪里。目的地必须是自贸港内的其他区域。运往内地不在此列,那是”二线”的问题,由另一组文件管;复运出境属于出口。通知只管岛内这一段。

三项条件合起来,划出的是一条相当窄的通道:从境外进境,进入被认可的场所保税存放,期间未被触动,随后转到岛上另一点。这就是通知为之而写的情形。更复杂的动作——混兑、检测、维修、改变货物形态的再包装——都落在通道之外,经营者需要回到一般规则,并查看针对该业务的具体政策。

还有一点值得留意:通知没有要求货物必须已经售出,也没有要求事先确定买方;它没有对货物在保税状态下可以存放多久才发生转移设定时限。这些事项如果另有规定,规定在别处。

通道在哪里断开:三种情形

抽象条件放到具体作业里,才更容易用。保税实务中有三种情形出现频率足够高,值得单独说清。三种情形面对的是同一个问题——货物状态有没有改变——但答案并不总是直觉能给的。

第一种是混兑。液体散货、农产品以及部分化工原料之所以常年在保税状态下存放,正是为了让不同批次的货能够合并,达到买方要求的规格。通知把混兑列为改变货物状态的操作,理由也直观:混兑之后,这一票货不再是入库时那一票货。货物的海关身份被改写了,随原始批次而来的那套记录,已经不能描述罐里现在装着什么。在保税状态下完成混兑、再把结果转到岛内其他区域的经营者,落在通道之外,无论原始验放多干净。

第二种是维修与检测。保税维修或质量控制作业,把入库时某一状态的货物,以另一状态交还,或者至少确立了此前未曾确立的某种结论。这两项都在列举之中。这类情形最容易让经营者意外,因为维修与检测在商业上属于服务,而不是制造,感觉像是仓储的延伸。通知并不作这个区分。起作用的是对货物的实际影响,不是合同上的名目。

第三种是拆票。答案取决于拆的是什么。把整板拆成箱,箱里还是同一批货、同一状态,改变的只是搬运单元,那么”什么也没变”这个说法是站得住的。如果拆的过程中重新包装成零售规格、更换标签以致申报品名发生变化,或者任何触及货物本身的处理,这个说法就难得多。分界线在货物状态,改变状态的包装落在另一侧。

还有第四种情形,严格说不是例外,却常被误当成例外:货物离开海南运往内地。那是一次”二线”移动,由”二线”文件管,通知的第一条实体规定对此不作任何交代。以为一份干净的保税档案就能自动把货物送过”二线”的经营者,是从通知里读出了它没有写的东西。

“不再重复实施”省下的是什么

第一条实体规定的第二句很短,但在日常操作层面可能是最值钱的一句:此前已经完成检疫、检验、许可证件核验等管理措施的,不再重复实施。

设想一票货物从境外进入海南,在”一线”完成了检疫与检验,许可证件也核验过了,随后入库保税。当它后来转到岛内另一区域时,接收端通常想自行确认监管手续是否齐备。按通知,它不再重复做一遍——文件跟着货物走。

省下来的东西有三种计价方式。时间最直观:第二轮检验意味着第二次预约、第二次排队、第二次放行。成本其次:确有检验费用的场合是费用,更常见的是滞箱费、免堆期之外的仓储费,以及把货物经手两遍的人工。第三是货物状态:每多一次搬倒,就多一次货损机会;对温控货物而言,还多一次冷链中断的机会。

措辞与好处同样重要。通知说的是”不再重复实施”,不是”免于实施”。一开始就没做的措施,不在覆盖范围内;做得不完整的措施,也不会因此补齐。这项便利的前提是档案干净。原始验放本身是部分的,或者许可证件附带了尚未履行的条件,经营者应当预期缺口会被补上,而不是被忽略。

正因如此,通知隐含的操作纪律是单证纪律。便利属于能够证明”此前做过什么”的经营者。证书、检验记录、放行通知、许可证件编号,应当随货同行,或者能在短时间内调取;岛内转移记录应当与这些材料互相勾连。拿不出”一线”手续的仓库,会发现下一道关口只能从头再来。

让规则运转起来的那份档案

通知的两条实体规定都是附条件的,而两个条件都要靠单证来证明。这不是起草上的偶然。一条以”某事没有发生”或者”某事已经做过”为由给予便利的规则,只能对着档案来执行。

三份记录承担了大部分重量。第一份是保税入库记录:进了什么、何时、从哪来、数量多少、凭哪份申报、附哪些许可证件。这份文件确立了此后一切判断所依据的初始状态。第二份是状态台账:经营者自己留存、记载货物在库期间被动过什么的内部记录。它的价值在于同步——在存储期末尾凭回忆补写的台账,价值远低于随事件发生逐笔写下的台账。第三份是转移单:把起运场所与目的区域连起来、写明日期、并与前两份互相引用的文件。

通知的便利若依赖于”此前措施已完成”,起作用的是入库记录及其引用的许可证件;若依赖于”什么也没做”,起作用的是状态台账,再加上经营者自身系统里确实找不到任何加工、检测或维修指令这一事实。两者在没人追问之前就已形成,说服力最强。

把这些记录做扎实,还有一层不声张的好处。通知所描述的风险排查机制,依赖跨部门共享的信息。保税记录、状态台账、转移单三者一致的货物,验放顺畅,对风险模型而言也不显眼。三者之中缺一份、或者彼此对不上,就会招来一个问题,而在移动环节被问问题,正是通知想要避免的事。

岛内销售的二线规则

通知的第二条实体规定,从仓储转向制造。自贸港内属于鼓励类产业的企业,生产的货物含有进口料件,且在自贸港内加工增值达到或者超过百分之三十的,这些货物在岛内销售的,参照经”二线”进入内地所适用的加工增值政策文件要求办理。

三个要素必须同时具备。生产者必须是鼓励类产业企业——这个归类决定了封关的产业优惠是否适用。货物必须含有进口料件,纯境内料件不触发这条规则。加工增值必须达到或超过百分之三十。这个门槛与”二线”进入内地所用的门槛是同一个,通知借用现成机制,而不是另造一套并行的算法。

变化发生在目的地这一端。此前,加工增值规则与”货物离开海南运往内地”联系在一起;通知把同一个参照点延伸到了留在岛内的货物:向岛内买方销售,在加工增值政策文件的意义上,按已经过”二线”处理。对客户是海南本地酒店、零售商、建筑商或公共项目的制造商来说,这抹平了外向业务与内销业务之间的一道缝。

条文写的是”参照”,不是”授予”。它说加工增值政策文件参照适用,没有复述那些文件给的是什么待遇,也没有创设一项独立的权利。因此,想知道一次岛内销售的实际财税结果,必须去读底层的加工增值文件,并且必须按那些文件要求的方式,把百分之三十的测算做实。

三个要素中的第一个,值得单独提一句,因为它最常被默认,而最少被核对。鼓励类产业身份是对企业业务的归类,不是对某一天在产什么的描述。一家企业在某条产品线上落在目录之内,另一条产品线未必也在。通知没有把参照适用延伸到不属于鼓励类产业的企业,也没有延伸到完全不含进口料件的货物。这两点在依据”规则适用”作出定价决定之前,都应当先落定。

这项参照在商业上的后果,最容易在开票环节看出来。一笔依赖通知的岛内销售,应当能够指向它背后的测算——进口料件价值、在岛上发生的加工成本、由此得出的比例——并且以复核者不必重建整个业务就能看懂的形态呈现。同一产品如果同时销往内地,两个渠道共用一套方法,比维护两套更简单,也能减少两组数字日后走样的风险。

测算才是大部分工作量所在。增值不是一句声明,它是对投入价值、加工成本与产出价值的计算,并且要经得起核查。已经为内销内地做过这套测算的企业,方法学是现成的,扩用到岛内销售即可;从未算过的企业,应当在开出第一张岛内发票之前把模型搭起来,而不是之后。

谁来落实,谁来监督

通知把落实分成两层。省直单位按职责分工落实各自那部分。其下,市县财政、发改、商务部门履行属地职责:做好政策解读、宣传引导和服务保障。

这个分工对寻求指引的人有意义。省级文本很短,操作细节留给直接面对具体货物、具体企业的层级。某个仓库是否属于那三类场所、某次转移应当怎样留痕,这类问题多半由市县部门而不是省级起草者回答。

与落实并行的是一套三层风险防控机制。第一层是常态化排查:风险要持续识别、持续评估,而不是等出了事再回头看。第二层是研判预警:在苗头变成损失之前发现规律的机制。第三层是防控处置:已经识别的风险如何实际处理。

通知还要求跨部门信息共享与协同联动,这是上述任何一层能够运转的现实前提。一个依赖”知道什么在保税、从哪来、到哪去”的封关制度,如果每个部门只握着一块碎片,是转不动的。而一旦发现重大风险隐患,必须第一时间按规定程序和渠道上报。”第一时间”与”按规定渠道”并提,值得注意:它表明升级要快,但也要有序。

对经营者而言,这套监管架构的含义很直接。通知给的便利,前提是货物与档案一致。一个跨部门运转的排查系统,会注意到保税记录与岛内转移记录对不上的那票货。让这份通知变得有用的合规姿态,恰恰也是让经营者对风险模型而言”不显眼”的姿态:记录完整、申报一致、存放与移动之间没有缺口。

两级分工还带来一个时序上的后果,值得提前安排。省级文件先到,定下原则;地方做法随后形成,且是一地一地形成。在不止一个城市设有设施的集团,应当预期同一类转移在各地对单证的要求会略有差别,至少在初期如此;内部标准宜按两者中更严的那个来定,而不是按更省事的那个。只有一个枢纽的集团,标准就是枢纽所在地执行的那一套,而这套标准最好在第一次转移之前书面确认,而不是之后。

该向属地部门问什么

通知很短,落实层级又贴近货物,所以实务工作多半发生在一场对话里,而不是在文本阅读里。有五个问题值得早早用书面方式,提给场所所在市县的财政、发改或商务部门。

第一,确认场所的归类。通知点了三类,而一次转移如何对待,取决于货物身处哪一类。内部文件里一直写得含糊的仓库,在围绕它安排转移之前,应当对照其正式状态重新核一遍。

第二,把打算做的作业描述清楚,问它是否被视为改变货物状态。多数个案就卡在这个问题上,提前带着工艺流程图去问,好过在移动环节才发现。得到的答复,哪怕是口头的,也值得留档。

第三,问属地层级对岛内转移要求哪些单证。通知给的是原则;转移单的格式、状态台账要留哪些证据、此前的检验结果应当如何引用,这些由地方定。

第四,问目的区域是否有自己的要求。通知是参照”一线”进口和封关政策文件来管这次移动的;接收地可能另有操作上的期待,满足了起运地的要求,未必等于在目的地也已齐备。

第五,问出现不一致时怎么处理。档案与货物对不上——缺一份许可证件、漏记一次处理作业——事先知道能否补正、怎么补正,比等货物停在那里时才知道答案要有用得多。

这些问题没有全国统一的答案。它们是关于一份地方文件的地方性问题;把这份通知用足的人,多半是在第一次移动之前就问过,而不是之后。

保税经营者的实操清单

  • 先确认货物究竟存放在哪一类场所,并留存能证明该状态的文件。保税仓库、保税物流中心、海关特殊监管区域是三种不同存在,通知三者都点名,但在其他方面并不等同视之。
  • 转移之前先画路线。标明起运场所、目的区域、路径,并记录日期。通知管的是进入自贸港其他区域的移动;运往内地或复运出境,需要另备一套文件。
  • 建立”货物状态台账”。入库后未做任何处理,就书面写下来并能举证;做过处理,就对照通知的列举归类——流转、加工、检测、维修、混兑,或者任何改变货物状态的其他操作——在确认不属于例外之前,先按例外对待。
  • 把”一线”档案往前调。检疫记录、检验结果、许可证件核验材料应当编好索引,与岛内转移记录相互关联,因为”不再重复”这项好处,取决于能否证明此前做过什么。
  • 涉及岛内销售的,尽早搭好增值模型。确认鼓励类产业身份,单独剥离进口料件价值,并按加工增值文件要求的口径,把测算到百分之三十以上的过程记录下来。
  • 读底层的封关文件,而不只是读这份通知。通知是路标,它指向的待遇写在被它引用的政策文件里。
  • 留意省市两级后续的操作指引,尤其是岛内转移的单证标准。通知给的是原则,表格会从落实层级出来。

以上都不要求改变商业模式,只要求档案与货物对得上,并且经营者事先清楚:某一次具体移动,落在这份通知划出的哪一条通道里。对一个分拨中心来说,这点行政纪律换来的,是一条不必再靠推测的规则。

这份通知也值得从它透露的施政方式去读。一套愿意把窄问题答准、并且靠引用现行文件而不是另造并行制度来作答的框架,暗示后续问题会以同样的方式处理:一次一类移动,用不长的文件,操作细节留给看得见货物的层级。把档案理清、把问题问得具体的经营者,会发现这种路数比”先出一部大而全的法规、再反复修订”更好用。

来源

  • 海南省人民政府,《关于海南自由贸易港全岛封关运作有关管理事项的通知》(琼财税〔2026〕986 号),2026-11-02。https://www.hainan.gov.cn/hainan/0101/202611/926377e2319c47eb8ff62e034689d5a0.shtml
  • 海南省人民政府,《海南自由贸易港全岛封关运作有关管理事项政策解读》,2026-11。https://www.hainan.gov.cn/hainan/tingju/202611/9a26d8be2ecf4cada93fd4ea210a6809.shtml
  • 三亚市中级人民法院(转载),《海南自由贸易港全岛封关运作有关管理事项通知及政策解读》,2026-11。https://syzy.hicourt.gov.cn/article/detail/2026/11/id/9560564.shtml
  • 中国经济网,《海南明确全岛封关运作有关管理事项》,2026-11-03。https://www.ce.cn/xwzx/gnsz//gdxw/202611/t20261103_3281236.shtml

China’s Segmented Pharmaceutical Production Rules Move From Pilot to Standing Procedure

  • The National Medical Products Administration issued a consultation draft on 13 November 2026 that would convert segmented pharmaceutical production from a case-by-case pilot into a standing procedure, with comments due by 30 November 2026.
    国家药监局于 2026 年 11 月 13 日发布征求意见稿,拟把药品分段生产从”一事一议”的试点转为常规程序,反馈截止 2026 年 11 月 30 日。
  • The draft runs to six parts and twenty-three articles and rests on the revised Regulation for the Implementation of the Drug Administration Law, in force since 15 May 2026, while the biologics pilot it supersedes runs out on 31 December 2026.
    征求意见稿共六部分二十三条,上位依据是 2026 年 5 月 15 日起施行的新修订《药品管理法实施条例》;它所接替的生物制品试点将于 2026 年 12 月 31 日到期。
  • Four categories of product may be split across sites, and the fourth — an originator drug already approved in China but made abroad, with some or all steps moved onshore — is the new addition.
    可分段生产的品种共四类,其中第四类为新增:已取得境内上市许可、在境外生产、部分或全部工序转移至境内分段生产的原研药品。
  • At least one side of a sterile arrangement must hold three years of commercial sterile manufacturing experience in the same dosage form, and only two of the four relaxations listed in the 2025 No. 134 announcement are carried over.
    无菌药品安排中,委托方与受托方至少一方须具备同剂型三年以上商业化生产经验;2025 年第 134 号公告所列四项放宽情形中,仅两项被沿用。
  • Cross-border commissioning opens in one direction only: a foreign Marketing Authorization Holder may move steps into China, while a domestic holder may not in principle commission manufacturing abroad, save for the fourth category.
    跨境委托只单向开放:境外持有人可以把工序放到境内,境内持有人原则上不得委托境外生产,第四类原研药除外。
  • Antibody-Drug Conjugate intermediates that are not managed as drugs or as active pharmaceutical ingredients are excused from holding a drug manufacturing licence, but still face GMP compliance, inspection and a licence annotation.
    抗体偶联药物中不按药品或原料药管理的中间产品,可免于办理药品生产许可证,但仍须符合 GMP、接受检查并在许可证上载明。
  • The obligations land squarely on the holder: two or more technical staff stationed on site for each product in production, one full-system GMP audit of every site each year, and a quality risk review chaired by the legal representative or the enterprise head.
    义务落在持有人身上:每个在产品种驻厂技术人员不少于两名,每年对全部生产场地至少开展一次全体系 GMP 审核,并由法定代表人或企业负责人主持质量风险会商。

China’s Segmented Pharmaceutical Production Rules Move From Pilot to Standing Procedure | 中国药品分段生产:从试点走向常规程序

Why this matters now

On 13 November 2026 the general office of the National Medical Products Administration published a consultation draft titled Announcement on Matters Concerning Segmented Production of Entrusted Drugs. Comments close on 30 November 2026 and go to a dedicated mailbox. The text is a draft. Nothing in it binds anyone until the final version is issued, and the final version may differ in wording, in scope, and in the transitional arrangements it attaches to products already in the pipeline.

What makes the draft worth reading now rather than in December is the calendar behind it. The segmented production pilot for biologics opened in October 2024 and closes on 31 December 2026. The revised Regulation for the Implementation of the Drug Administration Law has been in force since 15 May 2026. Between those two dates sits a gap: the Regulation provides the legal basis for splitting manufacturing across sites, but the operational route has been a pilot run on a case-by-case basis, with entry negotiated rather than published. The draft fills that gap by writing the criteria down.

Segmented production, in plain terms, means one product whose manufacturing steps are carried out at more than one site, sometimes by more than one legal entity, under a single quality assurance system that the marketing authorization holder owns. It is not outsourcing in the ordinary sense. The holder does not hand over responsibility along with the process; it keeps the responsibility and distributes the work. That distinction drives almost every clause in the draft.

For a foreign group, three features of the draft stand out. The first is the fourth eligible category, which for the first time gives an approved originator product made overseas a route to move some or all of its steps into China without re-registering as a new drug. The second is the direction of the cross-border rule: the door swings inward and, with one exception, not outward. The third is the carve-out for certain antibody-drug conjugate intermediates, which relieves a specific and expensive licensing burden without relieving the quality obligations that sit around it.

Each of those has a commercial consequence. A company that has been running a global supply chain with China as a finishing and packaging site can now contemplate the reverse: bulk or intermediate manufacture onshore, with the regulatory footprint that follows. A company that has been waiting for the pilot to become permanent can plan investment against published criteria rather than against a negotiating position. And a company in the antibody-drug conjugate space can stop treating a mature small-molecule intermediate as if it needed a drug manufacturing licence, provided it can satisfy the conditions attached.

The draft also narrows as it clarifies. New applicants must be the holder’s own development or a development the holder participated in end to end. The first category has no post-approval change route, which means a product that is already on the market and falls only within that category cannot use this announcement to restructure its manufacturing after the fact. Reading the draft as a general liberalisation would misread it. It is a procedural consolidation with a deliberately bounded scope.

From pilot to standing procedure

The pilot that the draft replaces was launched in October 2024 for biologics. Its logic was experimental: take a small number of products, work out how a split manufacturing chain could be supervised, and learn from the cases. That model has real advantages when the regulator is still deciding what the standards should be. It has an obvious disadvantage when a company needs to commit capital: entry depends on a conversation, not on a rule, and the outcome of the conversation is not published.

A standing procedure changes the nature of the decision. Instead of asking whether a product might be allowed, a company asks whether it meets published conditions. The answer becomes auditable, and a negative answer becomes something that can be addressed — by changing the product scope, by changing the site configuration, or by choosing a different route.

The draft is structured as six parts and twenty-three articles. The parts follow the life of an application rather than the structure of the statute: general provisions, eligible products, the application and approval route, the holder’s obligations, cross-border arrangements, and supplementary provisions. That ordering is itself informative. Cross-border arrangements sit in a part of their own, near the end, which reflects the fact that they are treated as a distinct policy question rather than as one more variation on a domestic application.

The legal foundation is the revised Regulation for the Implementation of the Drug Administration Law, effective 15 May 2026. The Regulation settled the principle: a holder that genuinely needs to may entrust qualified enterprises with segmented production, subject to a unified quality assurance system covering the whole process and every site. What the Regulation did not do was specify which products qualify, what an application looks like, how licensing and registration interact, or what happens when a site is outside the country. Those are the questions the announcement answers.

The timing is not accidental. A pilot that expires on 31 December 2026 and a standing procedure that has not yet been finalised in mid-November leave a narrow window. Companies with products in the pilot need continuity; companies outside it need to know whether to prepare an application. The thirty-day comment period is short for a text of this density, which suggests the regulator is working to a fixed schedule and expects comment to be targeted rather than exhaustive.

There is also a signal in what the draft does not do. It does not extend segmented production to every product that could technically be split. It does not create a general right to commission manufacturing abroad. It does not remove the requirement for a drug manufacturing licence except in one defined case. The consolidation is real, but it is a consolidation of a narrow permission, not a broadening of it.

For companies, the practical difference between a pilot and a procedure shows up in the diligence file. Under a pilot, a legal opinion on manufacturing structure could describe the regulator’s practice and little more; under a procedure, it can cite a condition and test the facts against it. That shift is small in words and large in what it lets a board approve, because a condition can be assessed before money is committed, while a practice can only be assessed after a conversation that may or may not happen.

The four eligible categories

The draft lists four categories of product that may be produced in segments. The list is exhaustive, and a product that does not fall within one of the four cannot use the procedure however sensible the manufacturing logic may be.

The first category is innovative drugs whose production process or facilities and equipment carry special requirements. The wording points at products where the manufacturing itself is the constraint: a process that needs dedicated equipment, an environment that cannot be shared, a step that does not fit inside a general-purpose plant. For these products, splitting the chain is not a cost exercise but a feasibility one.

The second category covers drugs and vaccines that departments under the State Council have identified as clinically urgently needed, and drugs and vaccines needed for responding to public health emergencies or for reserve purposes. This is the category that carries the public-interest rationale most visibly. It also carries the most external dependency, because the identification comes from outside the drug regulator.

The third category is multi-valent and multi-component vaccines. The logic here is structural: a combination vaccine may require several antigen components, each with its own manufacturing chain, and consolidating all of them at a single site is not always realistic. Segmentation lets the components be made where they are best made and combined where the combination is validated.

The fourth category is the new one, and it is the one most likely to change behaviour. It covers an originator drug that has already obtained a marketing authorization in China, is manufactured outside the country, and has some or all of its steps transferred onshore for segmented production. In substance this is an onshoring route for products that are already approved. The product does not become a new drug; it becomes a product with a different manufacturing footprint.

The legal gateway for the fourth category is the third item of Article 32 of the Regulation, which leaves room for other drugs designated by the national drug regulator. The draft uses that room. The significance is procedural as much as substantive: it shows that the reserved category is not decorative, and that the regulator intends to use it to solve specific problems rather than to keep a general discretion in reserve.

Two limits sit on top of the four categories, and both point in the same direction. A new application for marketing must concern a product that the holder developed itself or in whose development the holder participated throughout. A licensee that acquired a product and now wishes to restructure its manufacturing does not automatically qualify. And the first category has no post-approval change entry at all: only products within the second, third and fourth categories may apply to change an existing authorization into a segmented arrangement.

The combined effect is a procedure that favours companies with an unbroken development history and a live pipeline. For a group that in-licenses assets into China and then looks for manufacturing flexibility, the draft offers less than a first reading might suggest. For a group that develops in China, or that developed globally and holds the full development record, the draft offers a route that did not previously exist in published form.

Two-track procedure and the sterile-experience threshold

An application runs on two tracks at once, and confusing them is the most common way to lose time.

The licensing track runs through the provincial drug regulator where the site is located. The holder, or the entrusted manufacturer, applies for the issue or the amendment of a drug manufacturing licence covering the site and the process. The licence is the permission to manufacture; it is not the permission to market the product made there.

The registration track runs through the drug evaluation centre for products not yet approved, and through the post-approval change framework for products already on the market. For the latter, the holder assesses the change category under the Measures for the Administration of Post-Approval Changes to Drugs (Trial) and files accordingly. A change in manufacturing site is not a uniform event: the same physical move can fall into a different category depending on the product, the process and the validation data. The classification determines the depth of review, and getting it wrong is a substantive error rather than a formatting one.

The two tracks are not sequential in a strict sense. Licensing work can proceed while the registration question is being resolved, and in practice it must, because a registration application that names a site without a licence is incomplete. But the two tracks answer to different reviewers, and a company that treats a licence amendment as the whole project will find itself with permission to manufacture a product it is not cleared to place on the market.

On organisation, the draft sets a principle rather than an absolute rule: the same process step should, in principle, be entrusted to one manufacturer. The principle is stated in the application and recorded in the approved process. The practical effect is that a holder cannot quietly split a single step between two contractors to manage capacity, and cannot move a step between contractors without the change being visible in the approved documentation.

Intermediates carry their own requirement. Where a product passes between sites in an unfinished state, the intermediate must have a clear quality standard that has been approved. This is the clause that turns a logistics arrangement into a regulatory object. An intermediate without an approved standard is not a legitimate handover point; it is an unregulated material in transit.

The sterile threshold is the hardest condition in the draft. For sterile products, at least one of the two parties — the holder or the entrusted manufacturer — must have three years or more of commercial production experience in the same dosage form. The requirement is deliberately relational: it does not demand that both sides be experienced, but it does demand that the experience exist somewhere in the pair. A new entrant cannot be paired with another new entrant, however strong their respective quality systems may look on paper.

The draft then addresses relaxations. A 2025 announcement, numbered 134, set out four situations in which the experience requirement could be relaxed. The draft recognises only the second and the fourth: the case where the parties sit within the same group under a unified quality system, and the case of an entrusted manufacturer that has been materially involved in developing the product and in manufacturing clinical trial supplies. The first and third relaxations are not carried over.

The omission is significant and easy to miss. A company that has been relying on one of the two excluded relaxations during the pilot should assume that the reliance does not survive into the standing procedure. Whether the final text restores them is a question worth putting in a comment, because the draft as published does not.

Where the holder’s obligations land

The draft distributes work but not responsibility. The holder remains the party answerable for the product, and the obligations listed in the text are written to make that answerability operational rather than nominal.

The first is presence. For each product in production, the holder must station two or more technical staff at the manufacturing site. This is not an audit visit and not a periodic review; it is a continuous presence during production. For a foreign holder using a domestic contractor, it means either seconding staff or contracting for a resident technical function that the regulator will treat as the holder’s own.

The second is audit. At least once a year, the holder must conduct a full-system GMP audit covering all manufacturing sites. The phrase “all sites” is the operative one: an audit programme that covers the domestic contractor but not the overseas site, or that covers the main site but not a site performing a single step, does not meet the requirement.

The third is the cold chain. Where bulk drug substance or another intermediate travels a long distance, the holder must validate the transport, monitor temperature, and inspect the material on arrival. The three obligations are cumulative. Validation without monitoring produces a document; monitoring without incoming inspection produces a record of a failure discovered too late.

The fourth is governance. A product quality risk consultation must be chaired by the legal representative or the enterprise head. Placing the chair at that level is a deliberate choice: it removes the possibility of treating a cross-site quality question as a technical matter settled below the level at which trade-offs are made.

The fifth is data. At steps where humans and machines interact, video data must be collected. The requirement reflects a supervisory reality: in a segmented chain, the reviewer cannot rely on walking the line, so the record of the line becomes the evidence. Companies should expect the retention, accessibility and integrity of that video to be examined alongside the batch records.

None of these obligations is novel in substance — a manufacturer operating a single site faces equivalents — but their combination is demanding for a chain that has been cut into pieces. The audit obligation looks outward to every site; the presence obligation looks inward to a single line; the data obligation looks backward at what actually happened. A holder that runs them as three separate programmes usually discovers, at the worst moment, that the evidence each produces does not line up.

Supervision follows the same logic. Provincial regulators are to manage on a basis described as one file per enterprise and one approach per product, with at least one GMP compliance inspection per product each year. For cross-province arrangements, the two sides are to notify each other periodically of inspection results, sampling results, adverse reaction information and major changes, and to conduct joint investigations or assist each other where a major risk emerges.

The cross-province mechanism deserves attention from foreign groups because it is where delay usually appears. A product split between two provinces has two supervisory relationships, and the notification duty is what keeps them from diverging. A holder that maintains its own parallel record of what each province has been told will find the arrangement easier to manage than one that relies on the two regulators to reconcile.

Cross-border arrangements: a one-way opening

The fifth part, spanning Articles 17 to 20, deals with arrangements that cross the border. It is the part most relevant to foreign holders, and it is the part where the draft is most explicit about direction.

Inbound is permitted. A foreign holder may entrust some or all of its process steps to segmented production inside China, provided the product falls within one of the four categories. The condition is not waived by the cross-border character of the arrangement; it is applied to it. A product that is not in one of the four categories does not become eligible because the holder is foreign.

Outbound is restricted. A domestic holder may not, in principle, entrust a foreign manufacturer with segmented production. The single exception is the fourth category, the originator drug that was approved in China while made abroad and is now being brought onshore. In that case the arrangement is the reverse of the general prohibition, because the product’s history already involves an overseas site.

The asymmetry is a policy choice, and it is worth stating plainly rather than reading a motive into it. The draft opens a route into the country and keeps the route out of the country closed except where a specific product history justifies it. Companies planning a regional manufacturing footprint should not assume that the inbound permission implies a reciprocal outbound one.

A group weighing an inbound arrangement should also look at its contract architecture earlier than it usually does. Joint liability shifts the risk allocation between the holder and the domestic party, and the annual audit of overseas sites shifts the cost base. Both are easier to negotiate before a licence annotation exists than after, because after the annotation the domestic party knows it cannot walk away without a regulatory consequence.

On documentation, the draft offers a practical concession. A cross-border application may use production qualifications and marketing authorization materials issued by domestic or foreign regulators to substitute for application materials that do not fit the arrangement. This matters most where a foreign site holds approvals that have no Chinese equivalent document. The concession is about form, not about substance: it does not reduce the quality standard, it reduces the paperwork that would otherwise be impossible to produce.

Annotation differs by direction, and the difference is operational. Where a foreign holder uses a domestic entrusted manufacturer, the arrangement is recorded on the copy of the domestic party’s drug manufacturing licence. Where a domestic holder commissions a foreign manufacturer, the foreign enterprise’s name, the site address and the product are recorded on both the original and the copy of the licence. The distinction reflects who holds the licence: the annotation follows the licensed entity.

The most consequential clause concerns responsibility. Where a foreign holder commissions segmented production inside China, a domestic responsible person performs the foreign holder’s obligations and bears joint liability. Joint liability is not a formality. It means the domestic party is exposed to the same regulatory consequences as the holder for failures in the arrangement, and it changes the negotiation of any contract that gives effect to the arrangement.

The audit obligation travels with it. The domestic responsible person must conduct at least one full-system GMP audit each year covering the overseas sites as well. For a foreign group, this is the clause that turns a Chinese entity into a genuine quality gate for global manufacturing, not merely a local representative. Groups should consider whether the entity they nominate has the technical depth and the mandate to audit a site it does not control.

The ADC carve-out

Article 22 addresses a problem specific to antibody-drug conjugates. The manufacturing chain for these products includes small-molecule intermediates that are chemically well characterised, stable in handling, and controllable in quality, and that play a decisive role in the quality and efficacy of the finished product. Some of these intermediates are not managed as drugs and not managed as active pharmaceutical ingredients.

Under a literal reading of the licensing rules, a site making such an intermediate could be treated as needing a drug manufacturing licence. The draft resolves the question by excusing the site from holding one, on conditions.

The conditions are cumulative. The site must comply with GMP. It must be inspected by the provincial regulator where the holder is located. The site and the process must be recorded on the licence. And the site remains subject to routine supervision and to extended supervision. Where the site is in another province, the provincial regulator at the site must additionally issue an opinion consenting to the entrusted production.

Read together, the carve-out is narrower than a headline reading suggests and more useful than a cautious one. It removes a licensing requirement that was poorly matched to the material, and it replaces it with an inspection and annotation regime that keeps the site inside the supervisory perimeter. The site does not become unregulated; it becomes regulated through the holder’s licence rather than through a licence of its own.

For groups with conjugates in development, the practical question is whether a given intermediate meets the description. Maturity of process, stability of physicochemical properties, controllability of quality, and criticality to quality and efficacy are the stated criteria. A company that wants the carve-out should be able to document each of them, because the inspection will ask for exactly that.

The clause also has a supply-chain consequence. Conjugation and payload manufacturing are often spread across specialist sites, some of which are not pharmaceutical facilities in the ordinary sense. The carve-out allows those sites to remain in the chain without each acquiring a licence, which reduces a structural barrier to locating conjugate work in China. It does not reduce the holder’s obligation to audit, to annotate, and to answer for the result.

Vaccines and the sequencing question

Vaccines appear in the second and third categories, and the draft adds a sequencing rule for a subset of them. Where the circumstances in Article 33 of the Regulation apply, the applicant must first seek approval from the national drug regulator under the Vaccine Administration Law, and only then proceed to licensing and registration.

The sequencing matters because it inverts the ordinary order of work. In a standard application, licensing and registration run in parallel with review. For the vaccines caught by Article 33, the approval comes first, and the licensing and registration steps follow it. A project plan that assumes parallel tracks will be wrong for these products, and the error will surface late.

The draft does not restate the substance of Article 33, and companies should read the Regulation directly rather than infer the scope from the announcement. What the announcement contributes is the procedural consequence: approval under the Vaccine Administration Law is a precondition, not a parallel filing.

What foreign holders should do before 30 November

The comment window closes on 30 November 2026, and the mailbox is the one named in the notice. A comment that identifies a specific article and a specific operational consequence is more likely to be useful than a general statement of support or concern. Four questions are worth answering internally before that date.

First, does the portfolio map onto the four categories, and onto which one? A product may appear to fit the first category because its process is unusual, while in fact fitting the fourth because its history is an overseas approval followed by an onshore transfer. The categories carry different consequences, including whether a post-approval change route exists at all.

Second, is the development history clean? For a new application, the holder must have developed the product itself or participated throughout. Groups that acquire assets should establish, before planning a segmented arrangement, whether the development record supports the claim. Where it does not, the route is closed regardless of the manufacturing logic.

Third, does the sterile experience sit on the right side? At least one party must hold three years of commercial experience in the same dosage form, and only two of the four relaxations are recognised. A group relying on an excluded relaxation should test the assumption now rather than at filing.

Fourth, who will be the domestic responsible person, and can that entity audit? Joint liability plus an annual full-system audit of overseas sites is a demanding combination. The entity needs technical capability, access to the sites, and a mandate that survives commercial pressure.

Beyond the four questions, three preparatory steps are worth taking. Map every site in the proposed chain against the licence annotation rules, because the annotation differs by direction and an omission is a defect. Confirm that each intermediate handover point has an approved quality standard, since an unapproved intermediate is not a valid boundary. And for conjugates, assemble the evidence that the intermediate meets each of the four criteria in Article 22, because the carve-out is granted on documentation and inspection rather than on description.

Outlook

The draft is a procedural document, and its effects will be felt in individual applications rather than in a single announcement. The parts most likely to be adjusted before the final text are the two excluded relaxations and the treatment of products whose development history is shared between an originator and a Chinese licensee. Both are the kind of question that a comment period exists to surface.

For planning purposes, the safe assumption is that the four categories, the two-track procedure, the one-way cross-border rule and the antibody-drug conjugate carve-out will survive in substance. The variables are the transitional arrangements for products currently in the pilot, and the precise wording of the experience requirement.

Companies with pilot products should treat the 31 December 2026 expiry as a real deadline and plan continuity rather than assume an automatic rollover. Companies without pilot products now have, for the first time, a published description of what a segmented arrangement looks like — which is itself the main change. The permission was always there in principle. What was missing was the procedure, and the procedure is now on the table for comment.

Sources

  • 国家药监局综合司·《关于药品委托分段生产有关事项的公告(征求意见稿)》征求意见页面(反馈截止 2026-11-30):https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20261113111413106.html
  • 中国政府网·国务院公报 2026 年第 4 号《中华人民共和国国务院令(第 828 号)中华人民共和国药品管理法实施条例》(2026-01-16 公布,2026-05-15 施行,含第三十二条分段生产条款):https://www.gov.cn/gongbao/2026/issue_12546/202602/content_7057461.html
  • 蒙城县人民政府(转载)·《中华人民共和国药品管理法实施条例》(2026 年修订,含第三十二条、第三十三条分段生产条款):https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

中国药品分段生产:从试点走向常规程序

为什么此刻值得看

2026 年 11 月 13 日,国家药监局综合司发布《关于药品委托分段生产有关事项的公告(征求意见稿)》。反馈截止 2026 年 11 月 30 日,意见投递到公告指定的邮箱。这份文本是征求意见稿,在正式稿印发之前不对任何人产生约束力,正式稿的措辞、范围以及对在审品种的过渡安排,都可能与现在不同。

让这份稿子值得现在读、而不是等到十二月再读的,是它背后的时间表。生物制品分段生产试点 2024 年 10 月启动,2026 年 12 月 31 日到期。新修订的《药品管理法实施条例》2026 年 5 月 15 日起施行。两个日期之间留着一道缝:条例给了分段生产的法律依据,但落地路径一直是试点,逐案商议,入口靠谈、不靠公布。这份公告要做的,就是把标准写下来。

用平实的话说,分段生产指的是同一个产品的不同生产工序分散在多个场地完成,有时还分散在多个法人主体手里,而这些场地与主体共同处在一套由上市许可持有人拥有的质量保证体系之下。它不是通常意义上的外包。持有人并没有随工序一起把责任交出去,它保留责任,只把工作分出去。这条区分,几乎决定了公告里的每一条。

对外资集团而言,这份稿子有三处值得注意。第一是第四类品种,它第一次为”已在境内获批、在境外生产”的原研药开出一条把部分或全部工序搬到境内、又不必按新药重新注册的路。第二是跨境条款的方向:门朝里开,除一种情形之外不朝外开。第三是抗体偶联药物某些中间产品的豁免,它卸掉了一项与物料性质并不匹配、代价却很高的许可负担,但并没有卸掉围绕着它的质量义务。

这三点各有商业含义。一家长期把中国当作成品加工与包装基地的全球企业,现在可以设想反过来做:把原液或中间产品放在境内生产,并接受随之而来的监管足迹。一家一直在等试点转正的企业,可以按公布的条件而不是按谈判地位来安排投资。而一家做抗体偶联药物的企业,可以不再把某个工艺成熟的小分子中间体当作需要药品生产许可的对象——前提是它能满足附在后面的条件。

这份稿子在澄清的同时也在收窄。新申请上市的品种,必须是持有人自主研发或者全程参与研发的。第一类没有上市后变更入口,也就是说,一个已经上市、且只落在第一类的产品,不能借这份公告在事后重组生产布局。把稿子读成一次普遍放开,是误读。它是一次程序上的收口,范围被有意画得很清楚。

从试点到常规程序

这份稿子接替的试点,2024 年 10 月针对生物制品启动。它的逻辑是试验性的:挑少量品种,摸索一条被切开的制造链该怎么监管,再从个案里学。在监管方还没决定标准应该是什么的时候,这种模式有实实在在的好处。但当企业需要押上资本时,它的短板也很明显:能不能进,取决于一次谈话;谈出什么结果,不会公布。

常规程序改变的是决策的性质。企业不再问”这个产品有没有可能被允许”,而是问”它是否满足已经公布的条件”。答案变得可核查,否定性的答案也变成可以处理的东西——调整品种范围、调整场地配置,或者换一条路走。

稿子的结构是六部分、二十三条。各部分的划分顺着一个申请的流程走,而不是顺着法条的体例走:总则、可分段品种、申请与审批、持有人义务、跨境安排、附则。这个次序本身带着信息。跨境安排单独成篇、位置靠后,说明它被当作一个独立的政策问题处理,而不是境内申请的一个变体。

法律基础是 2026 年 5 月 15 日施行的新修订《药品管理法实施条例》。条例把原则定了下来:确有需要的持有人可以委托符合条件的企业分段生产,前提是建立覆盖全过程、全部生产场地的统一质量保证体系。条例没有做的是:说明哪些品种够格、一份申请长什么样、许可与注册怎么衔接、场地在境外时怎么办。这些正是公告要回答的问题。

时间上的安排并非偶然。一个 2026 年 12 月 31 日到期的试点,加上一份十一月中旬还没定稿的常规程序,中间的窗口很窄。已在试点里的品种需要连续性,试点之外的品种需要知道要不要准备申报。对一份密度这么高的文本给出三十天反馈期,说明监管方按固定日程推进,并且预期意见是点对点的,而不是面面俱到的。

稿子没做什么,也是一种信号。它没有把分段生产扩展到所有技术上可以拆分的品种;它没有创设一项委托境外生产的普遍权利;除了一种明确情形,它没有免除药品生产许可。收口是真的,但收的是一项范围很窄的许可的口,而不是把它放宽。

对企业而言,试点与程序之间的实际差别,会出现在尽职调查文件里。试点之下,一份关于生产结构的法律意见只能描述监管惯例,再多也就到此为止;程序之下,它可以引用一项条件,并拿事实去比对。这个转变在字面上很小,在”董事会能批什么”上却很大——条件可以在掏钱之前评估,惯例只能在一场不知会不会发生的谈话之后评估。

四类可分段品种

稿子列出四类可以分段生产的品种。这份清单是穷尽式的,一个品种只要不落在这四类里,无论制造逻辑多么合理,都用不上这套程序。

第一类是生产工艺、设施设备有特殊要求的创新药。这个表述指向的是制造本身构成约束的产品:需要专用设备的工艺、不能共用的环境、塞不进通用厂房的一道工序。对这类产品,拆链不是成本问题,而是可行性问题。

第二类是国务院有关部门提出的临床急需药品及疫苗,以及应对突发公共卫生事件急需或者储备需要的药品及疫苗。这是公共利益理由最外显的一类。它同时也最依赖外部:认定来自药品监管系统之外。

第三类是多联多价疫苗。这里的逻辑是结构性的。一支联合疫苗可能要由几种抗原组分构成,每种组分各有自己的制造链,把它们全部塞进一个场地并不总是现实。分段让各组分在最适合的地方生产,再在组合工艺经过验证的地方完成组合。

第四类是新加的,也是最可能改变行为的一类。它指已取得境内上市许可、在境外生产、把部分或者全部工序转移至境内分段生产的原研药品。实质上,这是一条针对已获批产品的境内落地通道。产品不会因此变成新药,它只是换了一套生产足迹。

第四类的法律入口,是《实施条例》第三十二条第三项——为”国家局规定的其他药品”留的那道口子。稿子用掉了这道口子。意义一半在程序、一半在实体:它说明这项保留条款不是摆设,监管方打算用它解决具体问题,而不是留着一项笼统的裁量。

四类之上还压着两条限制,方向一致。新申请上市的品种,必须是持有人自主研发、或者全程参与研发的。一家把品种买进来、现在想重组生产的持证企业,并不自动够格。第一类则完全没有上市后变更入口:只有落在第二、第三、第四类的产品,才可以把已有的批件改成一种分段安排。

两条限制合起来,形成一套偏向”研发史完整、在研管线在手”的企业的程序。对一个把资产引进中国、再去找制造灵活度的集团来说,这份稿子给的东西比初读时感觉的要少。而对一个在中国做研发、或者在全球做研发并握有完整研发记录的集团来说,这份稿子给的是一条此前没有以公布形式存在的路。

两条线并行与无菌门槛

一份申请同时跑两条线,把两条线混为一谈,是最常见的误时方式。

许可线走场地所在地的省级药品监管部门。持有人或者受托生产企业,就场地与工艺申请《药品生产许可证》的核发或者变更。这张证是生产的许可,不是把那里生产出来的产品拿去上市的许可。

注册线走两条分支:尚未上市的品种报药品审评中心;已经上市的品种,按《药品上市后变更管理办法(试行)》走上市后变更。后一条分支里,持有人要先判定变更类别,再据以申报。生产场地的变化不是一件整齐划一的事:同样一次物理搬迁,因为品种、工艺、验证数据不同,可能落在不同类别。类别决定审评的深浅,判错类别是实体错误,不是格式错误。

两条线在严格意义上并不是先后关系。许可工作可以在注册问题解决的同时推进,实践中也必须如此,因为一份写明了场地却没有相应许可的注册申请是不完整的。但两条线面对的是不同的审评人,把许可证变更当成整个项目的企业,最后会拿到一张”可以生产、但不能上市”的许可。

在组织方式上,稿子给的是原则而不是铁律:同一道工序原则上委托一家生产企业。这条原则要在申请中说明,并在核准的工艺中载明。实际效果是,持有人不能为了调节产能把一个工序悄悄分给两家受托方,也不能在没有留下文件痕迹的情况下把一道工序从一家换到另一家。

中间产品有自己的要求。产品以未完成状态在场地之间流转的,中间产品必须有明确、且经过核准的质量标准。这一条把一项物流安排变成了监管对象。没有核准标准的中间产品,不是一个合法的交接点,而是一批处在监管真空里的物料。

无菌门槛是稿子里最硬的条件。对无菌药品,委托方与受托方之中至少一方,必须具备同剂型三年以上的商业化生产经验。这个要求是有意设计成”关系型”的:它不要求双方都有经验,但要求这份经验确实存在于这一对组合之中。两个新手凑在一起,无论各自的质量体系在纸面上多漂亮,都不行。

稿子接着处理放宽。2025 年的一份公告(第 134 号)列了四种可以放宽经验要求的情形。稿子只认其中第二项和第四项:双方同处一个集团、实行统一质量体系的;以及主要参与该药品研发、并生产过临床试验用药品的受托方。第一项与第三项没有沿用。

这个省略很重要,也很容易被忽略。在试点期间依赖那两项被排除的放宽情形的企业,应当假定这份依赖不会带进常规程序。正式稿会不会恢复,是一个值得写进意见的问题,因为按现在公布的文本,答案是否定的。

义务落在持有人身上

稿子把工作分了出去,但没有把责任分出去。持有人始终是对产品负责的一方,文本列出的义务,是为了让这份责任可执行,而不是停留在名义上。

第一项是在场。每个在产品种,持有人要在生产场地派驻两名以上技术人员。这不是一次审计访问,也不是一次阶段性复核,而是生产期间的持续在场。对使用境内受托方的境外持有人来说,这意味着要么派人,要么安排一项常驻的技术职能,而监管方会把这项职能视为持有人自己的。

第二项是审核。持有人每年至少开展一次覆盖全部生产场地的全体系 GMP 审核。”全部场地”是这句话的关键。一套只覆盖境内受托方、不覆盖境外场地的审核方案,或者只覆盖主场地、不覆盖承担单道工序场地的方案,都不满足要求。

第三项是冷链。原液或者其他中间产品长距离运输的,持有人要验证运输、监控温度,并在入厂时检验。三项义务是叠加的。做了验证不做监控,得到一份文件;做了监控不做入厂检验,得到一份”发现得太晚”的记录。

第四项是治理。产品质量风险会商必须由法定代表人或者企业负责人主持。把主持人定在这一层是有意的选择:它排除了把跨场地质量问题当成技术细节、在做出取舍的那一层之下解决的可能。

第五项是数据。在人机交互的环节,要采集视频数据。这条要求反映的是一种监管现实:在一条被切开的链上,检查员没法靠走线来确认,于是产线的记录就成了证据。企业应当预期,这些视频的留存、可调取性与完整性,会和批记录一起被看。

这几项义务单拎出来都不新鲜——只经营一个场地的生产企业面对的是同类要求——但叠在一条被切开的链上,要求就变得苛刻。审核义务朝外看,看的是每一个场地;在场义务朝内看,看的是某一条产线;数据义务朝后看,看的是当时到底发生了什么。把三者当成三个互不相干的项目的持有人,往往会在最糟糕的时候发现:三套证据对不上。

监督遵循同样的逻辑。省级监管部门按”一企一档、一品一策”管理,每个品种每年不少于一次 GMP 符合性检查。跨省安排的,两地要定期互相通报检查结果、抽检结果、不良反应信息与重大变更;出现重大风险的,联合调查或者相互协查。

跨省机制值得外资集团多看一眼,因为拖延通常就出在这里。一个跨两省的产品有两段监管关系,而通报义务是防止两段判断分叉的东西。自己另建一份”哪个省被告知了什么”的台账的持有人,会比指望两地监管方自行对账的持有人更省事。

跨境安排:只朝一个方向开

第五部分(第十七条至第二十条)处理跨越关境的安排。这是与境外持有人最相关的一部分,也是稿子把方向讲得最明白的一部分。

进来可以。境外持有人可以把部分或者全部工序委托境内分段生产,前提是品种落在四类之中。这个条件不会因为安排具有跨境性质而免除,而是被适用到跨境安排上。不在四类里的品种,不会因为持有人是境外的就变得够格。

出去受限。境内持有人原则上不得委托境外生产企业分段生产。唯一的例外是第四类——那个在境内获批、在境外生产、如今正在往境内搬的原研药。这种情形下,安排本身就是一般禁令的反面,因为产品的历史里本来就有一个境外场地。

这种不对称是一项政策选择,值得平实地陈述,而不必去揣测动机。稿子开了一条进国的路,同时把出国的路关着,只在特定产品历史足以支撑时例外。规划区域制造布局的企业,不应当从”进来可以”推出”出去也可以”。

考虑把工序搬进来的集团,还应当比惯常更早去看合同架构。连带责任改变的是持有人与境内一方之间的风险分配,对境外场地的年度审核改变的是成本结构。两件事在许可证载明之前谈,都比在载明之后谈容易——载明之后,境内一方清楚自己没有退路,因为退出本身就是一项监管后果。

在材料上,稿子给了一项务实的让步。跨境申请可以用境内、境外监管部门出具的生产资质与上市许可材料,替代那些不适用于该安排的申请材料。这在境外场地持有境外批件、而该批件在境内没有对应文件时最有用。这项让步是形式上的,不是实体上的:它不降低质量标准,只是减少了本来无法产出的那部分纸面工作。

载明方式按方向不同,而这个差别是操作性的。境外持有人委托境内生产的,在境内受托方《药品生产许可证》副本上载明。境内持有人委托境外生产的,境外企业名称、场地地址、产品要在许可证正本与副本上同时载明。区别的来源是谁持证:载明跟着持证主体走。

最有分量的条款是责任。境外持有人跨境委托境内分段生产的,由境内责任人履行境外持有人的义务,并承担连带责任。连带责任不是手续。它意味着境内一方要为这项安排中的失误承担与持有人同等的监管后果,也意味着任何落实这项安排的合同,谈判方式都要改。

审核义务随之同行。境内责任人每年至少要做一次覆盖境外场地的全体系 GMP 审核。对境外集团来说,这一条把一家中国主体变成了全球制造体系里一道真实的质量关口,而不只是一个本地代表处。集团需要考虑:拟指定的这家主体,有没有技术深度和授权去审核一个它并不控制的场地。

抗体偶联药物的例外

第二十二条处理的是抗体偶联药物特有的一个问题。这类产品的制造链里有小分子中间体,化学性质清楚、处置中稳定、质量可控,并且对成品的质量与疗效起关键作用。其中一些中间体既不按药品管理,也不按原料药管理。

按许可规则的直白读法,生产这种中间体的场地可能被当作需要药品生产许可证。稿子用”附条件豁免”回答了这个问题。

条件是叠加的。场地要符合 GMP;要经持有人所在地省级监管部门检查;场地与工艺要在许可证上载明;场地仍要接受日常监管与延伸监管。场地在另一省的,还须由场地所在地省级监管部门出具同意受托生产的意见。

合起来读,这项例外比标题式读法要窄,也比保守式读法要有用。它卸掉了一项与物料性质并不匹配的许可要求,换上一套检查加载明的安排,把场地留在监管边界之内。场地不会因此变成无人监管,它变成通过持有人的许可证接受监管,而不是自己持一张证。

对有偶联药物在研的集团来说,实际问题是一项给定的中间体是否落入这个描述。工艺成熟、理化性质稳定、质量可控、对质量疗效起关键作用,是文本给出的四项标准。想要用上这项例外的企业,应当能为每一条留下文件,因为检查要的正是这些。

这一条还有供应链上的后果。偶联与载荷的生产常常分散在专业场地之间,其中一些并不是通常意义上的制药车间。例外让这些场地可以留在链上而不必各自去拿一张证,从而降低了把偶联环节放在境内的结构性障碍。它不降低持有人的审核、载明与最终担责义务。

疫苗与先后顺序

疫苗出现在第二类和第三类里,稿子又为其中一个子集加了顺序规则。符合《实施条例》第三十三条情形的,要先按《疫苗管理法》向国家药监局申请批准,再办许可与注册。

这个顺序之所以重要,是因为它把通常的工作次序倒了过来。在一般申请里,许可与注册同审评并行推进。对落入第三十三条的疫苗,批准在前,许可与注册在后。按并行双线做的项目计划,在这些品种上是错的,而错误会在很晚的时候才暴露。

稿子没有复述第三十三条的实体内容。企业应当直接去读条例,而不是从公告反推适用范围。公告贡献的是程序后果:按《疫苗管理法》取得批准,是前置条件,不是一条并行的申报。

境外持有人应在 11 月 30 日之前做什么

反馈窗口 2026 年 11 月 30 日关闭,邮箱是公告里写明的那个。点名到具体条文、并说明具体操作后果的意见,比泛泛的支持或担忧更有用。在此之前,有四个问题值得先在内部回答清楚。

第一,产品组合落在四类的哪一类?一个产品可能看起来像第一类,因为工艺特殊;实际上却属于第四类,因为它的历史是”境外获批、再往境内搬”。不同类别的后果不同,包括到底有没有上市后变更入口。

第二,研发史是否干净?新申请上市,持有人必须自己研发、或者全程参与研发。收购资产的企业,在规划分段安排之前,应先确认研发记录能否支撑这个主张。支撑不了,无论制造逻辑多顺,路都是关着的。

第三,无菌经验是否落在对的一侧?至少一方要有同剂型三年以上商业化生产经验,而四项放宽只有两项被承认。依赖被排除的那两项的企业,现在就应当检验这个假设,而不是等到申报。

第四,境内责任人是谁,它审得动吗?连带责任加上对境外场地的年度全体系审核,是很硬的一组要求。这家主体需要技术能力、需要能进入那些场地、还需要一份不会被商业压力磨掉的授权。

四个问题之外,还有三件准备工作值得做。把拟设链条上的每个场地对照许可证载明规则过一遍,因为载明方式按方向不同,漏一处就是缺陷。确认每一个中间产品交接点都有核准的质量标准,因为没有核准标准的中间产品不是一个有效的边界。做偶联药物的,把中间体满足第二十二条四项标准的证据攒起来,因为这项例外是凭文件与检查给出的,不是凭描述给出的。

展望

这是一份程序性文件,它的效果会体现在一个个具体申请里,而不是体现在某一次发布里。正式稿最可能调整的地方,是那两项被排除的放宽情形,以及研发史由原研方与境内被许可方共享的品种怎么处理。这两类问题,正是反馈期存在的理由。

做规划时,稳妥的假设是:四类品种、双线程序、单向跨境、抗体偶联药物例外,在实体上会保留下来。变量在于试点内品种的过渡安排,以及经验要求的具体措辞。

手上有试点品种的企业,应当把 2026 年 12 月 31 日当作真实期限,按”需要接续”来准备,而不是假定会自动顺延。没有试点品种的企业,第一次拿到了一份关于”分段安排长什么样”的公开描述——这本身就是主要的变化。许可在原则上一直存在。缺的是程序,而程序现在摆上了桌面,等着被评论。

来源

  • 国家药监局综合司·《关于药品委托分段生产有关事项的公告(征求意见稿)》征求意见页面(反馈截止 2026-11-30):https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20261113111413106.html
  • 中国政府网·国务院公报 2026 年第 4 号《中华人民共和国国务院令(第 828 号)中华人民共和国药品管理法实施条例》(2026-01-16 公布,2026-05-15 施行,含第三十二条分段生产条款):https://www.gov.cn/gongbao/2026/issue_12546/202602/content_7057461.html
  • 蒙城县人民政府(转载)·《中华人民共和国药品管理法实施条例》(2026 年修订,含第三十二条、第三十三条分段生产条款):https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

Hengqin’s New Recognition List: Overseas Qualifications, Filing, and a Subsidy Window Closing on 31 December

  • Hengqin’s talent bureau issued the 2026 edition of the overseas professional qualification recognition list on 11 November 2026, effective on publication and replacing the 2025 edition.
    横琴粤澳深度合作区人才发展和社会保障局于 2026 年 11 月 11 日印发境外职业资格便利执业认可清单(2026 年版),自发布之日起实施,同时废止 2025 年版。
  • The list lets holders serve in the zone under the relevant implementation measures, through practice filing, registration or exemption from specific examination subjects.
    清单允许持证人员按相关实施办法在合作区提供专业服务,路径包括执业备案、登记以及专业科目免考。
  • Overseas practice experience may be treated as equivalent to mainland experience, which affects how a career is counted rather than who may sign.
    境外从业经历可视同境内从业经历,影响的是职业年限如何计算,而不是谁有权签字。
  • A one-off subsidy of 30,000 yuan for Macao professionals is open for applications from 11 November to 31 December 2026, and late filings are not accepted.
    澳门专业人才一次性补贴 3 万元,申报期为 2026 年 11 月 11 日至 12 月 31 日,逾期不予受理。
  • Four conditions must all hold: Macao residency, a one-year contract with six months of tax payments, six months of qualifying work, and a listed qualification with a permit to serve.
    四项条件须同时满足:澳门居民身份、一年及以上劳动合同并连续缴纳个税六个月以上、从事相关工作六个月以上、持清单内资格并取得执业许可。
  • The list is maintained by annual replacement, so a professional should treat the current edition as the only operative reference.
    清单按年度替换维护,专业人员应把现行版本当作唯一有效依据。

Hengqin’s New Recognition List: Overseas Qualifications, Filing, and a Subsidy Window Closing on 31 December | 横琴新版认可清单:境外资格、执业备案与年底关窗的补贴

What changed on 11 November

On 11 November 2026 the talent development and social security bureau of the Hengqin Guangdong-Macao Deep Cooperation Zone issued the 2026 edition of the list of overseas professional qualifications recognised for convenient practice in the zone. It takes effect from the date of publication. The 2025 edition, issued as 粤澳深合经发通〔2025〕36 号, is repealed on the same day.

Two features deserve attention before anything else. It is a replacement, not an addition: from 11 November the operative document is the 2026 edition, and a file that cites the 2025 notice cites a repealed instrument. Project proposals, cooperation agreements and internal compliance manuals drafted earlier in the year will all need the citation updated, and a surprising number of organisations discover this only when a counterparty asks for the current version.

The second feature is structural. The list is published as an attachment to the notice, so its scope is settled qualification by qualification rather than by the covering text. A professional who wants to know whether a particular licence is covered has to open the attachment, not read the notice. That sounds like a formatting detail, but it changes the order in which people work: check the list first and then the measures, or read the measures first and come back to the list, and the two routes can produce different conclusions.

The reason is that three documents have to line up. The covering notice tells you the mechanism — filing, registration, exemption. The attachment tells you whether your qualification is inside the scope. The implementation measures for the profession tell you what to do next and in what order. Where any one of the three is missing, a service sits in a zone with no clear basis.

The legal basis in the Master Plan

The notice grounds itself in a single sentence of the Master Plan for the Guangdong-Macao Deep Cooperation Zone. Professionals holding Macao and other overseas practice qualifications in finance, construction, planning and design may, where they meet industry regulatory requirements, provide services in the zone after filing, and their overseas practice experience may be treated as equivalent to mainland experience. The same sentence supports convenient measures encouraging medical professionals with Macao and other overseas qualifications to obtain mainland practice qualifications lawfully.

Two ideas sit inside that sentence, and they are not the same idea. Filing is a route to service without a mainland licence: the professional registers with the competent authority and works within a defined scope. Experience equivalence is a rule about counting: it affects how years of practice are treated when a person applies for a title, a grade, or a post that requires domestic experience.

There is also a difference in grammar worth noticing. For finance, construction, planning and design, the Master Plan says professionals may serve after filing. For the medical field, it says the zone should encourage professionals to obtain mainland practice qualifications lawfully. The first limb lands on filing; the second lands on obtaining a licence. A reader who treats the list as a single mechanism will overestimate what it does for the second group.

Read together, the pair lowers the cost of carrying a practice across the border without pretending that the mainland licensing requirement has disappeared. That distinction matters more than it looks, because the two are frequently conflated in material written about the zone, and the conflation produces two opposite mistakes: assuming filing equals exemption from examination, or assuming equivalence of experience equals automatic qualification.

What the list actually grants

The notice permits holders of qualifications on the 2026 list to provide professional services in the zone “in accordance with the relevant implementation measures”. That phrase carries the weight. The list is the door; the profession’s measures are the handle.

Three mechanisms recur across the professions covered: practice filing, registration, and exemption from specific subjects of a professional examination. Which one applies depends on the profession and its regulator, and the notice does not choose for you. A qualification on the list does not by itself create a right to sign opinions, appear before a court, or hold a licensed post. It creates eligibility for whichever route that profession’s measures describe.

The practical reading is that the list is a scope document. It answers whether someone with a given qualification may serve here at all, and leaves the terms to the profession-specific rules. For an employer building a team in the zone, the due-diligence question is therefore not only whether the qualification appears, but which mechanism applies and whether the candidate has completed it.

This also explains a confusion that surfaces in almost every intake conversation. Two qualifications on the same list can differ sharply in how quickly they convert into practice. One may require only a filing with complete documents; another may require an entry on a register that depends on a regulator’s review cycle. The list does not show that difference, because it is not designed to; only the profession’s measures do.

Filing versus registration: two different doors

Because the notice groups three mechanisms into one phrase, it is worth separating them, since the paperwork and the timeline differ.

Filing produces a record. The professional submits documents to the competent authority, the authority accepts the record, and the professional may then work within the scope the filing describes. The controlling documents are the filing itself and the scope it names. A filing is usually the fastest of the three, and it is also the one most sensitive to scope: work outside the filed scope is not covered by the filing.

Registration produces an entry on a register. The professional is listed, and the right to practise follows from being on that list. Registration typically involves a review rather than a receipt, so the timeline depends on the regulator rather than on the applicant’s readiness.

Examination exemption produces a decision on specific subjects. It is the narrowest of the three in the sense that it addresses part of a qualification process rather than the right to serve directly, and it matters most where the profession requires a mainland examination as the route to a licence.

Two of the three routes lead to service without a mainland licence; the third is a step inside the licensing route. A professional who needs to advise a client next month and a professional who is building a ten-year practice in the zone may therefore need different routes even where they hold the same qualification. Reading the list alone will not tell them which.

Finding out which applies is a matter of asking the right authority the right question. The useful question is not “am I recognised” — the list answers that — but “what does my profession’s implementation measure require me to complete before I can serve”. In some professions the answer is a filing with a defined scope; in others it is an entry on a register maintained by a regulator; in others it is a decision on exempted subjects followed by the ordinary licensing steps. The same qualification can sit on the list while the route behind it differs entirely from the route behind a neighbouring qualification on the same page.

That has a planning consequence that is easy to miss. If the route is a filing, the professional controls the timeline, because the work is documentary. If the route is a register, the regulator controls it, and the professional’s preparation only sets the earliest possible date. Firms that budget three weeks for everything, on the assumption that all three mechanisms behave like a filing, are the ones that miss the window.

Counting experience: where equivalence is used

The second half of the Master Plan sentence — that overseas practice experience may be treated as equivalent to mainland experience — is the part most often overlooked, because it produces no certificate. It changes arithmetic rather than permission.

The places where that arithmetic matters are familiar to anyone who has worked across the border. A title or grade review asks how many years of relevant practice the candidate has, and whether those years were spent in a recognised setting. A tender or a client mandate may specify a number of years of domestic experience in the field. An internal promotion matrix may count years in the profession, with a question about whether overseas years count the same.

Equivalence addresses that question. It does not convert a Macao qualification into a mainland one, and it does not create a right to sign. What it does is allow the years behind the qualification to be counted when someone is being assessed — which is often the difference between a candidate who looks junior on paper and one who looks experienced.

For employers, the practical implication is documentary. If equivalence is going to be relied on in a title application or a tender submission, the evidence of the overseas years should be assembled at the same time as the filing, not reconstructed years later from memory and bank records. The list tells you that equivalence is available; the file you keep is what makes it usable.

The subsidy and its four conditions

On the same day the bureau opened the 2026 round of applications for the cross-border practice subsidy for Macao professionals. The application period runs from 11 November to 31 December 2026, and applications after the close are not accepted. The grant is a one-off 30,000 yuan.

Four conditions must all be met. The applicant must hold Macao resident status. The applicant must have a labour contract of one year or more with an employer in the zone, must actually work for that employer, and must have paid individual income tax continuously for six months or more, with the employment relationship and the zone tax payments still in place on the date of application. The applicant must have actually worked in the zone for six months or more in technical or managerial work consistent with, or close to, the qualification held. And the qualification must appear on the subsidy catalogue, with a permit to provide the relevant service in the zone already obtained — by filing, registration, another form of registration, or examination.

Two details are easy to miss. The six-month tax test is counted backwards from the application period, so the qualifying months have to sit before the filing, not after it; someone who joins in the final quarter of the year is, in practice, looking at the next round. And social insurance, where it is referenced, means contributions made in the zone in the employer’s name under law — a payment made elsewhere does not substitute.

The services covered by the round are professional services in finance, accounting, taxation, law, medical care and education, consistent with the catalogue. The subsidy is administered under the zone’s measures and implementing rules for high-quality talent development, and the catalogue itself is updated with the annual application guidance rather than frozen once.

Why applications get returned

The four conditions are short, but each has a failure mode that appears repeatedly in practice. Naming them is more useful than restating the conditions.

The employment record breaks. A contract of one year or more is a condition, and so is continuous tax payment for six months with the relationship still live on the application date. A change of employer during the qualifying period, a gap between contracts, or a switch from one entity in the zone to another can break continuity even where the person never stopped working.

The scope does not match the certificate. The condition is work consistent with, or close to, the qualification held. A professional who holds a qualification in one specialism but spends the qualifying period on work in another will have difficulty showing the match, even if the work itself is senior.

The permit is incomplete. The condition requires a permit to provide the service in the zone, obtained through filing, registration, another form of registration, or examination. An application that shows the qualification but not the permit, or a permit that covers a narrower scope than the work performed, will not meet it.

The two catalogues are confused. The recognition list decides whether a qualification may be used to serve in the zone. The subsidy catalogue decides whether the holder may claim the grant. They are separate documents, and both have to line up; a qualification that appears on one but not the other produces an application that cannot succeed in its current form.

Deadlines, the platform and the two clocks

Applications are submitted through the zone’s platform for enterprises and residents, under the project application section, following the guidance published with the notice. The notice advises against filing on the closing day, when the system is at its busiest — advice that reflects experience rather than caution, since a submission that fails on 31 December has no remedy.

Two different clocks are running here, and confusing them is the most common way to miss the one that actually expires. The subsidy has a hard close on 31 December 2026 for the 2026 round; there is no late window and no discretion written into the notice. The list, by contrast, has no expiry date in the notice: it remains in force until replaced, in the same way that the 2025 edition was replaced by the 2026 edition.

The practical consequence is a planning rule. Work backwards from 31 December: six months of qualifying work and six months of tax payments have to be complete before the application, the permit has to exist before that, and the qualification has to be on both catalogues before any of it starts. For anyone not already partway through that sequence, the realistic target is the following round.

How the list is maintained year to year

The most useful thing to understand about this instrument is that it is a series, not a one-off announcement. The 2026 edition replaced the 2025 edition in full, and the notice repealed the earlier document on the same day rather than leaving both in force. That design has consequences for anyone who relies on it.

First, citations age quickly. A contract, a marketing brochure or a job description that refers to the 2025 list refers to something that no longer exists. Second, the scope can change in either direction between editions, so a qualification that was covered last year is not guaranteed to be covered this year, and one that was absent may have been added. Third, the maintenance model is consistent with how the zone handles the subsidy catalogue, which is updated with the annual application guidance rather than fixed permanently.

For a firm, the operational answer is a small one: keep a note of which edition each person’s file was checked against, and re-check at the start of each year. For an individual, the answer is simpler — treat the current edition as the only operative reference, and treat anything written before 11 November as background.

One question follows immediately, and the notice answers it only indirectly: what happens to someone who filed under the 2025 edition. Because the earlier notice is repealed rather than amended, the practical instruction is to re-check the qualification against the 2026 list and confirm the permit still matches the work being done. A person whose qualification remains listed and whose filing covers the same scope is, in substance, in the same position as before. A person whose qualification has moved, or whose work has drifted outside the filed scope, is not — and that is exactly the case a re-check is meant to catch.

The notice does not set out a separate transition procedure, so the conservative reading is the right one: no automatic carry-over should be assumed, and the file should be re-verified rather than left as it was.

What it means for small Macao firms

The measures are written for individuals, but their commercial effect lands on small professional firms — the accounting practices, tax advisory shops and law offices that serve clients on both sides of the border.

For those firms, the zone has always presented a specific problem. A partner qualified in Macao can advise a client on Macao law from Macao, but serving a client inside the zone requires a basis to do so. Filing provides that basis without requiring the partner to sit a mainland examination, and the recognition list is what makes the filing possible for a defined set of qualifications.

The economics are modest but real. A one-off grant of 30,000 yuan does not transform a practice, and it is not designed to; it offsets the cost and friction of the first year — the filing, the tax registration, the travel, the time spent building a client base that is not yet paying. For a two- or three-partner firm, that is often the difference between opening a small office in the zone and continuing to serve clients from a distance.

The constraint is the same as everywhere else in this policy: the firm still has to check that the specific qualification its partners hold is on the list, that the mechanism for that profession is one it can complete, and that the work it intends to do sits inside the scope the filing covers. A firm that assumes the list covers “accountants” in general, without checking the specific qualification, is the one most likely to be disappointed.

There is a further point about how small firms actually use the zone. A two-partner practice rarely moves. What it does is add: one partner files, spends part of each week in the zone, and builds a client group that needs a Macao-qualified adviser physically present for meetings, filings and negotiations. The grant is calibrated to that pattern — a one-off payment that offsets the first year’s friction, not a salary subsidy that supports a permanent relocation.

That also means the compliance burden is lighter than it first appears, provided the scope is respected. A firm that keeps one person’s filing narrow, and refers work outside the scope back to the Macao office, has a manageable file. A firm that treats the filing as a general permission to practise will accumulate mandates it cannot support, and the exposure surfaces later, when a client or a counterparty asks for the basis.

Two catalogues, two purposes

There are two lists in this policy area and they are routinely confused, which is why they deserve a section of their own rather than a footnote.

The recognition list — the one issued on 11 November — decides whether a qualification may be used to serve in the zone. It is the document that opens the route, whether that route is filing, registration or examination exemption. Its unit of analysis is the qualification.

The subsidy catalogue — the one referenced in the grant notice — decides whether the holder of a qualification may claim the one-off payment. Its unit of analysis is the qualification as well, but its purpose is different: it defines the population that the incentive is meant to reach, and it is updated with the annual application guidance rather than fixed once.

The two overlap substantially, which is what makes the confusion understandable, but they are not the same list and they are not maintained by the same process. A qualification that appears on the recognition list but not on the subsidy catalogue supports a practice but not a claim. A qualification on neither supports neither.

For a professional, the sequence is therefore: check the recognition list, check which mechanism applies, complete the mechanism, check the subsidy catalogue, and only then plan a claim. For a firm advising a candidate, the same sequence applies, and the most common error is to start from the subsidy — because the money is the visible part — and work backwards into a route that turns out not to exist for that qualification.

There is a practical test that resolves most of the confusion in a single step. Ask whether the person could serve a client in the zone next month without the grant. If the answer is yes, the recognition route is in place and the subsidy question is separate. If the answer is no, the subsidy is not the problem to solve first.

The test is worth applying at the level of the individual rather than the firm, because the two catalogues can produce different answers for two colleagues sitting in the same office. One may hold a qualification that is on both, another one that is on the recognition list only, and a third one that is on neither but is nevertheless the firm’s most experienced adviser. The policy addresses qualifications, not seniority, and a staffing plan built on seniority alone will not map onto it.

Who the list is not for

A recognition list invites over-reading, and it is worth being explicit about what it does not do.

It does not create a licence valid outside the zone. A professional who files in Hengqin is not thereby entitled to practise in another mainland city, and the notice makes no such claim. The geographic scope is the cooperation zone, and a client outside it is outside the scope of the filing.

It does not convert an overseas qualification into a mainland one. The holder remains a person with a Macao or other overseas qualification who is permitted to serve in the zone under defined conditions. Where a client, a court or a regulator requires a mainland credential, the list does not supply it; the licensing route does.

It does not cover every profession. The Master Plan sentence names finance, construction, planning, design and the medical field, and the list defines its own scope through an attachment. Professions outside that scope are not assisted by the instrument, however similar the work may look from the outside.

It does not remove the regulator. Filing and registration are interactions with a competent authority, not notifications to nobody. A filing can be refused or returned for incompleteness; a registration can take time. The list reduces the number of doors, not the fact that a door has to be opened.

And it does not settle the commercial question. Whether a practice in the zone makes sense depends on clients, pricing, competition and the cost of running two offices. The policy lowers the entry cost; it does not create demand. Firms that treat recognition as a business case tend to discover the difference in the second year.

What a firm should put in place before the next round

For firms that will not complete the 2026 sequence in time — which, given the six-month tests, is most of them — the useful work now is preparation for the following round. Four items cover most of it.

A per-person file. For each professional: the qualification certificate, the edition of the recognition list it was checked against, the mechanism chosen, the filing or registration record, the scope it covers, the labour contract, and the tax records. Kept together, this file answers both the subsidy question and any later question about the basis on which a service was delivered.

A calendar that starts from the end. The binding constraint is six months of qualifying work plus six months of tax payments, both completed before an application. Working backwards from a closing date gives a start date; firms that work forwards from a hiring date usually arrive late.

A scope note. For each filed professional, a short written description of what the filing covers and what it does not. This is the document that prevents a partner from accepting a mandate that sits outside the scope, which is the failure that matters most commercially.

A client-side explanation. Clients ask why a Macao-qualified adviser can act in the zone. A one-page explanation of the filing basis, the scope and the limits is more useful than a policy citation, and it is the kind of document that a client’s own compliance team will ask for.

None of this requires the grant to exist. All of it makes the grant, when it is available, a matter of filing rather than reconstruction.

How this fits the wider GBA talent picture

Hengqin’s instrument is narrower than a mutual recognition agreement and more concrete than a statement of intent. It creates no licence valid across the Greater Bay Area; it creates, for a defined set of qualifications, a documented route to serve inside one zone, plus a cash incentive for Macao residents who use it within the year.

That places it differently from the approach taken elsewhere in the region. Some platforms in the Greater Bay Area work through equivalence directories that map an overseas qualification onto a domestic vocational grade or professional title, so that the holder can apply for the corresponding domestic credential. Hengqin’s list works instead by opening a route to serve, with the qualification itself remaining the overseas one. The two designs are complementary rather than competing: one converts credentials, the other permits service.

The relationship with the region’s individual income tax preference is similar in character. The tax measure operates on the person’s liability; the recognition list operates on the person’s right to work. A professional who qualifies under both gets the benefit of both, and neither substitutes for the other — a point worth stating because the two are sometimes described as if they were a single package.

For a professional the calculation is short: check the 2026 list and the subsidy catalogue, check which mechanism the profession’s measures provide, check whether six months of qualifying work can be completed and evidenced before the window closes. For an employer the value sits in the filed record — the document that shows a client, or a regulator, that the service was delivered on a permitted basis.

The larger point is about how to read a document like this. It is not a gateway that opens once and stays open; it is an annual instrument with a defined scope, a set of profession-specific routes behind it, and a separate incentive attached to one of them. Treated that way, it is genuinely useful to a small firm deciding whether to test the zone. Treated as a general recognition of Macao qualifications, it will produce expectations the text does not support, and those expectations tend to surface at the worst moment — in front of a client who has asked for the basis of the advice.

Sources

  • 横琴粤澳深度合作区人才发展和社会保障局·《关于印发〈横琴粤澳深度合作区境外职业资格便利执业认可清单(2026 年版)〉的通知》,2026-11-11:https://www.hengqin.gov.cn/macao_zh_hans/zwgk/tzgg/gg/content/post_3959289.html
  • 横琴粤澳深度合作区人才发展和社会保障局·《关于开展横琴粤澳深度合作区 2026 年度支持澳门专业人才跨境执业补贴申报工作的通知》,2026-11-11:https://www.hengqin.gov.cn/macao_zh_hans/zwgk/tzgg/gg/content/post_3958312.html
  • 横琴粤澳深度合作区·第 3/2026 号经济发展局规范性文件《横琴粤澳深度合作区支持人才高质量发展奖补实施办法》(第十九条、第二十条为跨境执业补贴条款):https://www.hengqin.gov.cn/lab/gfxwj/all/content/post_3931634.html

横琴新版认可清单:境外资格、执业备案与年底关窗的补贴

11 月 11 日变了什么

2026 年 11 月 11 日,横琴粤澳深度合作区人才发展和社会保障局印发《横琴粤澳深度合作区境外职业资格便利执业认可清单(2026 年版)》,自发布之日起实施。原《横琴粤澳深度合作区境外职业资格便利执业认可清单(2025 年版)》,即粤澳深合经发通〔2025〕36 号,同日废止。

有两件事要先看清。第一,这是替换,不是增补:从 11 月 11 日起,生效的是 2026 年版,任何仍在引用 2025 年通知的材料,引用的都是一份已废止的文件。年内的项目建议书、合作协议、内部合规手册,只要写了旧文号,都需要更新;不少机构是在交易对手索要现行版本时才发现的。

第二,这是结构问题。清单本身以附件形式发布,适用范围要逐项核对,不能只看正文。想知道某个具体资格是否在列,得打开附件,而不是读通知。这听上去像排版细节,实际改变的是工作顺序:先查清单再查办法,和先读办法再回查清单,两条路径得出的结论可能不同。

原因在于三份文件必须对得上。正文告诉你走哪条路——备案、登记、免考;附件告诉你手里的资格在不在范围内;该专业的实施办法告诉你下一步做什么、按什么顺序做。三份缺一份,服务就落在一块没有明确依据的地带。

总体方案里的依据

通知的依据来自《横琴粤澳深度合作区建设总体方案》中的一句话:允许具有澳门等境外执业资格的金融、建筑、规划、设计等领域专业人才,在符合行业监管要求条件下,经备案后在合作区提供服务,其境外从业经历可视同境内从业经历。同一句话还支持在合作区采取便利措施,鼓励具有澳门等境外资格的医疗领域专业人才依法取得境内执业资格。

这句话里有两个概念,不能混为一谈。备案是一条”不取内地牌照也能执业”的路径:向主管部门完成备案,在核定范围内提供服务。从业经历视同,是一条关于”怎么算”的规则:它影响的是年限如何被认定,在评职称、评级,或应聘要求境内经历的岗位时起作用。

还有一处措辞差别值得注意。对金融、建筑、规划、设计,总体方案说的是”经备案后可以提供服务”;对医疗,说的是”鼓励依法取得境内执业资格”。前一句落在备案,后一句落在取证。把清单当成单一机制的读者,会高估它对第二类人的作用。

合起来看,这两条降低了把一门执业带到河对岸的成本,但并没有假装内地的牌照要求已经消失。这个区分比看上去更重要,因为在关于合作区的宣传材料里,两者经常被揉在一起,而混淆会带来两种相反的误解:以为备案等于免考,或者以为经历视同等于自动取得资格。

清单实际给了什么

通知的表述是:允许持有 2026 年版清单内境外职业资格的专业人员,按照相关实施办法在合作区提供专业服务。这句话的分量全在”按照相关实施办法”上。清单是门,各专业的实施办法是门把手。

覆盖的专业里反复出现三种机制:执业备案、登记、以及专业科目免考。具体适用哪一种,取决于专业和它的主管部门,通知本身不做选择。一项资格出现在清单上,并不自动等于可以签署意见、出庭,或担任需要持证上岗的职位;它带来的是”有资格去走那一条路”。

实务上可以把清单读成一份范围文件:它回答”持这个资格的人能不能在这里执业”,把”按什么条件执业”留给专业规则。对在合作区组建团队的雇主来说,尽职调查的问题因此不只是”资格在不在清单上”,还包括”对应办法规定的是哪种机制,候选人走完了没有”。

这也解释了一个几乎每次沟通都会出现的困惑:同一份清单上的两个资格,落地速度可能相差很远。一个只需备案,材料齐备即可;另一个要走登记,还要等主管部门的审核节奏。清单本身不体现这种差别,因为它不是为此设计的;只有翻到各专业的实施办法才看得出来。

备案与登记:两扇不同的门

通知把三种机制放在一句话里,值得拆开看,因为材料和周期都不一样。

备案产生一份记录。专业人员向主管部门提交材料,主管部门接受记录,此后可在备案写明的范围内执业。起控制作用的文件是备案本身和它列明的范围。备案通常是三者中最快的,也是对范围最敏感的一种:超出备案范围的工作,不受这份备案覆盖。

登记产生登记簿上的一条记录。专业人员被列入名册,执业权利来自”在册”这一事实。登记通常包含审核而不只是收件,所以周期取决于主管部门的节奏,而不是申请人准备得是否充分。

免考产生的是关于具体科目的决定。三者中它最窄,因为它处理的是取得资格过程中的一部分,而不是直接的服务权;在必须以内地考试作为取证路径的专业里,它最关键。

三条路里,前两条通向”不取内地牌照即可服务”,第三条是取证路径中的一步。一个下个月就要给客户出意见的人,和一个准备在合作区做十年执业的人,即便持同一项资格,需要的路径也可能不同。只看清单,看不出这一点。

经历怎么算:视同用在哪里

总体方案那句话的后半段——境外从业经历可视同境内从业经历——最容易被忽略,因为它不产生任何证书。它改变的是算术,不是许可。

算术在哪里起作用,跨境工作过的人都熟悉。职称或等级评审会问候选人有多少年相关执业经历,以及这些年限是否在可认定的机构里度过。招标文件或客户委托可能规定若干年境内从业经验。内部晋升矩阵会统计从业年限,同时留一个问号:境外那几年算不算。

视同回答的就是这个问号。它不把澳门资格变成内地资格,也不创设签字权;它做的是在评估一个人时,允许把资格背后的年限算进去——而这往往就是”纸面上像新人”和”纸面上像老手”的差别。

对雇主来说,实务含义在证据上。如果要在职称申报或投标材料里用上视同,境外年限的证明材料应当与备案同时准备,而不是几年后凭记忆和银行流水去重建。清单告诉你视同是存在的;你自己留下的档案,才让它变得可用。

判断走哪条路,方法是向对的主管部门问对的问题。有用的问法不是”我有没有被认可”——清单回答的是这个——而是”我这个专业的实施办法,要求我先完成什么才能执业”。有些专业答案是一份写明范围的备案;有些是进入主管部门维护的名册;有些是先就免考科目作出决定,再走通常的取证步骤。同一页上相邻的两项资格,背后的路可能完全不同。

这带来一个容易漏掉的排期后果。如果路径是备案,时间表掌握在申请人手里,因为工作本质是文档;如果路径是登记,时间表掌握在主管部门手里,申请人准备得再好,也只能决定最早可能的日期。把三种机制都按备案来估算、给什么都留三周的机构,正是错过窗口的那一类。

补贴与四项条件

同一天,该局启动 2026 年度支持澳门专业人才跨境执业补贴申报。申报期为 2026 年 11 月 11 日至 12 月 31 日,逾期不予受理。补贴标准为一次性 3 万元。

四项条件须同时满足。申请人须具有澳门居民身份。须与合作区用人单位签订一年及以上劳动合同,在该单位实际工作,且连续缴纳个人所得税六个月以上;截至申请补贴之日,劳动关系仍存续,且仍在合作区缴纳个人所得税。须在合作区用人单位实际从事与其执业资格证书相一致或相近的专业技术及管理工作六个月以上。所持执业资格须在《支持澳门专业人士跨境执业补贴目录清单》之内,且已取得在合作区提供相关服务的许可——形式包括备案、注册、登记、考试。

两个细节容易漏。六个月纳税期是以申报期往前推算的,合格月份必须在申报之前,而不是之后;换句话说,年底才入职的人,这一轮基本赶不上。社会保险指的是按法律规定以用人单位名义在合作区参加的社会保险,在别处缴的不能替代。

本轮覆盖的服务领域是金融、会计、税务、法律、医疗、教育等专业服务,与目录清单相对应。补贴依据《横琴粤澳深度合作区支持人才高质量发展若干措施》及《横琴粤澳深度合作区支持人才高质量发展奖补实施办法》执行;目录清单则随年度申请指南动态更新,并非一次定死。

申报为什么会被退回

四项条件都不长,但每一条都有固定的失手方式,把失手方式讲清楚,比重复条件更有用。

劳动关系断了。 一年及以上劳动合同是一条,连续缴纳个税六个月且申请之日关系仍存续是另一条。合格期内换过雇主、两份合同之间有空档,或者从合作区一家主体转到另一家,都可能打断连续性,哪怕人一直在工作。

执业范围与证书对不上。 条件要求从事与资格”相一致或相近”的专业技术及管理工作。持某一专业的资格、却在合格期主要做另一专业的事,即便职级更高,也难以说明这种对应关系。

许可不完整。 条件要求已取得在合作区提供相关服务的许可,形式包括备案、注册、登记、考试。只提交了资格证书、没有许可,或者许可覆盖的范围比实际从事的工作窄,都不满足条件。

两份清单混了。 执业认可清单决定”这个资格能不能在合作区执业”,补贴目录清单决定”持证人能不能领钱”。这是两份文件,两份都要对上;只在其中一份里的资格,按现状申报是走不通的。

时限、平台与两个时钟

申报通过横琴粤澳深度合作区惠企利民服务平台提交,进入”项目申报”栏目,按通知发布的指引填报。通知特别提示,不要集中在申报截止当天提交,以免系统拥堵、影响申报——这条提示来自经验而非客套,因为 12 月 31 日提交失败的申请,没有补救窗口。

这里有两个不同的时钟,把它们混为一谈是最常见的错过方式。补贴有硬截止:2026 年度申报到 12 月 31 日为止,通知里没有逾期通道,也没有留下酌情空间。清单则不同,通知没有给它失效日期:在被替换之前持续有效,就像 2025 年版被 2026 年版替换那样。

由此得出一条排期规则:从 12 月 31 日往前倒推。六个月合格工作和六个月纳税要在申报前完成,许可要在那之前取得,资格要在更早的时候就在两份清单上。对尚未走到一半的人来说,现实的目标是下一轮,而不是这一轮。

清单如何逐年维护

理解这份文件最有用的一点是:它是一套序列,不是一次性公告。2026 年版整体替换了 2025 年版,通知在同一天废止旧文件,而不是让两份并行。这个设计对依赖它的人有直接影响。

第一,引用会过期。合同、宣传册、岗位说明里如果写的是 2025 年版清单,写的就是一份已不存在的东西。第二,范围可能在两个版本之间双向变化:去年在列的资格,今年未必还在;去年不在的,今年可能已增补。第三,这套维护方式与补贴目录清单一致——后者随年度申请指南更新,而不是长期固定。

对机构来说,应对办法很小:记录每个人的档案是按哪一版核对的,并在每年年初重新核对一次。对个人来说更简单:把现行版本当作唯一有效依据,11 月 11 日之前写的东西一律当背景材料看。

紧接着有一个问题,通知只间接回答:按 2025 年版完成备案的人怎么办。由于旧通知是被废止而非修改,实务上的做法是按 2026 年版重新核对资格,并确认许可仍然与正在从事的工作匹配。资格仍在清单上、备案覆盖范围没变的,实质上与此前处在同一位置;资格有变化,或实际工作已经漂出备案范围的,就不一样了——而这正是复核要抓的情况。

通知没有另设过渡程序,所以稳妥的读法是:不要假定自动延续,把档案重新核一遍,而不是原样放着。

对澳门中小专业机构意味着什么

措施是写给个人的,但商业效果落在中小专业机构身上——那些服务两地客户的会计师事务所、税务顾问和法律事务所。

对这类机构,合作区一直有个具体难题。一位在澳门取得资格的合伙人,可以在澳门为客户的澳门法律事务出意见;但要在合作区内服务客户,就需要一个依据。备案提供了这个依据,而且不要求合伙人去考内地试;执业认可清单则让备案在一份确定的资格范围内成为可能。

还有一点关于小机构实际怎么用合作区。两三位合伙人的事务所很少整体搬迁。它做的是加法:一位合伙人完成备案,每周有一部分时间在合作区,逐步积累起一批需要在现场开会、递件、谈判的、由澳门资格顾问服务的客户。补贴正是按这种模式校准的——一次性款项,抵消第一年的摩擦,而不是支撑永久迁移的薪酬补贴。

这也意味着,只要守住范围,合规负担比看上去轻。把一个人的备案做得窄、把范围外的工作退回澳门办公室的机构,档案是可控的。把备案当成通用执业许可的机构,会积下一批它支撑不了的委托,而风险会在之后浮现——当客户或交易对手追问依据的时候。

经济账不大,但真实。一次性 3 万元不会改变一家事务所的命运,也不是为此设计的;它抵消的是第一年的成本与摩擦——备案、税务登记、往返、以及建立尚未产生收入的客户基础所花的时间。对两三位合伙人的事务所,这往往就是”在合作区开个小办公室”和”继续远程服务”之间的差别。

约束与其他地方一样:机构仍要确认合伙人持有的具体资格在清单上,该专业对应的机制是它能走完的,打算做的业务落在备案覆盖的范围内。最容易失望的,正是那些以为清单覆盖了”会计师”这个大类、而没有核对具体资格的机构。

两份清单,两个用途

这个政策领域里有两份清单,经常被混为一谈,所以值得单独一节说清楚,而不是放在脚注里。

执业认可清单——11 月 11 日印发的那一份——决定某项资格能不能在合作区执业。它是打开通道的文件,无论通道是备案、登记还是免考。它的分析单位是”资格”。

补贴目录清单——补贴通知里引用的那一份——决定持证人能不能申领那笔一次性补贴。它的分析单位同样是资格,但用途不同:它界定这项激励要覆盖的人群,并随年度申请指南更新,而不是一次定死。

两份清单重合度很高,这正是混淆可以理解的原因,但它们不是同一份清单,也不由同一套流程维护。只在执业认可清单里、不在补贴目录里的资格,支撑得起执业,支撑不起申报;两份都不在的,两样都不成立。

因此,对个人的顺序是:查执业认可清单,查对应机制,走完机制,查补贴目录清单,最后才谈申报。对替候选人做判断的机构,顺序一样;最常见的错误是从补贴倒推——因为钱是最显眼的部分——结果倒推出一条对这个资格并不存在的路径。

有一个一步就能化解大部分困惑的检验:问这个人下个月能不能在没有补贴的情况下为合作区客户提供服务。能,说明执业路径已经就位,补贴是另一个问题;不能,说明补贴不是当下要解决的事。

这个检验要按人来用,而不是按机构来用,因为两份清单可能给同一间办公室里的同事不同答案。甲持有的资格两份都在,乙只在执业认可清单上,丙两份都不在,却是机构里资历最深的那位。政策针对的是资格,不是资历;只按资历来排的用人计划,和这套政策对不上号。

这份清单不是给谁用的

一份认可清单很容易被读过头,所以有必要把”它不做什么”讲明白。

它不创设在合作区之外通用的执照。在横琴完成备案的专业人士,并不因此有权在另一个内地城市执业,通知也没有这样主张。地域范围就是合作区,客户在区外,就落在备案范围之外。

它不把境外资格变成内地资格。持证人仍然是”持澳门等境外资格、在约定条件下获准在合作区服务的人”。当客户、法院或主管部门要求内地证书时,清单提供不了,得走取证路径。

它不覆盖所有专业。总体方案那句话点到金融、建筑、规划、设计以及医疗领域,清单则通过附件界定自身范围。范围之外的专业不受这份文件帮助,无论工作看起来多相似。

它不免除主管部门这一环。备案与登记是与主管部门的往来,不是向无人处通报。备案可能因材料不全被退回,登记可能要等。清单减少的是门的数量,不是”门得有人开”这个事实。

它也不解决商业问题。在合作区执业是否划算,取决于客户、定价、竞争和两地办公的成本。政策降低的是进入成本,不创造需求。把认可当成商业论证的机构,通常会在第二年发现差别。

机构在下一轮之前该准备什么

对赶不上 2026 年这一轮的机构——考虑到六个月的门槛,多数机构都属于这一类——现在该做的是为下一轮做准备。四件事基本够用。

一人一档。 每位专业人士一份:资格证书、核对时依据的是哪一版认可清单、选择了哪种机制、备案或登记记录、记录覆盖的范围、劳动合同、纳税记录。放在一起,这份档案既能回答补贴的问题,也能回答日后”这项服务凭什么可以做”的问题。

从终点倒推的日历。 硬约束是六个月合格工作加六个月纳税,都要在申报之前完成。从截止日倒推得出起始日;从入职日顺推的机构,通常会迟到。

一份范围说明。 每位已备案的专业人士,用一小段文字写清备案覆盖什么、不覆盖什么。这份文件能防止合伙人接下超出范围的委托——那是商业上最要命的一种失手。

一份面向客户的说明。 客户会问:为什么一位澳门资格的顾问可以在合作区执业。一页纸讲清依据、范围和边界,比引用政策条文有用,而且往往是客户自己的合规团队会来索要的那份材料。

这些都不依赖补贴是否存在。但它们会让补贴在可以申请时,变成一次递交,而不是一次重建。

放在大湾区人才版图里看

横琴这份文件的定位,比互认协议窄,比意向表述实。它不创设一张通行大湾区的牌照;它为一份确定的资格清单,开出一条在特定区域执业的有据可循的路径,并给在年内用上这条路径的澳门居民一笔现金激励。

这让它区别于区域内的另一种做法。大湾区有些平台走的是比照认定目录:把境外资格对应到境内职业技能等级或职称,持证人可以据此申报相应的境内证书。横琴的清单走的是另一条路——开一条执业通道,资格本身仍是境外的。两种设计互补而非竞争:一种转换证书,一种允许执业。

与区域个人所得税优惠的关系也类似。税收措施作用在个人的税负上,认可清单作用在个人的执业权上。两项都符合条件的专业人士,两项都能享受,而彼此不能替代——这一点值得说明,因为二者有时被描述成同一个政策包。

对澳门专业人士,算账很短:核对 2026 年版清单与补贴目录清单,核对对应办法规定的是哪种机制,再核对能否在窗口关闭前完成并留下六个月的合格工作记录。对雇主,价值落在备案记录上:那是能向客户或主管部门说明”这项服务是按规定提供的”的文件。

更关键的是怎么读这类文件。它不是一道开一次就一直敞着的门;它是一份按年度发布、范围明确、背后挂着一整套分专业路径、并对其中一条附有单独激励的文件。按这个方式去读,它对一家想试水合作区的小机构确实有用;把它当成”澳门资格被普遍认可”,则会生出文本并不支持的期待,而这些期待往往在最不合时宜的时候浮出水面——在客户追问意见依据的那一刻。

来源

  • 横琴粤澳深度合作区人才发展和社会保障局·《关于印发〈横琴粤澳深度合作区境外职业资格便利执业认可清单(2026 年版)〉的通知》,2026-11-11:https://www.hengqin.gov.cn/macao_zh_hans/zwgk/tzgg/gg/content/post_3959289.html
  • 横琴粤澳深度合作区人才发展和社会保障局·《关于开展横琴粤澳深度合作区 2026 年度支持澳门专业人才跨境执业补贴申报工作的通知》,2026-11-11:https://www.hengqin.gov.cn/macao_zh_hans/zwgk/tzgg/gg/content/post_3958312.html
  • 横琴粤澳深度合作区·第 3/2026 号经济发展局规范性文件《横琴粤澳深度合作区支持人才高质量发展奖补实施办法》(第十九条、第二十条为跨境执业补贴条款):https://www.hengqin.gov.cn/lab/gfxwj/all/content/post_3931634.html

Nansha’s Talent Regulation Turns an Overseas Certificate Into a Chinese Title

  • Guangzhou’s Nansha talent regulation took effect on 1 November 2026 and runs to twenty articles, the city’s second local statute written for the district alone.
    广州市为南沙人才发展制定的这部条例自 2026 年 11 月 1 日起施行,共二十条,是该市专为南沙区量身打造的第二部地方性法规。
  • Article 13 requires a mechanism that compares overseas professional qualifications with China’s vocational skill levels and professional titles, backed by a catalogue that is updated rather than fixed once.
    第十三条要求建立境外职业资格与境内职业技能等级、职称的比照认定机制,并配套一份动态管理的比照认定目录。
  • A certificate on that catalogue lets its holder apply for the corresponding skill level or title; the wording is “may apply”, not “is granted”.
    持目录内证书的人才可以申报对应的职业技能等级或专业技术职称,条文用的是”可以申报”,而不是直接授予。
  • The chain runs from a catalogue entry to a filed application, then to assessment by the human resources and social security authorities; the regulation fixes the machinery but not the timetable.
    链条是:目录在册、提交申报、由人力资源社会保障部门组织评审;条例把机制定下来,但没有规定时限。
  • Articles 14 and 15 make service officers, rental housing, talent apartments, international schools and classes for Hong Kong and Macao children a legal duty, and let the district write and review its own talent household registration rules.
    第十四条、第十五条把服务专员、租赁住房、人才公寓、国际学校与港澳子弟班写成了法定职责,并允许南沙自行制定人才入户办法、自主审核办理。
  • Article 16 commits the police and the district government to smoothing visas, work permits, residence permits and permanent residence for foreign talent, plus a green channel for Hong Kong and Macao endorsements.
    第十六条要求公安机关与南沙区政府为外籍人才办理签证、工作许可、居留许可以及申请永久居留提供便利,并设立办理往来港澳商务签注、人才签注的绿色通道。
  • State organs, public institutions, statutory bodies and state-owned enterprises in Nansha may recruit qualified Hong Kong and Macao talent, a door that was previously closed.
    南沙的国家机关、事业单位、法定机构、国有企业可以招录或招聘符合条件的港澳人才,这在此前是关着的门。
  • Nansha reports a catalogue of 137 international qualification certificates, 248 recognised qualifications across 12 priority industries, and more than 400 Hong Kong and Macao professionals practising locally.
    据权威报道,南沙已建立涵盖 137 项国际职业资格证书的职称对应关系目录,实现 12 大重点产业 248 项境外职业资格认可,超过 400 名港澳专业人士在当地便利执业。

Nansha’s Talent Regulation Turns an Overseas Certificate Into a Chinese Title | 南沙人才条例:把一张境外证书换算成中国职称

A local statute with national significance

On 1 November 2026 the Guangzhou Nansha Talent Development Promotion Regulation came into force. It runs to twenty articles and is the second local regulation Guangzhou has written specifically for Nansha District.

The first thing to notice is what the text does not contain. There is no fund, no application window, no quota and no subsidy table. Anyone who opens it looking for a number to budget against will close it disappointed. What the twenty articles contain instead is a division of labour: named government bodies are told what they must build, and the thresholds, lists and procedures are pushed into catalogues and supporting rules that will be issued later.

That structure is why the regulation matters beyond its own district. A foreign professional’s file in China is rarely decided by one document. It is decided by a chain of them: a qualification, a recognition decision, a title, an employer’s registration, a residence permit. A local regulation that takes one link in that chain and gives it a legal basis changes the terms on which the other links are negotiated. There is a second reason to read it closely, which has little to do with Nansha’s own ambitions. Local legislation is where national policy becomes administrable. The centre sets the framework, the province sets the direction, and a city regulation decides which office keeps the list, which department answers the telephone, and what happens when the two disagree. For a company planning hiring two or three years out, that last layer is the one that decides whether a promise turns into a process.

The timing says something too. Regulations are written when a practice has become stable enough to codify, not while it is still being invented. The fact that Guangzhou chose to legislate on talent development for a single district suggests that the arrangements described in the text have been running long enough for the drafters to know where they break.

What kind of document this is

A local regulation is not a departmental notice. It is adopted through a local legislative procedure and it binds the government bodies named in it, not only the enterprises it talks about. A departmental normative document can be revised by the department that issued it, sometimes quietly, sometimes within a single budget cycle. A regulation has to be amended through the legislature again, and until then it stands.

For a company planning three to five years ahead, that difference is the whole value. The promise “the district will maintain a comparison catalogue and review it periodically” is worth more than a one-off recognition list, because the obligation survives the official who signed it.

The limit is equally important. A local regulation cannot create an entitlement that national law does not allow. It cannot lower the statutory conditions for a work permit or a permanent residence application, and it cannot grant a licence to practise a regulated profession. What it can do is organise how the city uses the discretion it already has — which desk handles a file, which department maintains a list, which channel a family uses. Read within those limits, Article 13 is ambitious; A practical test of the difference is what happens when an official leaves. A departmental document tends to leave with its author: the next incumbent reviews it, and the practice softens or disappears without anyone announcing a change. A regulation stays, and so does the duty to maintain the catalogue, publish the service list and staff the service desks. That continuity is what a five-year hiring plan actually needs.

The limit is just as practical. Because the regulation cannot alter national conditions, it should be read as a map of local discretion rather than a source of new rights. Where it says the district will facilitate something, the facilitation is real; where it is silent, the national rule governs unchanged.

Article 13: from a certificate to a title

Article 13 directs the municipal and district governments to carry out the reform and piloting requirements attached to Nansha’s three designations — a national pilot zone for talent management reform, a demonstration zone for Guangdong-Hong Kong-Macao talent cooperation, and an internationalised talent special zone — and to draw on how Qianhai, Hetao and Hengqin have handled Hong Kong and Macao talent policy.

Then the operative sentence. The municipal human resources and social security department, working with the industry regulators and the district government and taking account of what local industries need, is to establish a mechanism comparing overseas professional qualifications with domestic vocational skill levels and professional technical titles, and is to draw up a comparison catalogue that is managed dynamically.

The consequence follows in a single line: a person holding an overseas professional qualification certificate listed in that catalogue may apply for the corresponding national vocational skill level or professional technical title. Two verbs carry the weight. “Establish” binds the bureaucracy to build the machinery. “May apply” tells the individual what the machinery is for. Neither promises an outcome, and The three designations in the first paragraph are not decoration. A national pilot zone for talent management reform carries authority to try institutional changes other districts cannot; a demonstration zone for Guangdong-Hong Kong-Macao talent cooperation carries a mandate to align rules across the three jurisdictions; an internationalised talent special zone carries a mandate to serve foreign nationals specifically. Article 13 stacks all three as the legal hook for the comparison mechanism.

That is why the article can use “explore” for one half of its subject and “establish” for the other. Exploration covers what depends on agreement with Hong Kong and Macao. Establishment covers what lies inside the city’s own competence. One half waits for counterparts; the other half does not.

The chain from certificate to title

Read as a process rather than a principle, the article describes four steps, and each has its own owner.

The first is the catalogue. Nothing starts until a certificate appears on it, and the list is maintained by the human resources and social security department together with industry regulators. For an applicant, this is a screening question that can be answered before any paperwork is prepared: either the certificate is listed, or the conversation ends there for now.

The second is the application itself. The regulation uses the language of filing — the holder applies for the corresponding grade — which means the initiative sits with the individual and, in practice, with the employer’s human resources team that assembles the evidence.

The third is assessment. The article assigns the mechanism, not the decision, to the human resources and social security authorities. What the assessors weigh, which documents they accept for a qualification earned outside mainland China, and how long the review takes are matters for the catalogue and the implementing rules. The regulation does not fix a deadline, and no deadline should be inferred from it.

The fourth is the outcome: a vocational skill level or a professional technical title. These are two different ladders. Skill levels are graded through assessment arrangements organised around employers and evaluation bodies; titles run through the professional title evaluation system, which is where public institutions, state-owned employers and many talent programmes look when they need a grade. The catalogue has to say which ladder a given certificate maps to, The employer’s role deserves its own note. In most cases the individual holds the certificate, but the employer holds the evidence: the contract, the job description, the record of what the person actually does. Assessors read a file as a story about a job, not as a certificate in isolation, and an application that describes the role vaguely tends to produce a grade that undersells it. Human resources teams that have been through the process once usually rewrite the job description before the second attempt.

What happens when a certificate is not on the list is worth knowing too. The answer is not an appeal against the catalogue; it is either a different route to a grade, or a wait for the next revision. A company with several staff in the same position should check the list once for the group rather than once per person.

What equivalence does not cover

Three boundaries keep expectations calibrated, and all three are visible in the text.

Application is not award. The regulation opens a filing route; assessment and decision stay with the authorities under rules the article does not rewrite. A certificate on the list converts an eligibility question into a procedure, which is a real gain but a procedural one.

A title is not a licence. A professional title says where a person sits in an evaluation hierarchy. Permission to practise a regulated profession — medicine, law, architecture — is a separate authorisation with its own examination and registration route. Article 13 places mutual recognition of practice qualifications alongside mutual recognition of evaluation standards and calls it something to be explored, which is the careful wording of a subject still under negotiation among the three jurisdictions.

And the catalogue moves. Managed dynamically and tied to industry demand, the list that governed a decision two years ago may not be the list that governs the next one. The date to check is the filing date, A further distinction catches people out: recognition and examination are different acts. Recognition asks whether a qualification earned elsewhere is equivalent to something here; examination asks whether a person meets a standard set here. Article 13 is about the first. A regulated profession normally requires the second as well, and no amount of catalogue work substitutes for it.

That is why the article is more useful to some professions than others. For an engineer, an accountant, or a project manager in a sector where titles drive grading and programme eligibility, the mechanism does real work. For a physician or a lawyer, it may smooth one step while leaving the licensing step untouched. Reading the article against your own profession, rather than against its headline, is the only way to know which case you are in.

Borrowed ground: Qianhai, Hetao and Hengqin

Article 13 tells Nansha to draw on the practice of three other platforms in the Greater Bay Area, and the instruction is more than courtesy. It signals that the comparison mechanism is not a Nansha experiment starting from zero; it is a codification of a route that has already been walked elsewhere in the region.

The practical consequence is that the questions have answers. A professional who has been through a similar process in Qianhai, Hetao or Hengqin knows what kind of evidence tends to be accepted, how a title evaluation body reads a foreign certificate, and where a file usually stalls. That knowledge transfers, at least in outline.

What Nansha adds is a statutory basis and a delivery structure that reaches down to the district. The mechanism is assigned jointly to the municipal department, the industry regulators and the district government, which is a different arrangement from a pilot run by a single office. It also ties the work to three designations that carry their own reform mandates, For a professional who has already been through a similar process elsewhere in the region, the value is a shorter learning curve. The questions are the ones that mattered in Qianhai or Hengqin: which body holds the catalogue, whether a translation and notarisation are expected, whether the assessors want the syllabus of the overseas course or only the certificate, and how a grade awarded by an employer compares with one awarded through the evaluation system.

The difference in Nansha is the delivery layer. Because the mechanism is assigned jointly to the municipal department, the industry regulators and the district government, a company with a specific problem has more than one place to take it — and the industry regulator is often the most useful of the three, since it knows what the sector needs, which is the reason the article gives for having a catalogue at all.

Articles 14 and 15: services, housing and schooling

Article 14 is administrative but practical: a published list of talent introduction service items, an online platform alongside physical service stations, and a service officer for anyone entered in the high-level talent database. None of that changes a legal status, but it changes how quickly a newcomer can find out what applies to them.

Article 15 addresses what families ask first. The district may adopt its own rules on household registration for talent and handle applications itself. It is to build international, Hong Kong and Macao, and youth communities; provide rental housing, talent apartments and purchase subsidies; strengthen international schools and schools and classes for Hong Kong and Macao children; and push hospitals toward cross-border medical insurance settlement.

The order of that list is not accidental. Housing and schooling are the two items on which a relocation decision usually turns, and they are the two items a company can least credibly promise on its own. When they appear in a local regulation rather than in an investment agreement, they become duties that can be reported on, The service officer is the least glamorous item in the article and, for a newly arrived family, often the most useful. A named person who can say which window handles a residence permit renewal, which school has a place in the international stream, and which housing scheme the employer’s registration qualifies for is worth more than a portal with fifty links. The regulation pairs the two: a platform for information, stations for presence, and a person for the cases that do not fit a form.

The community provisions work the same way. International, Hong Kong and Macao, and youth communities are not just addresses; they are where a trailing spouse finds a professional network and Schooling deserves one more paragraph, because it is where timetables collide. International schools and schools for Hong Kong and Macao children keep their own admission cycles, language streams and waiting lists, and a family that arrives in March for a September place is already late in a way no residence permit can fix. The regulation does not promise a place. It puts the duty to strengthen those schools into a text the district must answer for, which is the difference between a brochure and a plan.

Continuity is the second point. Children who move between systems lose time when the curricula do not line up, and classes for Hong Kong and Macao children exist to soften that transition. An employer negotiating a package should ask which of those options has capacity in the relevant year group, rather than which ones exist in principle.

The household registration power, read closely

Buried in Article 15 is a competence that deserves separate attention: the district may formulate differentiated regional rules on talent household registration and review and process the applications itself.

Household registration is the hinge on which much of the rest turns. It is commonly the precondition for school admission, for purchase eligibility in a controlled housing market, and for the long-term planning that a family does before it commits to a city. A district that can set its own criteria and process its own files can respond to a labour shortage faster than a city-wide queue allows.

The caveat is that this is a power to make rules, not a promise of a quota. The district still has to write the implementing measures, and the criteria will still be published. For an employer, the useful question is not whether the power exists but For a family, the practical sequence usually runs like this: a job offer, a decision about schooling, a decision about housing, and only then a decision about how long to stay. Household registration sits underneath all three. Where a district controls both the rules and the review, it can shorten the interval between the offer and the enrolment — which is often the interval in which a candidate accepts a competing offer instead.

Two cautions are worth keeping. The power is to make differentiated rules, so the criteria will be specific and will change; and the review is autonomous, which means the district’s own reading governs. Employers should ask for the current measures in writing rather than rely on what a colleague was told last year.

Article 16: entry, residence and permanent residence

Article 16 is the one foreign employees will read first. The municipal public security authorities and the district government are to improve consultation on entry and residence policy and language training, and to ease access to visas, work permits, residence permits and permanent residence. The district is also to open a green channel for Hong Kong and Macao business and talent endorsements.

The honest reading is that this creates a service obligation, not a new eligibility standard. The conditions for a work permit, a residence permit or permanent residence remain where they were, in national law and the implementing rules of the immigration authorities. What the article does is connect those conditions to a local delivery system: named desks, a green channel, interpretation and language support, and staff whose job is to explain the rules before a file is submitted rather than after it is rejected.

That connection matters more than it sounds. The work permit system already sorts foreign employees into categories that determine what an employer must show and how long a permit can run. Article 16 does not touch those categories. The work permit system is the piece most often misunderstood at this point. Foreign employees are already sorted into categories that determine what an employer must show and how long a permit may run, and those categories are set nationally. Article 16 does not create a new one and does not promise a faster one. It promises that the local handling of an existing category will be explained, staffed and, where the file is straightforward, moved through a dedicated channel.

The endorsement green channel is a separate item that is easy to overlook. It concerns Hong Kong and Macao business and talent endorsements, which mainland staff need for short trips south. Placing it in the same article as visas and residence permits says something about how the district sees mobility: Permanent residence is the item most often misread. The article speaks of facilitating an application, not of changing the criteria; those are set nationally and are demanding. What a district can add is advice before the file is built, an officer who stays with it, and a realistic account of the residence history the application will need. Companies that read the article as a reason to start earlier, rather than as a reason to expect a different answer, get the most from it.

Public-sector recruitment and its knock-on effects

Separately, the regulation states that state organs, public institutions, statutory bodies and state-owned enterprises in Nansha may recruit or employ qualified Hong Kong and Macao talent.

For Hong Kong and Macao residents this widens the set of employers worth approaching, including institutions that previously had no route to hire them at all. Public-sector posts on the mainland have generally been closed to non-mainland residents, and removing that bar in one district is a structural change rather than a symbolic one.

For firms, the effect is indirect but worth tracking. Where tender documents score the credentials of named staff, or where a client’s project team must include people with public-sector experience, a wider pool of qualified professionals changes what a bidder can credibly offer. The regulation does not mention procurement; it does not need to. It changes who can be on the team.

Two effects follow. The first is on the market for experienced Hong Kong and Macao professionals: a public-sector employer that can now hire them becomes a competitor for the same people that consultancies and corporate functions recruit. The second is on how credentials are read. A curriculum vitae that includes a stint in a mainland public institution reads differently in a tender than one that does not, and the regulation quietly widens the pool of people who can acquire that line.

Neither effect arrives on 1 November. Both depend on recruitment rules, job design, and how personnel systems handle Hong Kong and Macao identity documents. The regulation removes a bar; the operating details decide how wide the opening becomes.

A practical note for firms: the effect is easiest to see in the composition of a bid team. Where a tender asks for named staff with experience of public projects, a candidate pool that now includes people who have worked inside a mainland public institution is worth mapping before the next submission, even if nobody on the current team is affected.

The mapping already in place

According to authoritative reports, Nansha has built a catalogue mapping 137 international qualification certificates to Chinese titles, extended recognition to 248 overseas qualifications across 12 priority industries, and seen more than 400 Hong Kong and Macao professionals take up practice under facilitated arrangements.

Those figures describe the pilot. What the statute adds is durability: a legal basis, a catalogue with a maintenance duty, and obligations on named departments rather than a programme that ends with its funding cycle.

The useful follow-up questions are administrative. Which department maintains the list, how often it is revised, and what changed between the last two versions. Answers to those tell a professional more about whether a certificate is worth pursuing It is also worth noticing what the regulation does not do with these numbers. It does not freeze them, endorse them or turn them into a target. They remain a description of how the pilot has behaved, and the statute’s job is to keep the machinery that produced them running under a legal duty. For a reader, that is a more useful relationship than a promise of a particular total. The second is to distinguish a certificate recognised for practice from one that maps to a title; the reported totals usually count both, and the two do different things for a career.

The regulation’s contribution is that these questions now have an address. A catalogue maintained by named departments, under a duty to keep it current, is a different object from a list published once at the launch of a pilot. It can be queried, compared across versions, and cited in an internal business case — It is worth noticing what the regulation does not do with these numbers. It does not freeze them, endorse them or turn them into a target. They remain a description of how the pilot has behaved, while the statute’s task is to keep the machinery that produced them running under a legal duty.

What a foreign professional should prepare

None of this amounts to a filing checklist, because the checklist has not been published. What can be settled now is where you stand: whether the certificate is listed, which ladder it maps to, and whether the employer’s job description supports the grade being sought. The rest follows from those three answers, and each of them can be obtained in a single conversation with the district bureau rather than through a consultant.

  • Confirm whether your qualification is on the current comparison catalogue, and note the date of the version you checked.
  • Separate two questions: whether you may practise, and what grade you will be placed at. They run on different tracks.
  • Establish which ladder your certificate maps to — vocational skill level or professional title — because the downstream uses differ.
  • Ask the district human resources and social security bureau which body assesses your file and what evidence it accepts for a qualification earned abroad.
  • Involve your employer early; titles are read by employers and by the talent programmes they apply for.
  • If you are a Hong Kong or Macao resident, look at the public-sector employers the regulation now opens, not only the private market.
  • Diarise the catalogue review cycle. A dynamic list invites re-checking, not a one-time answer.
  • Keep a copy of the version you relied on; a later revision will not retroactively explain an earlier decision.
  • If your employer is preparing a title application, check that the job description matches the grade you are asking for.

Sources

  • 广州市南沙区人民政府·《广州市南沙人才发展促进条例》中英双语全文:https://www.gzns.gov.cn/zwgk/rdzt/hgazczl/cyzc/hgazxzc/rc/content/post_11083998.html
  • 广东省人民政府·11 月起施行法规解读(含南沙境外职业资格比照认定机制):https://www.gd.gov.cn/zwgk/zcjd/snzcsd/content/post_4973852.html
  • 广东省人民政府新闻办公室·南沙人才政策报道:https://gdio.southcn.com/node_5201f00af5/8623acaa6c.shtml

南沙人才条例:把一张境外证书换算成中国职称

一部有全国意义的地方性法规

2026 年 11 月 1 日,《广州市南沙人才发展促进条例》施行。全文共二十条,是广州市专为南沙区量身打造的第二部地方性法规。

首先要看的是它没有写什么。没有资金、没有申报窗口、没有名额,也没有补贴表。抱着找一个可以写进预算的数字的期待翻开它,多半会失望地合上。二十条里写的是分工:点名要求哪些政府部门去建什么,把门槛、目录和程序推到之后出台的比照认定目录与配套细则里。

也正因如此,这部条例的意义不止于一个区。一位外籍专业人士在中国的材料,很少由一份文件决定,而是由一串文件决定:一张资格证书、一次认可决定、一项职称、一份用人单位登记、一张居留许可。地方性法规的作用,是从这条链上取下一环,给它一个法律依据,从而改变其余各环的谈判条件。还有一层理由与南沙自身的抱负无关。国家层面的政策要落地,靠的是地方立法:中央定框架,省里定方向,而一座城市的法规决定由哪个部门保管目录、由谁接电话、两边口径不一致时听谁的。对需要提前两三年规划用工的企业来说,正是这最后一层决定了承诺能不能变成流程。

时间点也说明了问题。法规通常在做法足够稳定、可以成文的时候才写,而不是在试验刚起步的时候写。广州选择为一个区的人才发展专门立法,说明条文描述的那些安排已经运行了足够久,起草者知道它们会在哪里卡住。

这是一份什么性质的文件

地方性法规不是部门通知。它经过地方立法程序通过,约束的是条文里点名的政府机关,而不只是它谈论的企业。部门规范性文件可以由发文部门自行修改,有时悄无声息,有时就在一个预算周期之内;法规要改,得再走一次立法程序,在那之前,它一直有效。

对做三到五年规划的企业来说,这个差别就是全部价值所在。“本区将维护一份比照认定目录并定期复审”这句承诺,比一份一次性的认可名单更有分量,因为它所附带的义务会一直存在,不会随着签字的官员离任而消失。

边界同样重要。地方性法规不能创设国家法律不允许的权利:它不能降低工作许可或永久居留的法定条件,也不能授予受管制职业的执业资格。它能做的是安排本市如何行使既有的裁量权——哪个窗口受理、哪个部门维护目录、家庭走哪条通道。在这个边界内看,第十三条是进取的;一个实用的检验办法是看官员离任之后会怎样。部门文件往往随作者一起走:继任者重新审一遍,做法慢慢松掉甚至消失,也没有人正式宣布改变。法规留了下来,维护目录、公布服务清单、配备服务专员的义务也留了下来。五年期的用工规划真正需要的,正是这种连续性。

边界同样务实。既然法规改不动国家层面的条件,就应当把它读成一张地方裁量权的地图,而不是新权利的来源。它说本区将提供便利,那个便利就是真的;它没有说的地方,仍然按国家规定办。

第十三条:从一张证书到一项职称

第十三条要求市人民政府、南沙区人民政府在南沙落实三项定位所附带的改革创新、先行先试要求——全国人才管理改革试验区、粤港澳人才合作示范区、国际化人才特区——并借鉴前海深港现代服务业合作区、河套深港科技创新合作区、横琴粤澳深度合作区在港澳人才政策上的做法。

接下来是真正起作用的那句条文。市人力资源和社会保障部门会同市相关行业主管部门、南沙区政府,结合产业需求,在南沙建立境外职业资格与境内职业技能等级、职称的比照认定机制,并制定一份动态管理的比照认定目录。

再往下是后果,只有一句话:持有目录内境外职业资格证书的人才,可以申报对应的国家职业技能等级或者专业技术职称。两个动词承重。“建立”把机制建设变成对政府部门的硬约束;“可以申报”告诉个人这套机制是给谁用的。两者都不承诺结果,而这两者之间的距离,第一段里的三项定位不是装饰。全国人才管理改革试验区带有尝试制度改革的授权,别的区做不了的事这里可以试;粤港澳人才合作示范区带有推动三地规则衔接的任务;国际化人才特区则明确指向服务外籍人才。第十三条把三者叠加起来,作为比照认定机制的法律抓手。

这也是同一条条文里,一半用“探索”、另一半用“建立”的原因。“探索”覆盖的是需要与港澳达成一致的部分;“建立”覆盖的是本市权限之内的部分。一半在等对手方,另一半不用等。

从证书到职称的四个环节

把这一条当成流程而不是原则来读,它描述的是四个环节,每个环节都有各自的负责人。

第一个环节是目录。证书没有进入目录,后面的事都不会发生;目录由人力资源社会保障部门会同行业主管部门维护。对申请人来说,这是一道可以在准备任何材料之前就先问清的问题:要么在册,要么暂时谈不下去。

第二个环节是申报。条文用的是“申报”这个词,意思是主动权在个人手里,实务中则往往由用人单位的人事团队来组织材料。

第三个环节是评审。条文把机制交给人力资源社会保障部门,而不是把决定权写死。评审看什么、境外取得的资格接受哪些证明、审核要多久,属于目录与配套细则的范畴。条例没有规定时限,也不应当从条文中推断出时限。

第四个环节是结果:一项职业技能等级,或者一项专业技术职称。这是两把不同的尺子。职业技能等级围绕用人单位与评价机构组织的认定展开;职称走的是专业技术职称评审体系,事业单位、国有用人单位和不少人才计划看的正是这一级。因此,目录必须写清一张证书对应的是哪一把尺子——对应错了,用人单位的角色值得单独说一句。多数情况下证书在个人手里,但证明材料在单位手里:劳动合同、岗位说明、这个人实际做什么的记录。评审机构读的是一份关于岗位的叙述,而不是一张孤立的证书;岗位描述写得含糊,评出来的等级往往偏低。走过一次流程的人事团队,通常会在第二次申报之前先把岗位说明重写一遍。

证书不在目录上时该怎么办,同样值得知道。答案不是去申诉目录,而是换一条通往等级的路径,或者等下一次修订。同一岗位有多名员工的企业,应当按群体查一次目录,而不是一个人查一次。

比照认定不覆盖什么

三条边界让预期停在合适的位置,而且三条都能在条文里看到。

第一,申报不等于授予。条例打开的是一条申报通道,评审与决定权仍在主管部门手里,依据的是这一条并未改写的规则。证书进入目录,把“够不够资格”的问题变成了一道程序,这是实实在在的收获,但收获是程序性的。

第二,职称不是执业许可。职称说明一个人在评价序列里处在什么位置;从事受管制职业的许可——医师、律师、建筑师——是另一套授权,有自己的考试与注册路径。第十三条把执业资格互认与评价标准互认并列,用的词是“探索”,这是三地之间仍在协商的话题所特有的谨慎措辞。

第三,目录会动。动态管理、与产业需求挂钩,意味着两年前决定过一次的那一版,未必就是下一次适用的那一版。要核对的是申报当日有效的那一版,还有一处区分常常让人误判:认可与考试是两件事。认可问的是在别处取得的资格与这里的某种资格是否等价;考试问的是一个人是否达到了这里设定的标准。第十三条讲的是前者。受管制职业通常还需要后者,目录做得再好也替代不了它。

这也是为什么这一条对某些职业更有用。对工程师、会计师,或者在职称直接影响定级与项目申报资格的行业里做项目管理的人,这套机制是实打实起作用的。对医师或律师,它可能只抹平了一步,而许可那一步原地不动。

借来的地基:前海、河套、横琴

第十三条要求南沙借鉴另外三个平台的做法,这句要求不只是客套。它说明比照认定不是从零开始的南沙试验,而是把一条已经在区域内走通的路径写成地方法规。

实际影响是:问题已经有了答案。在前海、河套或者横琴走过类似流程的专业人士,大致知道什么样的证明材料容易被接受、职称评审机构怎么读一张境外证书、材料通常卡在哪一环。这些经验至少在大框架上可以平移。

南沙增加的是两样东西:一个法律依据,以及一套下沉到区的执行结构。机制由市人社部门、行业主管部门与区政府共同承担,这与单一办公室主导的试点不同;同时它挂靠在三项本身带有改革授权的定位上,对已经在区域内走过类似流程的专业人士来说,实际价值是学习曲线变短。该问的问题与前海、横琴并无不同:目录由哪个机构保管、是否要做翻译与公证、评审方要看课程大纲还是只要证书、用人单位评的等级与评审体系评的等级如何对应。

南沙的不同在于执行层。机制由市人社部门、行业主管部门与区政府共同承担,遇到具体问题的企业因此有不止一个地方可以问;三者之中,行业主管部门往往最有用——它清楚本行业真正需要什么,而“结合产业需求”正是条文为目录给出的理由。

第十四条与第十五条:服务、安居与入学

第十四条偏行政,但很实用。市、区两级要编制并公布人才引进服务事项清单,建设线上人才服务平台与线下人才驿站,并为纳入高层次人才数据库的人才配备服务专员。这些都不改变任何法律状态,但会改变一个新来的人多快能弄清哪些规定适用于自己。

第十五条回答的是家庭最先问的那几个问题。南沙可以制定差异化区域性人才入户实施办法,并自主审核办理。条例要求建设国际人才社区、港澳社区、青年社区;提供租赁住房、人才公寓、购房补贴;加强国际学校、港澳子弟学校、港澳子弟班建设;推动医疗卫生机构实行跨境医疗保险直接结算。

这份清单的顺序不是随手排的。住房与入学,是举家迁移决策通常绕不开的两件事,也是企业最难单方面作出承诺的两件事。当它们出现在地方性法规里而不是投资协议里,就变成了可以被追问、被报告的法定职责,服务专员是条文里最不显眼的一项,对一个刚落地的家庭却往往最有用。一个能说清哪扇窗口办居留许可续期、哪所学校国际部还有名额、以本单位登记情况能申请哪一类住房的人,比一个挂着五十个链接的网站管用。条例把两者配在一起:线上平台负责信息,线下驿站负责在场,专员负责那些填不进表格的情形。

社区条款是同一个逻辑。国际人才社区、港澳社区、青年社区不只是地址,它们是随迁配偶找到职业圈子、入学值得再写一段,因为时间表在这里最容易撞车。国际学校与港澳子弟学校有自己的招生周期、语言分轨与等候名单;三月才到、九月要入学的家庭,往往在居留许可还没办完的时候就已经晚了。条例不承诺学位,它做的是把“加强建设”写进一份区里必须回应的文本——宣传册与工作计划之间的差别,就在这里。

另一个实务点是衔接。在不同体系之间转学的孩子,课程对不上就会损失时间,港澳子弟班存在的意义正是缓冲这一段。企业在谈薪酬方案时,应当问的是相关年级今年有没有名额,而不是原则上有没有这类学校。

人才入户这项权限,值得单独看

第十五条里藏着一条值得单独拎出来看的权限:南沙可以制定差异化区域性人才入户实施办法,并自主审核办理人才入户。

户籍是许多事情的门轴。它常常是入学的先决条件,是限购市场里购房资格的前提,也是一个家庭在决定扎根一座城市之前必须先算清的一项。一个可以自定标准、自己审自己批的区,回应用人缺口的速度,会比全市统一排队快得多。

需要提醒的是,这是一项制定规则的权力,不是名额承诺。实施细则仍要出台,标准仍要公布。对用人单位来说,有用的问题不是“这项权力有没有”,对一个家庭来说,实际顺序通常是这样:拿到录用通知、决定孩子上学、决定住哪里,最后才决定待多久。户籍压在这三件事下面。一个既掌握规则又掌握审核权的区,可以把从录用到入学之间的间隔压短,而这段间隔,往往正是候选人转投另一份录用通知的窗口。

两点提醒要留住。这项权力的内容是制定差异化规则,所以标准会很具体,也会变;审核是自主的,因此区里的解释就是准绳。用人单位应当索取现行办法的书面文本,而不是听同事转述去年听到的说法。

第十六条:签证、居留与永久居留

第十六条是外籍雇员会先翻到的那一条。市公安机关、南沙区政府要完善出境入境和居留政策咨询、语言文化培训等服务,为外籍人才办理签证、工作许可、居留许可以及申请在中国永久居留提供便利。南沙区政府还要设立绿色通道,为本行政区域内单位和人才办理往来港澳商务签注、人才签注提供便捷服务。

诚实的读法是:这一条创设的是服务义务,不是新的资格标准。工作许可、居留许可与永久居留的条件仍在原处,写在国家法律与移民管理部门的实施规定里。这一条做的是把这些条件接到一套本地的服务体系上:有指定的窗口、有绿色通道、有解释与语言支持,有专人在材料递交之前而不是被退回之后讲解规则。

这个衔接比听起来更重要。工作许可制度本来就把外籍雇员分成不同类别,类别决定用人单位要证明什么、许可可以批多久。第十六条没有改动这些类别,它是把它们当作前提,在这个节点上,最容易被误解的是工作许可制度。外籍雇员本来就被分成不同类别,类别决定用人单位要证明什么、许可可以批多久,而这些类别由国家统一设定。第十六条没有新设类别,也没有承诺更快的类别。它承诺的是:对既有类别的本地经办会有解释、有人负责,材料清楚的情形可以走专门通道。

绿色通道是另一项容易被忽略的内容。它针对的是往来港澳商务签注与人才签注——内地员工南下短期出差要用到的证件。把这件事与签证、居留许可写进同一条,其实是在表明本区如何看待人员流动:永久居留是最常被误读的一项。条文说的是为申请提供便利,不是改动条件;条件由国家设定,而且不低。一个区能增加的是材料成形之前的指导、一位跟到底的经办人,以及对居住年限证据的务实说明。把这一条读成“应当更早开始准备”的理由,而不是“结果会不一样”的理由,收获最大。

这也解释了为什么同一份条文对不同企业的价值差别很大:常年有外籍高管轮换的公司,受益于流程的确定性;偶尔办一次的公司,更需要的是一份写得清楚的清单。

公共部门招录,以及它的连带影响

在上述条款之外,条例还明确:南沙的国家机关、事业单位、法定机构、国有企业可以招录或招聘符合条件的港澳人才。

对港澳居民来说,值得接触的雇主范围因此变宽,其中还包括过去根本没有渠道招聘他们的机构。内地公共部门的岗位此前基本不向非内地居民开放,在一个区里移除这道门槛,是结构性的改变,而不只是象征性的姿态。

对企业来说,影响是间接的,但值得跟踪。在那些按拟派人员资历打分的招标文件里,或者在客户要求项目团队必须具备公共部门经历的场合,可选的专业人士池子变大,会改变一家投标方能够拿出什么样的组合。条例没有提到采购,也不需要提——由此产生两个效果。第一,对有经验的港澳专业人士来说,劳动力市场变了:一个现在可以招聘他们的公共部门用人单位,会成为咨询机构与企业职能部门争夺同一批人的竞争者。第二,资历的读法变了。简历上有一段内地公共机构经历的人,在投标材料里的分量与没有的人不同,而条例悄然扩大了能够获得这段经历的人群。

两个效果都不会在 11 月 1 日当天出现。它们取决于招录规则、岗位设置,以及人事系统如何处理港澳居民的身份证件。条例移除的是一道门槛,开口最终有多宽,由操作细节决定。

已经运行的那张对应表

据权威报道,南沙此前已建立涵盖 137 项国际职业资格证书的职称对应关系目录,实现 12 大重点产业 248 项境外职业资格认可,并有超过 400 名港澳专业人士在当地按便利化安排执业。

这些数字描述的是试点。法规增加的是耐久性:一个有法律依据的机制、一份负有维护义务的目录、以及落在具体部门头上的职责,而不是随经费周期结束就停下来的项目。

接下来更有用的问题偏行政:这张目录由哪个部门维护、多久修订一次、上一版与这一版之间改了什么。对这些问题的回答,要让这些数字真正可用,有两个习惯。第一是索取目录本身而不是目录摘要,并保留你依据的那一版。第二是区分“可用于执业的认可”与“可对应职称的认可”;公布的总数通常把两者合在一起算,而它们对一个人的职业路径作用并不相同。

条例的贡献在于,这些问题现在有了收件地址。由点名的部门维护、负有保持更新义务的目录,与试点启动时公布过一次的名单,是两种不同的东西:前者可以被查询、可以跨版本比较、可以写进内部立项说明。

外籍专业人士该准备什么

下面这几条不构成一份申报清单,因为清单本身还没有公布。现在能确定的是自己所处的位置:证书在不在目录上、对应哪一把尺子、单位的岗位说明是否撑得住你想申报的等级。其余问题都由这三个答案推出来,而且每一个都可以在区人社部门的一次沟通里问到,不必经由中介。

  • 先确认你的资格是否在现行比照认定目录内,并记下你核对的是哪一版、哪一天。
  • 把两个问题分开:你能否执业,以及你会被评到哪一级。这两件事走的是两条线。
  • 弄清你的证书对应哪把尺子——职业技能等级还是专业技术职称——因为两者的下游用途不同。
  • 向区人力资源社会保障部门问清楚:你的材料由哪个机构评审,境外取得的资格接受哪些证明。
  • 尽早让雇主参与。职称既被雇主读,也被雇主申报的人才计划读,这类申报很少是一个人的事。
  • 如果你是港澳居民,除了民营市场,也看看条例新打开的那批公共部门用人单位。
  • 把目录的复审周期记进日历。动态目录意味着要反复核对,而不是一次问清、长期有效。
  • 保留你依据的那一版目录;后来的修订不会自动解释此前的决定。
  • 如果单位正在准备职称申报,先核对岗位说明与你要申报的等级是否对得上。

来源

  • 广州市南沙区人民政府·《广州市南沙人才发展促进条例》中英双语全文:https://www.gzns.gov.cn/zwgk/rdzt/hgazczl/cyzc/hgazxzc/rc/content/post_11083998.html
  • 广东省人民政府·11 月起施行法规解读(含南沙境外职业资格比照认定机制):https://www.gd.gov.cn/zwgk/zcjd/snzcsd/content/post_4973852.html
  • 广东省人民政府新闻办公室·南沙人才政策报道:https://gdio.southcn.com/node_5201f00af5/8623acaa6c.shtml

Two Intellectual Property Plans for the 15th Five-Year Period: What Changes for Foreign R&D Centres

  • The State Council has issued the Intellectual Property Protection and Utilisation 15th Five-Year Plan, a directional document setting goals to 2030 rather than creating new filing channels.
    国务院印发《知识产权保护和运用”十五五”规划》,这是一份设定 2030 年目标的方向性文件,并未新设申报通道。
  • By 2030 the plan targets more than 22 high-value invention patents per 10,000 people, at least six more than at the end of the previous plan period.
    规划提出到 2030 年每万人口高价值发明专利拥有量超过 22 件,较”十四五”末增长 6 件以上。
  • The China National Intellectual Property Administration issued its Patent Examination Rules plan on 3 November 2026, with four task areas and seven special projects.
    国家知识产权局于 2026 年 11 月 3 日印发《专利和商标审查”十五五”规划》,设四方面重点任务与 7 个专项工程。
  • Examination standards for big data, Artificial Intelligence Inventions and gene technology will be revised, so specifications and claims should leave room to adapt.
    大数据、人工智能发明与基因技术的审查标准将予完善,说明书与权利要求应预留调整空间。
  • The plan will study protection objects for virtual and augmented reality designs and adjust submission rules for Graphical User Interfaces in due course.
    规划将研究虚拟现实、增强现实等数字领域外观设计保护客体,并适时调整图形用户界面提交规则。
  • Work on Standard Essential Patents examination policy continues, which matters to companies involved in standard setting and FRAND compliance.
    标准必要专利审查政策将继续完善,这对参与标准制定与 FRAND 合规的企业尤为重要。
  • Trademark measures target bad-faith filings through systematic regulation and penetrative supervision of applicants, changing how foreign brands plan their remedies.
    商标措施通过系统规制与对申请主体的穿透式监管治理恶意申请,改变外资品牌规划救济路径的方式。
  • Public training on foreign patent examination policy and information sharing is part of the plan, giving foreign companies a talent and training resource.
    加强国外专利审查政策公共培训与信息共享是规划内容之一,为外资企业提供了人才与培训资源。

Two Intellectual Property Plans for the 15th Five-Year Period: What Changes for Foreign R&D Centres | 知识产权两个”十五五”规划:外资研发中心要看的三个方向

Overview

In early November 2026 two five-year plans on intellectual property were released. The State Council issued the Intellectual Property Protection and Utilisation 15th Five-Year Plan; on 3 November 2026 the China National Intellectual Property Administration issued its plan for patent and trademark examination over the same period.

Both are directional documents: no application window, quota or threshold, only the direction examination practice will follow to 2030.

Two plans, one direction

The State Council plan anchors the building of an intellectual property power with Chinese characteristics and world standards. By 2030, comprehensive strength and international competitiveness should be further enhanced across protection, market value, public services, management and international cooperation, and the building of that power should reach a decisive stage.

Its headline indicator is more than 22 high-value invention patents per 10,000 people, at least six more than at the end of the previous plan period — a resource-allocation signal as much as a target.

The examination plan is the operational half. Its goal is that by 2030 a first-class examination institution with Chinese characteristics and world standards is basically established, with a maturing system, better quality, stronger support for development and globally leading capability.

Patent examination: emerging fields first

The patent side carries five deployments. It will strengthen alignment between China’s patent legal system and high-standard trade rules such as CPTPP; promptly improve examination standards for big data, artificial intelligence and gene technology; study and improve standards for bio-breeding and green low-carbon fields; improve the examination mechanism for traditional Chinese medicine patents; and establish an “AI plus” examination management mechanism.

For an applicant, substantive standards are moving, not only procedure; a specification drafted to current practice may need revisiting.

Seven special projects

The plan sets seven special projects, among them one on patent examination rules for emerging fields, one on trademark examination quality and one on “AI plus” examination.

The emerging-fields project lists the work to watch: the definition of a person skilled in the art and the scope of prior art for AI-assisted inventions; the inventor identity and patentability of AI-generated inventions; a declaration system for AI use in applications; improved policy for standard essential patents; and protection objects for virtual and augmented reality designs, with rules for graphical user interfaces to be adjusted in due course.

Every verb there is study, improve or adjust — none is a commitment to a date.

Trademarks: bad faith and penetrative supervision

The plan meets trademark registration demand from emerging fields including artificial intelligence and virtual reality, and explores pre-examination of applications there. It deepens treatment of deceptive trademarks, including ex officio invalidation of registered marks, strengthens systematic regulation of bad-faith filings, advances penetrative supervision of applicants and improves coordinated governance of bad-faith agency.

For a foreign brand owner the object of supervision becomes the filing chain, not the filing; monitoring, opposition and invalidation remain the tools.

International cooperation

The plan covers consultation under the WIPO framework, work through the five offices of China, the United States, Europe and Japan and the BRICS mechanism, and cooperation on examination, informatisation and training with Belt and Road partners.

Three lines for a foreign R&D centre

First, emerging-field standards. Where a portfolio rests on AI, big data or gene technology, drafting should leave room for a revised definition of the skilled person and a wider prior-art scope.

Second, designs. If GUI, VR or AR protection matters, submission rules are the point to watch and a design inventory is the preparation.

Third, standards. Where the company contributes to standards, examination policy for standard essential patents and FRAND practice should be tracked together.

The plan also calls for public training on foreign patent examination policy and information sharing — a resource for foreign companies in China, not an obligation.

What the plan does not promise

No new application channel is created. No grant period is promised. No category is said to be examined faster. Where the plan says study or explore, the rule has not changed yet.

Practical steps

  • Audit the portfolio for technical contribution rather than count.
  • For AI-related filings, prepare inventor attribution and a use declaration in advance.
  • List GUI and design assets, and track the submission rules for each.
  • Monitor trademark filings and keep an opposition and invalidation calendar.
  • For standards work, align the patent and FRAND positions before contributing.
  • Use the public training and information-sharing channels on examination policy.

Outlook

The plans describe a system that examines fewer things more carefully. For a foreign R&D centre the question is not whether filings become easier, but whether the portfolio can be explained in terms of technical contribution.

Sources

  • 国家知识产权局·《专利和商标审查”十五五”规划》印发:https://www.cnipa.gov.cn/art/2026/11/3/art_53_208900.html
  • 中国政府网·《知识产权保护和运用”十五五”规划》:https://www.gov.cn/
  • 国家知识产权局:https://www.cnipa.gov.cn/
  • 国家知识产权局·知识产权保护与运用政策专栏:https://www.cnipa.gov.cn/

知识产权两个”十五五”规划:外资研发中心要看的三个方向

概述

2026 年 11 月初,两份知识产权五年规划先后发布。国务院印发《知识产权保护和运用”十五五”规划》;2026 年 11 月 3 日,国家知识产权局印发《专利和商标审查”十五五”规划》。

两份都是方向性文件。它们不设申报窗口、不设名额、不设新的门槛,设定的是到 2030 年审查实践要走的方向。这也正是它们值得在配套规则出台之前先读一遍的原因。

需要先说明一点:规划不是法规。规划里写的”研究””探索””完善”,在转化为审查指南、部门规章或公告之前,不会改变当下某一类申请的实际审查结果。把它当作”即将生效的新规”来排期,容易高估短期影响;把它当作”未来五年的资源配置说明书”来读,判断会更稳。

两份规划的关系也需要分清。国务院规划管的是”保护与运用”,回答制度要往哪儿走;审查规划管的是”审查”,回答专利与商标在窗口那一端怎么被看。前者影响企业为什么申请,后者影响申请怎么写。

两份规划,一个方向

国务院规划锚定建设中国特色、世界水平的知识产权强国。到 2030 年,知识产权综合实力和国际竞争力进一步增强,保护更加有力、市场价值更加彰显、公共服务更加优质、综合管理体制更加高效、国际合作更加深入,知识产权强国建设取得决定性进展。

其核心预期性指标是:每万人口高价值发明专利拥有量超过 22 件,较”十四五”末增长 6 件以上。这类指标既是目标,也是资源配置信号——审查资源与评价导向会向”高价值”倾斜。

审查规划是操作层面的那一半。目标是到 2030 年,具有中国特色、世界水平的一流专利商标审查机构基本建成,审查制度日趋完善,审查质量显著提升,支撑发展更加有力,国际合作持续深化,审查能力全球领先。

专利审查:新兴领域先行

专利一侧有五项具体部署。加强中国专利法律制度与 CPTPP 等国际高标准经贸规则的衔接;及时完善大数据、人工智能、基因技术等新兴领域专利审查标准;研究完善生物育种、绿色低碳等重点领域专利审查标准;完善中医药专利审查机制;建立”人工智能+”审查业务管理机制。

对申请人而言,有用的读法是:变化落在实体标准上,而不只是程序上。按当下实践撰写的说明书,在这几个领域的标准完善之后可能需要回看。撰写的预留空间,比事后补救便宜。

具体到操作,可以在三个地方预留:一是权利要求的层次,独立权利要求写得过窄,标准调整后很难通过分案或修改补回范围;二是说明书中对技术效果的记载,标准一旦强调某类效果,缺少记载的部分无法后补;三是实施例的数量与分布,覆盖不足的实施例在审查趋严时会成为短板。

七个专项工程

规划设 7 个专项工程,其中包括新兴领域专利审查规则完善工程、商标审查质量提升工程、”人工智能+”审查工程等。

新兴领域工程列出了最受关注的一组工作:研究人工智能辅助发明的本领域技术人员定义与现有技术范围;研究人工智能生成发明的发明人身份和可专利性;研究专利申请中的人工智能使用声明制度;完善标准必要专利审查政策;研究虚拟现实、增强现实等数字领域外观设计保护客体,适时调整图形用户界面提交规则。

这一串动作的动词都是”研究””完善””调整”。它们不构成对时间表或结果的承诺。

专项工程的意义在于资源投向。列进工程的事项,通常会先有课题、再有指南、最后才是规则文本;对企业的含义是:这些领域的审查实践会在未来几年内持续变化,一次性的应对不够,需要有跟踪机制。

商标:恶意申请与穿透式监管

商标一侧,规划回应新兴领域的商标注册需求,探索研究人工智能、虚拟现实等领域对商标注册的需求,探索开展新兴领域商标注册申请预核;深化对带有欺骗性的商标治理,对已注册的依职权宣告无效;加强对恶意申请商标注册行为的系统规制,推进商标申请行为主体穿透式监管;加强对商标代理机构恶意代理行为的协同治理。

对外资品牌权利人来说,方向是把”申请链条”而不只是”申请”作为监管对象。监控、异议、无效仍是实务工具,变化的是这些工具所处的执法环境。

穿透式监管的含义值得单独说一句:监管关注的不只是提交了什么,还包括谁在提交、代理机构在其中扮演什么角色。对品牌方而言,这意味着选择代理机构也需要纳入合规评估,而不只是比价。

国际合作

规划提出做好 WIPO 框架下审查业务议题磋商;推动中美欧日韩知识产权五局、金砖国家等合作机制在国际规则形成中发挥作用;与共建”一带一路”国家和地区开展审查、信息化与培训合作。

对在中国有研发或品牌布局的企业,这些机制的实际用途是判断海外申请的优先顺序:五局与金砖机制覆盖的辖区,审查实践的可比性更高,先在这些辖区布局再向外延伸,通常比平均用力更省预算。

外资研发中心的三条线

第一条是新兴领域标准。组合以人工智能、大数据或基因技术为基础的,撰写时要为”本领域技术人员”定义的调整与现有技术范围的扩大留出余地。

第二条是外观设计。图形用户界面、虚拟现实与增强现实的保护如果有意义,提交规则就是观察点,设计清单就是准备工作。

第三条是标准。企业参与标准制定的,标准必要专利审查政策与 FRAND(公平、合理、无歧视)实务要放在一起跟踪,而不是分开处理。

三条线的共同点是都需要提前准备,而不是等规则落地再动。新兴领域标准的调整会改变撰写要求,外观设计提交规则会改变申请材料,标准必要专利政策会改变许可谈判的筹码。三者都不是一年内能补上的工作。

还有一条是培训。规划要求加强国外专利审查政策公共培训及信息共享,强化海外布局能力。对中国境内的外资企业来说,这是可用资源,不是新增义务。

规划没有承诺什么

没有新设申请通道,没有承诺授权周期,也没有说某一类申请会审得更快。规划写”研究””探索”的地方,规则尚未改变。

这一条对内部沟通很重要。把方向性表述转述成”明年会更快”,会在预算与排期上造成误判;把它转述成”审查会更看重技术贡献”,才是可执行的判断。

同样需要克制的,是把”探索开展新兴领域商标注册申请预核”读成”已经可以预核”。规划用”探索”,意味着机制尚在设计中,企业按现有程序准备材料即可,不必为此调整申请节奏。

操作清单

  • 按技术贡献而非数量梳理专利组合,与高价值指标的导向对齐。
  • 人工智能相关申请,提前准备发明人署名与使用声明材料。
  • 梳理图形用户界面与外观设计资产清单,逐项跟踪提交规则。
  • 建立商标监控,维护异议与无效的时间日历。
  • 参与标准制定的,在提交贡献前统一专利与 FRAND 立场。
  • 用好审查政策公共培训与信息共享渠道。

清单的第一项最难落地,因为它要求回答”这件专利解决了什么技术问题”,而不是”今年申请了多少件”。答不上来的部分,往往就是组合里价值最低的部分。

清单也建议按主体拆分:研发负责技术贡献的说明,法务负责权利要求的层次与地域布局,品牌与市场负责商标监控。合并成一张表时,最容易暴露的是”没有人负责”的那一项。

最后一条容易被当成软性建议。但培训与信息共享恰恰是外资企业成本最低的抓手:审查政策的变化通常先在培训与通报中出现,早一步知道,就少一次返工。

展望

两份规划描述的是一个”审得更少、审得更细”的体系。对外资研发中心而言,规划要回答的问题不是申请会不会更容易,而是组合能不能用技术贡献讲清楚。

这个判断对预算有直接影响:把资源从”多申请”转向”把关键申请写扎实”,短期件数会下降,但面对审查趋严时的稳定性会提高。对以数量考核的团队,这需要提前调整考核口径,否则规划的方向与内部激励会互相抵消。

来源

  • 国家知识产权局·《专利和商标审查”十五五”规划》印发:https://www.cnipa.gov.cn/art/2026/11/3/art_53_208900.html
  • 中国政府网·《知识产权保护和运用”十五五”规划》:https://www.gov.cn/
  • 国家知识产权局:https://www.cnipa.gov.cn/
  • 国家知识产权局·知识产权保护与运用政策专栏:https://www.cnipa.gov.cn/

The Bay Area Registration Zone: Online Incorporation for Hong Kong and Macao Investors

  • Guangdong launched the Bay Area Registration online service zone on 27 October 2026 for Hong Kong and Macao investors entering the nine mainland cities.
    2026 年 10 月 27 日,广东上线”湾区注册线上服务专区”,服务港澳投资者赴大湾区内地九市投资准入。
  • Notarial Document Digitisation now covers Macao instruments, the first such arrangement in the country.
    公证文书电子化流转现已覆盖澳门文书,这在全国尚属首次。
  • Remote Identity Verification works through a handwritten signature submitted online, facial recognition, or a lawyer or notary acting under authorisation.
    跨境身份核验可通过”手写签名 + 线上提交”、刷脸认证,或授权委托律师、公证员代为认证完成。
  • The zone embeds intelligent pre-review and a three-place company search, so filing, verification, real-name authentication, signing and archiving run electronically.
    专区嵌入智能预审与三地企业信息查询,使申报、核验、实名、签名、归档全流程电子化。
  • The zone serves Hong Kong and Macao investors only; other jurisdictions still follow notarisation and legalisation routes.
    专区只服务港澳投资者,其他司法辖区的投资者仍需走公证认证与纸质流转。
  • At the end of September 2026 Guangdong had 106,000 Hong Kong-invested and 15,000 Macao-invested enterprises, 55 per cent of the province’s foreign-invested legal persons.
    截至 2026 年 9 月末,广东登记在册港资企业 10.6 万户、澳资企业 1.5 万户,占全省外资法人企业的 55%。

The Bay Area Registration Zone: Online Incorporation for Hong Kong and Macao Investors | 湾区注册线上服务专区:港澳投资者如何在内地九市全程在线设立企业

Overview

On 27 October 2026 the Guangdong Provincial Administration for Market Regulation launched the Bay Area Registration online service zone, co-organised by the Commercial Service Bureau of the Hengqin Guangdong-Macao Deep Cooperation Zone. The zone sits on the Guangdong Government Service Network and handles market entry registration for Hong Kong and Macao investors establishing entities in the nine mainland cities of the Greater Bay Area. The service is paperless and runs end to end online.

The landing page carries an application entry point, a process walkthrough, a signing guide with video instructions, and zone news.

One boundary belongs at the top: the zone is built for Hong Kong and Macao investors, not for investors from other jurisdictions.

Three capabilities

Notarial document digitisation. Building on an earlier arrangement for Hong Kong notarial instruments, the zone is the first in the country to digitise the circulation of Macao notarial documents, so verification is paperless.

Remote identity verification. The zone introduces a model of a handwritten signature submitted online, widens identity verification channels, and supports facial recognition for Hong Kong and Macao residents, or verification through a lawyer or a notary acting under a power of attorney.

A rebuilt workflow. An intelligent pre-review mechanism and a company information search covering the three places are embedded, so that filing, verification, real-name authentication, signing and archiving all happen electronically.

The platform and the first licences

On the same day the administration opened the Bay Area soft-connectivity advisory platform in Hengqin, run through the cooperation zone’s commercial service bureau, to advise on market access policy. On the launch day, the first Hong Kong-invested and Macao-invested enterprises registered through the zone received their business licences.

How three bottlenecks fell

The history shows which steps were the obstacle. The notarial bundle went from 60 pages to four. A model combining facial recognition with signature by an authorised notary was introduced. In 2025 Hengqin and China Legal Service (Macao) set up an electronic verification mechanism for notarial documents in commercial registration, cutting processing time by more than four days.

Three bottlenecks recur in cross-border incorporation: the notarial document, the signature and the identity check. Each required a person or a paper to cross a border. Digitising the document removes the paper; a signature submitted online removes the trip to the counter; facial recognition removes the appearance in person.

What it changes for a holding structure

A group using a Hong Kong or Macao company as its investment platform meets three points of friction in a fixed order: the notarial document proves who the shareholder is, the signature proves who signed, and the identity check proves the signer is the person named.

Digitising the first does not merely save postage. A notarial document that circulates electronically can be verified at the moment of filing rather than in a batch, which is what makes pre-review possible at all.

The second changes who can sign without travelling. Where a director of the holding company is not in Guangdong, a handwritten signature uploaded online, or a notary under a power of attorney, replaces a flight. The authority document becomes the operative paper, and its scope is what a reviewer tests.

The third changes what evidence of identity looks like: facial recognition is a channel, not a substitute for the corporate documents.

The base it builds on

At the end of September 2026, Guangdong had 106,000 Hong Kong-invested enterprises and 15,000 Macao-invested enterprises on the register, together 55 per cent of the province’s foreign-invested legal persons.

That base explains the sequence: volume justifies investment in document interoperability, and proximity of the legal systems makes a verification mechanism negotiable.

What it does not settle

The zone removes friction in registration. It does not shorten the substantive obligations that follow — the foreign investment information report, the business scope and the beneficial owner filing. Those remain, with their own deadlines.

Nor does it publish a uniform completion time. A service that is faster in the ordinary case is not a service with a guaranteed clock; a project plan should not assume one.

The jurisdictional boundary is the other limit. A company incorporated in a third country cannot use the zone; notarisation and legalisation still apply, and documents still travel on paper. A group holding its China platform through a Singapore or Cayman entity should read this as a signal about structure.

Practical steps

  • Confirm the investor’s jurisdiction: a Hong Kong or Macao company can use the zone; a company incorporated elsewhere cannot.
  • Collect identity documents for every shareholder and signatory, and check the name forms against the notarial document; a mismatch is the commonest cause of a return.
  • If a power of attorney is used, name the lawyer or notary, the act authorised and the period; an authority silent on scope invites questions.
  • Keep the electronic archive: the same record is what a bank or a tax bureau will later ask for.
  • Sequence tax registration, the bank account and foreign exchange registration as one timeline; the licence starts several clocks at once.

Outlook

Expect the zone to widen its document coverage and to add guidance for sectors with specific approval requirements. For a group using a Hong Kong or Macao holding company as its China platform, the gain is narrow and real: the first step no longer needs a courier.

Sources

  • 广东省市场监督管理局·”湾区注册线上服务专区”上线新闻发布:https://amr.gd.gov.cn/zwdt/xwfbt/content/post_4971413.html
  • 广东省人民政府门户·大湾区注册服务专区相关报道:https://www.gd.gov.cn/gdywdt/zwzt/ygadwq/rlt/content/post_4972071.html
  • 横琴粤澳深度合作区·商事服务与注册便利化动态:https://www.hengqin.gov.cn/macao_zh_hans/hzqgl/dtyw/dtxx/content/post_3954787.html
  • 横琴粤澳深度合作区·商事登记公证核验全程电子化机制说明:https://www.hengqin.gov.cn/macao_zh_hans/hzqgl/dtyw/dtxx/content/post_3954787.html

湾区注册线上服务专区:港澳投资者如何在内地九市全程在线设立企业

概述

2026 年 10 月 27 日,广东省市场监督管理局上线”湾区注册线上服务专区”,横琴粤澳深度合作区商事服务局承办。专区设在广东政务服务网,为香港、澳门投资者赴大湾区内地九市投资准入办理登记注册,全程在线、无纸化。

专区首页设有业务办理入口与流程说明、操作指南与实名签名指引视频,以及湾区动态资讯等模块。

有一条边界要先说清楚:专区是为港澳投资者建的,不是其他司法辖区投资者可以使用的通道。

三项核心能力

公证文书电子化流转。 在落地香港公证文书电子化流转的基础上,专区在全国率先实现澳门公证文书电子化流转,核验全程无纸化。

跨境电子签名。 专区创新推出”手写签名 + 线上提交”模式,拓展身份核验渠道,支持港澳人士刷脸认证,也可以通过授权委托律师、公证员代为认证。

重塑登记流程。 专区嵌入智能预审机制与三地企业信息查询功能,申报、核验、实名、签名、归档全流程电子化。

配套平台与首批执照

同一天,广东省市场监督管理局大湾区软联通咨询服务工作平台(横琴)落地,依托横琴粤澳深度合作区商事服务局,提供市场准入政策咨询。上线当天,首批通过专区办理登记的港资、澳资企业获颁营业执照。

三道卡点是怎么被打通的

沿革能说明哪一步才是真正的障碍。公证文书从 60 页精简到 4 页;首创”人脸识别 + 委托公证人代理签名”模式;2025 年,横琴与中国法律服务(澳门)公司建立”商事登记公证核验全程电子化”服务机制,办理时间较此前压缩 4 天以上。

跨境设立企业,反复出现的卡点只有三个:公证文书、签名、身份核验。每一个都要求一个人或一张纸跨过边境。文书电子化拿掉了纸;手写签名线上提交,让人不必跑到窗口;刷脸认证,让人不必本人到场。

对持股架构意味着什么

以香港或澳门公司作为投资平台进入内地的集团,会按固定顺序遇到同样的三处摩擦:公证文书证明股东是谁,签名证明是谁签的,身份核验证明签名的人就是文书上的那个人。

第一项电子化,省下的不只是邮费。能够电子流转的公证文书,可以在申报的当下核验,而不是成批核验——这正是智能预审得以成立的前提。

第二项改变的是”谁可以不飞过来签字”。当持股公司的董事不在广东,线上提交的手写签名,或受托公证员的签名,替代了一趟航班。授权文本因此成为关键文件,审查要看的正是它的授权范围。

第三项改变的是身份证据的形态:刷脸是一条渠道,不是公司文件的替代品。

它建立在什么基础上

截至 2026 年 9 月末,广东全省登记在册港资企业 10.6 万户、澳资企业 1.5 万户,合计占全省外资法人企业比重的 55%。

这个存量解释了推进的顺序:体量足以支撑文书互通的投入,法律制度的接近程度则使核验机制谈得下来。

它没有解决什么

专区去掉的是登记环节的摩擦。它没有缩短其后的实体义务——外商投资信息报告、经营范围、受益所有人备案。这些仍然要做,各有各的时限。

专区也没有公布统一的办结时限。通常情况下更快,不等于有承诺的时钟;项目计划不应假定一个。

辖区的边界是另一重限制。在第三国设立的公司用不了专区,公证认证的老路仍然有效,文件仍然要纸质流转。以新加坡或开曼实体持有中国平台的集团,应当把它读成关于架构的信号。

落地步骤

  • 先确认投资者的辖区:香港、澳门公司可以用专区,在其他地方设立的公司不能。
  • 收集每一位股东、每一位签署人的身份文件,并把姓名写法与公证文书逐一核对;不一致是退件最常见的原因。
  • 使用授权委托时,写明受托律师或公证员、授权事项与授权期间;对范围含糊的授权,一定会被追问。
  • 保留电子档案:日后银行与税务机关要看的,是同一份记录。
  • 把税务登记、银行开户、外汇登记排成一条时间线,因为营业执照会同时启动好几个计时。

展望

可以预期专区会扩大文书类型的覆盖范围,并针对有专项审批要求的行业补充指引。对以香港或澳门控股公司作为中国平台的集团,实际收益不大但很实在:第一步不再需要快递。

来源

  • 广东省市场监督管理局·”湾区注册线上服务专区”上线新闻发布:https://amr.gd.gov.cn/zwdt/xwfbt/content/post_4971413.html
  • 广东省人民政府门户·大湾区注册服务专区相关报道:https://www.gd.gov.cn/gdywdt/zwzt/ygadwq/rlt/content/post_4972071.html
  • 横琴粤澳深度合作区·商事服务与注册便利化动态:https://www.hengqin.gov.cn/macao_zh_hans/hzqgl/dtyw/dtxx/content/post_3954787.html
  • 横琴粤澳深度合作区·商事登记公证核验全程电子化机制说明:https://www.hengqin.gov.cn/macao_zh_hans/hzqgl/dtyw/dtxx/content/post_3954787.html

Shipping Insurance Guidance: What Seven Ministries Set Out for Cover, Clauses and Pricing

  • Seven ministries released the Guidance on Accelerating the High-Quality Development of Shipping Insurance on 6 November 2026.
    2026 年 11 月 6 日,七部委联合印发《关于加快航运保险高质量发展的指导意见》。
  • The document sets five tasks: stronger cover, a more competitive market, better claims, stricter supervision and a sounder operating environment.
    文件提出五方面任务:提升保障水平、增强国际竞争力、优化理赔服务、推进严监管强监管、健全运行机制。
  • It calls for developing Standard Clauses for Shipping Insurance, expanding the use of the renminbi and strengthening independent pricing capability.
    文件提出制定航运保险标准条款、扩大人民币使用、提升自主定价能力。
  • Insurers are encouraged to pursue Risk Reduction and to build a Global Service Network for cross-border claims.
    文件鼓励保险机构开展风险减量,并加强全球综合服务网络建设。
  • High-value vessels and offshore equipment should carry cover across design, construction, operation and disposal.
    高价值船舶与海工装备应建立覆盖设计、建造、营运、处置等全生命周期的保险方案。
  • Geopolitical conflict, supply chain interruption, cyber security and ice navigation are named as priorities for product development.
    地缘政治冲突、供应链中断、网络安全、冰区航行被列为产品研发的重点方向。

Shipping Insurance Guidance: What Seven Ministries Set Out for Cover, Clauses and Pricing | 航运保险指导意见:七部委在保障、条款与定价上说了什么

Overview

On 6 November 2026 seven central departments jointly released the Guidance on Accelerating the High-Quality Development of Shipping Insurance: the National Financial Regulatory Administration, the Ministry of Transport, the National Development and Reform Commission, the Ministry of Finance, the Ministry of Commerce, the People’s Bank of China and the State-owned Assets Supervision and Administration Commission of the State Council.

The document is a guidance opinion. It sets a direction, lists tasks and assigns them to regulators and to the industry. It opens no application window, creates no licence and attaches no subsidy to a named activity. Read as a statement of where the market is heading — standard clauses, renminbi denomination, independent pricing — it tells a company how to align its programme.

What kind of document this is

Policy instruments are graded, and the grade decides what a company can do with the text. A catalogue or a negative list changes what is permitted; a guidance opinion does not. It sets an objective, lists tasks, and leaves the operative rules to the regulators who must draft them.

The distinction matters for three items — standard clauses, renminbi use and independent pricing. Each is written as something to be developed, not as something in force. Until the clauses are issued, the terms of a policy remain the terms the parties negotiate.

The five tasks in brief

Cover. A risk management system across a vessel’s whole life, a better mechanism for cargo in transit, and a larger supply of capacity.

Market and competitiveness. Develop standard clauses, expand renminbi use, strengthen independent pricing capability and deepen exchanges with foreign markets.

Claims. Better quality and efficiency, encouragement of risk reduction, and a global service network that lifts the standard of service abroad.

Supervision. Product management rules, conduct rules for brokers, and clearer responsibility for risk control inside insurers.

Environment. Support mechanisms, a crackdown on irrational competition, and a training system.

Together, the headings describe a market that prices its own risks rather than imports a price.

Clauses, currency and pricing

Standard clauses matter because a marine policy is assembled from clauses, and a clause recognised by both the insurer and the reinsurer behind it is easier to place. Where wording is standardised, a dispute becomes a dispute about facts.

Renminbi use matters because a shipping company’s revenue and a manufacturer’s freight cost are increasingly denominated in renminbi while the cover is not. A policy written in the settlement currency removes one basis risk from the hedge.

Independent pricing matters because a market that can price its own risks can also retain them. The guidance pairs pricing capability with retained capacity: insurers and the China Shipowners Mutual Assurance Association are asked to raise retained limits.

Cover across an asset’s life

Shipbuilders and shipping companies are asked to use insurance tools actively to disperse risk as they pursue greener and more digital operations, and to use the ship survey and evaluation mechanism to build programmes covering design, construction, operation and disposal for high-value vessels and offshore equipment. The list is specific: oil tankers, liquefied natural gas carriers, large container ships, large cruise ships, large bulk and ore carriers, and yachts.

For a company importing or building such an asset in China, the practical change is the unit of cover. A cargo policy covers a voyage; a lifecycle programme covers a shipyard delay, a construction period, a delivery voyage, an operating loss and a disposal. The gaps between those policies are where uninsured losses live.

The new risk list

New energy and clean energy vessels are to be supported with cover along the industrial chain — green fuel bunkering, battery system replacement, green retrofit and operational safety. Smart ships with autonomous navigation and remote control are to strengthen cover for emerging risks such as cyber security.

The document then names what a basic cargo policy does not reach: geopolitical conflict, logistics and supply chain interruption, cyber security, and ice navigation. It asks the market to optimise products for these in response to demand, and to speed up development for cross-border e-commerce and commodities.

What it means for pharmaceutical and cold-chain shippers

A pharmaceutical importer’s exposure is usually not the hull but the container. Temperature deviation, a broken cold chain, a delay at a transhipment port — these are cargo risks with a liability question attached, and the emphasis on claims and risk reduction speaks to them.

Two cautions apply. The standard clauses are being developed, not issued, so a contract today still rests on negotiated terms and on the actual policy wording. And the guidance does not address pharmaceutical market access: hospital investment, drug registration and device approval are separate regimes.

Practical steps

  • Read the programme as a chain — cargo, construction, installation, trial operation, operating loss, disposal — and mark where one policy ends and the next begins.
  • Ask where retained capacity sits and how much risk is ceded; a low premium behind a thin reinsurance tower is a price, not cover.
  • Align the insurance schedule with the customs and installation schedule; a week between discharge and installation is uninsured.
  • Match the currency of the policy to the currency of the loss; a renminbi policy and a dollar claim leave an unhedged exposure.
  • Keep the evidence chain for a cross-border claim: survey report, temperature log, notice of loss, and the letters showing when the carrier was told.

Outlook

Expect implementing rules on product management and broker conduct, and industry work on the standard clauses.

Sources

  • 国家金融监督管理总局·七部委《关于加快航运保险高质量发展的指导意见》新闻稿:https://www.nfra.gov.cn/cn/view/pages/ItemDetail.html?docId=1278246
  • 商务部·七部委联合印发《关于加快航运保险高质量发展的指导意见》:https://www.mofcom.gov.cn/syxwfb/art/2026/art_59e15dddb16b49559d6cc9253377493a.html
  • 国家金融监督管理总局·《关于加快航运保险高质量发展的指导意见》全文:https://www.nfra.gov.cn/cn/view/pages/ItemDetail.html?docId=1278317&itemId=928
  • 中国政府网·国务院政策文件库:https://www.gov.cn/

航运保险指导意见:七部委在保障、条款与定价上说了什么

概述

2026 年 11 月 6 日,七部委联合印发《关于加快航运保险高质量发展的指导意见》。印发单位为金融监管总局、交通运输部、国家发展改革委、财政部、商务部、中国人民银行、国务院国资委。

这是一份指导意见。它讲方向、列任务,把任务分派给监管部门和行业。它没有开放申报窗口,没有创设许可类别,也没有把补贴绑定到某一项具体活动上。如果把它读成”可以来申请优惠”,会发现没有表格可填;如果把它读成”市场往哪里走”的说明——标准条款、人民币计价、自主定价——那它现在就能告诉我们,应当怎样把自身的保险安排往这个方向对齐。

这是一份什么性质的文件

政策工具是分层的,层级决定了企业能拿这份文本做什么。目录、负面清单这类工具改变的是”允许做什么”,指导意见不改变这些。它设定目标、列出任务,把可执行的规则留给必须起草细则的监管部门。

这一区分对三项有商业分量的内容最关键——标准条款、人民币使用、自主定价。三者都写成”要制定””要扩大””要提升”,而不是”已经生效”。在条款起草发布之前,一份保单的条款仍然是双方谈出来的条款。

五方面任务概要

保障。 健全船舶全生命周期风险管理体系,完善货物运输风险保障机制,扩大航运保险保障供给。

市场与竞争力。 制定航运保险标准条款,扩大人民币使用,提升自主定价能力,深化对外交流合作。

理赔。 改进理赔服务质效,鼓励风险减量,加强全球综合服务网络建设,提升全球服务水平。

监管。 完善航运保险产品管理机制,规范航运保险经纪行为,严格落实监管职责,压实企业风险防控主体责任。

环境。 优化业务支持机制,整治非理性竞争,健全人才培养体系,细化配套支持政策。

五个方面合起来,描述的是一张自己给自己的风险定价、而不是进口一个价格的市场。

条款、币种与定价

标准条款之所以重要,是因为海上保单是由一条条条款拼装起来的文件,而一条同时被保险人和其背后的再保险人认得的条款,更容易分出。措辞一旦标准化,争议就从”这句话什么意思”变成”事实是什么”。

人民币使用之所以重要,是因为航运公司的收入与制造企业的运费正越来越多地以人民币计价,而保单不是。用结算币种书写的保单,从对冲里去掉了一重基差风险。

自主定价之所以重要,是因为能给自己风险定价的市场,也就能把风险留在自己手里。文件把定价能力与自留能力放在一起:推动保险公司与中国船东互保协会合理提升自留风险额度。

覆盖资产全生命周期

文件要求船舶制造企业、航运企业在推动绿色化、数智化发展的过程中,主动运用保险工具分散风险;要求充分利用船检评估机制,推动高价值船舶与海工装备健全覆盖设计、建造、营运、处置等全生命周期的保险管理方案。列举的船型是具体的:油轮、液化天然气船、大型集装箱船、大型邮轮、大型散矿船、游艇。

对在中国进口或建造这类资产的企业,实际变化是”保障单位”。一张货运险保单保的是一段航程;一套全生命周期方案保的是船厂延期、建造期、交付航程、营运损失与处置。这些保单之间的缝隙,正是没有保险的损失所在。

新的风险清单

新能源清洁能源船舶,要提升对绿色燃料加注、电池系统更换、绿色改装、运营安全等相关产业链的保险保障水平。具备自主航行、远程控制能力的智能船舶,要强化网络安全等新兴风险保障。

文件随后点出了基本货运险够不到的风险:地缘政治冲突、物流和供应链中断、网络安全、冰区航行。它要求市场响应需求、优化这些特殊和新型风险的产品供给,并加快跨境电商等新业态及大宗商品等重点领域的保险产品研发推广。

对医药与冷链货主意味着什么

医药进口方的暴露通常不在船壳,而在集装箱。温控偏差、冷链断链、转运港延误——这些是货物风险,同时挂着一个责任问题;文件对理赔质量和风险减量的强调,正对着这些场景。

两点需要提醒。标准条款正在制定、尚未发布,所以今天的合同仍要靠谈出来的条款和保单实际措辞。另外,文件不涉及医药市场准入:医院投资、药品注册、器械审批是另外的制度。

落地步骤

  • 把保险安排当链条读:货运、建造、安装、试运行、营运损失、处置,并标出上一张保单在哪里结束、下一张从哪里开始。
  • 向经纪人问清自留能力放在哪里、分出了多少风险;保费便宜而再保层级单薄,那是一个价格,不是一份保障。
  • 大型设备进口时,把保险排期与报关、安装排期对齐;卸船到安装之间空出的一周,就是没有保险的一周。
  • 让保单币种与损失币种一致;人民币保单配美元索赔,会留下一重没有对冲的折算暴露。
  • 跨境索赔留好证据链:检验报告、温度记录、损失通知,以及能够证明何时已告知承运人的往来函件。

展望

可以预期监管部门会就产品管理与经纪行为出台实施细则,行业层面会推进标准条款的起草。方向已经足够清晰,可以据此规划。

来源

  • 国家金融监督管理总局·七部委《关于加快航运保险高质量发展的指导意见》新闻稿:https://www.nfra.gov.cn/cn/view/pages/ItemDetail.html?docId=1278246
  • 商务部·七部委联合印发《关于加快航运保险高质量发展的指导意见》:https://www.mofcom.gov.cn/syxwfb/art/2026/art_59e15dddb16b49559d6cc9253377493a.html
  • 国家金融监督管理总局·《关于加快航运保险高质量发展的指导意见》全文:https://www.nfra.gov.cn/cn/view/pages/ItemDetail.html?docId=1278317&itemId=928
  • 中国政府网·国务院政策文件库:https://www.gov.cn/

Hainan’s Pilot on Importing Faulty Key Components for Automotive Research and Testing

  • The four-ministry notice of 29 October 2026 opens a pilot for importing faulty key components for automotive research and testing in the Hainan Free Trade Port, in one sentence that sets no eligibility, no quota and no procedure.
    2026 年 10 月 29 日四部门印发的通知,在海南自由贸易港开展汽车研发测试用故障关键零部件进口试点;这一条只有一句话,既没有规定适用主体,也没有规定额度,更没有规定办理程序,适用范围与监管方式都要等配套文件明确。
  • A failed part is the raw material of failure analysis, so moving such parts across a border lawfully is a research input rather than a procurement saving.
    故障件是失效分析的原料,因此能否合法地把这类零件送过边境,属于研发投入问题,而不是采购成本问题;对整车企业来说,样品能否进出,往往决定一个研发节点能否按期完成。
  • Under general trade a failed component reads as a used good and possibly as waste, so the research purpose that gives it value is what the tariff cannot see.
    在一般贸易项下,故障件会被读成旧货,并可能被读成废物;判定所依据的是货物的状态与外观,而不是它将被用于什么,于是赋予它价值的那层研发用途,恰恰是税则看不见的部分。
  • Bonded remanufacturing is the nearest route, but its output must meet every requirement for an equivalent new product, be marked as remanufactured, and is taxed on leaving for a domestic pilot free trade zone.
    保税再制造是现有最接近的路径,但它的产出必须符合对同等新品的全部要求、必须标注「再制造产品」,出区进入国内自贸试验区时还要照章征税;两条路径的差别不在税负高低,而在产出是否成为产品。
  • The notice is silent on who may apply, whether a Hainan entity or a Special Customs Supervision Area is required, how quantities are managed, and what happens after testing.
    通知对谁能申请、是否需要在海南设立主体、是否必须在海关特殊监管区域内、数量如何管理、测试之后如何处理,都没有作答;在细则出台之前,任何按「已经开放」来排期的计划都缺少依据。

Hainan’s Pilot on Importing Faulty Key Components for Automotive Research and Testing | 海南自贸港汽车研发测试用故障关键零部件进口试点:研发件的保税路径与边界

Overview

The four-ministry notice on trade liberalisation in the Hainan Free Trade Port was published on 29 October 2026 and dated 9 October. Among its sixteen measures sits one sentence: the port is to run a pilot for importing faulty key components for automotive research and testing.

That sentence is the whole measure. No applicant, no ceiling, no port of entry, no procedure. The direction is decided and the operating rules are not written; the customs supervision method and the provincial note are still to come, and until they exist nothing can be filed. The bonded remanufacturing clause appears below only as a contrast.

Why a failed part earns its own measure

A warranty return, a field failure, a part that cracked on a proving ground: these are the most informative objects in a vehicle programme. Cutting one open answers what simulation could not — which assumption was wrong.

The law sees no research specimen. It sees a used good, and possibly a waste: used machinery carries its own import requirements, and a component that failed in service can be characterised as solid waste, whose import is prohibited. Both readings are blind to the fact that the part carries information, not function.

So samples travel in luggage, are declared as something else, or fly to a third country for teardown. None of that is a compliance strategy, and all of it lengthens the loop between a failure in the field and a correction in the design.

Three routes and what separates them

General trade. The part is declared as a used component, exposing the shipment to used-goods requirements and to a waste determination — a judgment about an object whose value is invisible on the invoice.

Bonded repair and remanufacturing. Goods enter a Special Customs Supervision Area in bonded status. The classic exit is back abroad; the newer one, under the remanufacturing measure, is into a domestic pilot free trade zone, taxed as provided and marked. This route is built for products that will be used.

The research pilot. The purpose is measurement, not repair or resale. No existing regime offers “test it and send it back” as an outcome, which is why the measure is separate.

Five questions the notice leaves open

Who may apply. A manufacturer, a supplier, an independent test house or a research entity — the text does not say.

Whether a Hainan entity is required. A pilot inside the island’s customs territory implies local presence, but the notice is silent.

Whether a Special Customs Supervision Area is mandatory. Bonded treatment usually lives inside one; the measure neither places the pilot there nor keeps it out.

How quantities are managed. No quota, no ceiling, no per-shipment limit. Catalogue, project filing or case-by-case approval remains unknown.

What happens after testing. Re-export, supervised destruction, retention in bond, or domestic sale at the applicable rate — this silence decides the customs guarantee a company must post.

The boundary with bonded remanufacturing

Remanufacturing is a production route whose output is a product: as good as new, labelled, taxed on leaving. The research pilot is a use route whose object never becomes a product. A company that plans a remanufacturing line after reading about the automotive pilot budgets a factory it does not need.

What a carmaker can do now

  • Build the parts list by test question, not by supplier: part number, failure mode, vehicle programme, and the question the teardown must answer.
  • Write the test plan with dates and locations, so the time the parts must stay on the island is a number.
  • Assemble the evidence of purpose: the group project approval, the protocol, the analysis template, the named engineers.
  • Design the controls: segregation from production stock, a no-resale clause, a return-or-destroy record.
  • Talk to Haikou Customs and the provincial commerce department early, in writing. Where rules are unwritten, their reading is the only reliable input.

Outlook

Research follows the ability to move specimens. A jurisdiction that solves the specimen problem attracts the laboratory rather than the factory, and the pilot is an attempt to make Hainan that place.

Expect a slow landing: a new movement of goods needs a supervision method, a declaration code and a risk-control arrangement. Watch for a customs announcement on supervision and a provincial note naming the window. Until both exist, the status is direction confirmed, procedure pending.

Related reading

  • *Hainan’s Sixteen Trade Measures* (Article 492) — the full package and the remanufacturing contrast.
  • *Using Bonded Facilities Without a Domestic Entity* (Article 491).

Sources

  • Ministry of Commerce, NDRC, MEE and GACC, *Notice on Further Raising the Level of Trade Liberalisation and Facilitation in the Hainan Free Trade Port*, 29 October 2026: https://www.mofcom.gov.cn/zwgk/zcfb/art/2026/art_1396cc6581da478ebc9f3ee08b72a96b.html
  • gov.cn, Xinhua report on the four-ministry notice: https://www.gov.cn/lianbo/202610/content_7084472.htm
  • Hainan Provincial Government, report on the notice: https://www.hainan.gov.cn/hainan/mtkhn/202611/2a26895a2fac40e89c6dae4dc4b940cf.shtml
  • GACC, official site: http://www.customs.gov.cn/

海南自贸港汽车研发测试用故障关键零部件进口试点:研发件的保税路径与边界

概述

2026 年 10 月 29 日,商务部、国家发展改革委、生态环境部、海关总署联合印发的《关于进一步提高海南自由贸易港贸易自由化便利化水平的通知》对外公布,落款日期为 2026 年 10 月 9 日。这份通知共提出十六项措施,分布在货物贸易、服务贸易与贸易新业态新模式三个方面;汽车研发测试用故障关键零部件进口试点正是其中一项。在十六项之中,夹着一句话:在海南自由贸易港开展汽车研发测试用故障关键零部件进口试点。

在这一句话里,通知给出了一个方向,却没有给出任何一个可以据以行动的要素。它没有点名任何一类可以申请的主体,没有设定数量或金额的上限,没有指定进境口岸,也没有描述任何办理程序。换句话说,方向已经确定,而操作规则尚未写成:海关的监管办法与海南省的实施细则都还没有出台。在这两份文件出现之前,没有任何事项可以申报,也没有任何表格可以提交。对不熟悉海关业务的人来说,最容易犯的错误,是把「通知里写了」直接当成「现在可以办」。下文出现的保税再制造条款,只作为对照使用,因为这两项措施经常被放在一起读,而混读的代价并不低。因此本文要做的,是把这条措施的边界梳理清楚,而不是给出办理指引。

故障件为何值得单列一条

保修退回件、现场失效件、在试车场上开裂的零部件,是整车项目里信息量最大的物件。这类东西的共同点是:它们已经失去了原有的使用功能,却保留了最有价值的那部分信息,而且体积不大、价值不低、时效很强。把其中一个剖开,能够回答仿真回答不了的问题——究竟是哪一个假设错了;对竞争对手的零件做对标分析,则能回答另一个问题——他们是怎么解决的。对同时在几个大洲运行整车项目的企业来说,样品来自各处,实验室却只有一处,零件因此必须移动。

但法律看到的不是研发样本。它看到的是一件旧货,并且可能是一件废物:旧机电产品有其自身的进口要求,而在使用中失效的零部件,可能被判定为固体废物,而固体废物是禁止进口的。这两种读法各自都没有错,但都对同一个事实视而不见——这件东西承载的是信息,而不是功能。而税则与固体废物规则所依据的,恰恰是功能。换句话说,海关关心的是这件东西还能不能用,研发关心的是这件东西为什么不能用。

于是样品被装进行李箱,或者被报成别的东西,或者被送到第三国剖解、再把结论以照片形式传回。这些做法没有一项称得上是合规策略,而且每一项都在拉长从现场失效到设计纠正之间的回路。这条回路的长短,直接决定一款车改型的速度,也正是这项措施存在的理由:把一条不合规的绕行,变成一条可以说明的路径。

三条路径与它们之间的分别

一般贸易。 按零件的本来面目申报,也就是一件旧件。这会使货物落入旧机电产品的进口要求,以及固体废物的判定范围;而判定所针对的,是一个在发票上看不出价值的物件。旧机电产品的进口要求,本意是防止废旧设备流入,并不区分这台设备是拿去用,还是拿去做研究。研发团队无法据此排定测试计划,因为结论不由他们作出;实务中更常见的情形是,研发部门在货物到港之后,才知道还需要补什么材料。

保税维修与再制造。 货物以保税状态进入海关特殊监管区域,在区内接受维修或再制造。经典的出口是复运出境;较新的出口来自同一份通知中的再制造条款,即出区进入国内自由贸易试验区,照章征收进口关税、进口环节增值税和消费税,并在显著位置标注「再制造产品」。复运出境与出区内销是两种完全不同的商业结果:前者不产生税负,后者要照章征税。这条路径是为将被使用的产品设计的,它的每一步都假定货物最终要作为产品存在。对研发测试来说,这两条出口其实都用不上:货物既不是拿来维修的,也不复运出境,而是要在境内被拆开。

研发测试试点。 用途是测量,而不是维修,也不是转售。现有的各项制度,都没有把「测完、拿到结论、送回去」作为一种可选结果,而为货物设计的制度,本来就很难容纳一件并不打算继续作为货物存在的物件。这就是需要单列一条的原因:它补的不是税率优惠,而是制度上的一个空缺。

通知留下的五个问题

谁能申请。 整车生产企业、一级供应商、独立测试机构,还是不具备生产资质的研究主体——文本没有说明。这一条决定的是,零部件企业能否借用整车厂的试点资格,因为失效分析在今天的整车开发中往往由供应商或第三方实验室完成。如果最终只向整车厂开放,供应商就只能通过整车厂的资格间接参与。

是否需要在海南设立主体。 岛内海关区域内的试点通常意味着本地存在,但通知没有这样写;而一家注册子公司与一个项目办事处之间,隔着大约一年的设立工作量。对只打算做一个短期测试项目的集团来说,这一步的成本可能高于试点本身带来的便利。

是否必须在海关特殊监管区域内。 保税待遇通常发生在区内;这一条既没有把试点放进区内,也没有把它留在区外,两种读法都能从文本中找到空间。如果最终限定在区内,企业还需要与区内的仓库或平台运营方签约;如果放在区外,监管方式就要另设。两种可能都存在,只能等文件。

数量如何管理。 没有额度,没有上限,没有单次限量,也没有要求事先报备清单。究竟按目录管理、按项目备案,还是逐案审批,目前不清楚。对研发项目来说,件数管理的确定性,往往比额度大小更重要:按项目备案对研发最友好,按目录管理对海关最可控。

测试完成之后怎么办。 复运出境、在监管下销毁、留存保税仓库,还是按适用税率内销——这里的沉默,直接决定企业需要缴纳多少海关担保,也决定回程物流与报关成本要不要提前预留。不同的处置方式,对应的担保额度与单证要求也完全不同。

这五个问题里,前三个决定「能不能进场」,后两个决定「进场之后怎么算账」。在细则公布之前,任何按「已经开放」来排期的计划,都缺少可以援引的依据。

与保税再制造的边界

再制造是一条生产路径,产出是产品:在全部适用要求上等同于新品,必须标注,出区进入国内自贸试验区时照章征税。研发试点则是一条使用路径,它的对象根本不会成为产品。因为读到汽车试点就去规划再制造产线的企业,会为一间并不需要的工厂做预算;而在再制造条款下规划测试台架的企业,会发现该条款要求一种它从未打算生产的产出。两条路径在文本上只隔几条,在商业上隔着一整条产线;把这两个条款放进同一份商业测算,数字会失真。对董事会材料来说,最稳妥的写法是把两项措施分列,各自标注依据条款与适用对象,而不是合并成一段。两项措施可以并存,但不能互相替代。

车企现在能做什么

  • 零件清单按测试问题组织,而不是按供应商组织:件号、故障模式、所属整车项目,以及这次剖解必须回答的问题。在关员眼里,这两种清单是两份不同的材料。
  • 测试计划写明时间与地点,使「零件需要在岛内停留多久」成为一个数字,而不是一个估算。
  • 备齐用途证明:集团内部立项文件、测试方案、失效分析报告模板,以及实际执行工作的工程师名单。
  • 内控先行:与量产库存物理隔离,仓储合同中写入禁止转售条款,并保留可随时出具的复运或销毁记录。
  • 尽早以书面方式与海口海关、海南省商务主管部门沟通。规则尚未写成时,他们对措施的理解是唯一可靠的规划输入。
  • 把样品的进出做成可追溯的台账:谁带进来、存放在哪个库位、什么时候送出去、由谁签收。
  • 在清单之外,再准备一份简版项目说明,用于向不熟悉研发的窗口人员解释:这批零件为什么必须进来,测试之后为什么必须送出去。
  • 把「研发测试用途」写进合同与随附单证,而不是只写在内部邮件里;用途说明能否被核对,决定整批货物的通关体验。

展望

研发跟着样品走。能够解决样品流动问题的地区,吸引到的是实验室,而不是工厂;放在岛内保税设施的基础上看,这项试点是要让海南成为全球项目做失效分析的地方。对车企来说,真正值得关注的不是这一条能省多少税,而是它是否意味着研发环节可以更靠近中国市场。

落地节奏大概率偏慢。改变检验标准的措施,只需要一份技术性公告;而开辟新的货物移动路径,需要监管方式、申报代码和风险防控安排,这些都要更长时间。值得盯住的两份文件是:确立监管安排的海关公告,以及明确受理窗口与材料清单的海南实施办法。两份都出来之前,董事会材料里最准确的表述是:方向已确认,程序待明确。两份文件出现的时点,也决定这项试点能否赶上下一轮车型开发的节奏。

延伸阅读

  • 《海南自贸港贸易自由化便利化十六项措施:货物、服务、新业态三条主线与落地顺序》(第 492 篇)——政策全貌,含本文用作对照的再制造条款。
  • 《无需境内注册使用保税设施:海南液化天然气接收站条款与「轻资产入华」结构》(第 491 篇)。

两篇合读,可以看到同一份通知在「货物」与「设施」两个方向上的不同落点。

来源

  • 商务部、国家发展改革委、生态环境部、海关总署《关于进一步提高海南自由贸易港贸易自由化便利化水平的通知》,2026 年 10 月 29 日发布,落款日期 2026 年 10 月 9 日:https://www.mofcom.gov.cn/zwgk/zcfb/art/2026/art_1396cc6581da478ebc9f3ee08b72a96b.html
  • 中国政府网,新华社关于四部门印发通知的报道:https://www.gov.cn/lianbo/202610/content_7084472.htm
  • 海南省人民政府网,关于该通知的报道:https://www.hainan.gov.cn/hainan/mtkhn/202611/2a26895a2fac40e89c6dae4dc4b940cf.shtml
  • 海关总署,官方网站:http://www.customs.gov.cn/

Medical Device GMP: How the Four New Inspection Principles Judge Conformity

  • China’s revised Medical Device GMP took effect on 1 November 2026, together with four supporting inspection principles issued by the NMPA on 23 October 2026.
    新修订的《医疗器械生产质量管理规范》自 2026 年 11 月 1 日起施行,国家药监局已于 2026 年 10 月 23 日印发四个配套检查指导原则。
  • The principles cover Sterile Devices, implantable devices, In Vitro Diagnostic Reagents and customised dentures, replacing the 2015 and 2016 on-site principles on the same date.
    四个指导原则覆盖无菌医疗器械、植入性医疗器械、体外诊断试剂和定制式义齿,并于同日废止 2015 年、2016 年的现场检查指导原则。
  • From 1 November 2026, production licence verification and post-market supervision inspections for these four families are judged against the new principles.
    自 2026 年 11 月 1 日起,这四类产品的生产许可核查与上市后监督检查,均按新指导原则进行结果判定。
  • Inspection items are graded into Critical Items, major items and general items by each clause’s importance in the quality system and the risk its non-compliance creates.
    检查项目按各条款在质量管理体系中的重要性及不符合带来的风险,划分为关键项目、主要项目、一般项目三个等级。
  • The principles merge the GMP with its annexes and convert the combined text into inspection items, so the annex is no longer read on its own.
    指导原则是把规范与相应附录融合衔接、转化形成检查项目,附录不再作为单独文本另行对照。
  • A failed Critical Item normally means the inspection fails outright, but that is settled inspection practice rather than a rule written into these documents.
    关键项目不合格通常直接判定不通过,但这是检查实务的通行做法,不是这四份文件写明的条文。
  • New applicants and long-held licence holders are measured on the same new scale, so gap analysis cannot wait for the next renewal.
    新办证与老持证企业适用同一把新尺子,差距分析不能等到下一次换证。

Medical Device GMP: How the Four New Inspection Principles Judge Conformity | 医疗器械 GMP:四个新检查指导原则如何判定符合性

Overview

On 23 October 2026 the National Medical Products Administration issued four inspection principles to accompany the revised Medical Device Good Manufacturing Practice, which takes effect on 1 November 2026. The four cover sterile medical devices, implantable medical devices, in vitro diagnostic reagents and customised dentures, and they take effect on the same day as the revised GMP.

The notice also repeals what came before: the 2015 on-site inspection principles for sterile, implantable and IVD production (Shi Yao Jian Xie Jian [2015] No. 218) and the 2016 principles for customised dentures (Shi Yao Jian Xie Jian [2016] No. 165).

Why the annexes were folded in

The drafting method is stated plainly. Each principle takes the GMP and the corresponding annex — sterile, implantable and so on — merges them, and converts the combined text into inspection items. The annex stops being a separate document read beside the GMP; it becomes part of the checklist.

That changes how a quality team holds its documentation. A system that mapped its procedures to the GMP and treated the annex as a second layer now has one layer, and the mapping must be rebuilt rather than relabelled.

Who is measured on the new scale

Four product families: sterile devices, implantable devices, IVD reagents and customised dentures. Both production licence verification — new applications and scope changes — and post-market supervision inspections use the new principles to determine results.

That second channel is the one companies underestimate. A licence holder that passed verification years ago is not exempt; the next supervision inspection applies the same new scale. Contract manufacturers sit inside the same perimeter, because the rules attach to the production activity rather than to the brand on the label, and a customer audit does not substitute for the regulator’s.

For a foreign group, the exposure sits in Chinese plants making these four families, whether wholly owned or in a joint venture. A plant outside them is untouched by the four principles but still bound by the GMP itself.

What the three grades do

The notice states that items are graded into critical, major and general according to each clause’s importance in the quality system and the risk created when it is not met. The grading is a risk statement rather than a scoring system: it tells an inspector which findings can be tolerated and which cannot.

One point needs care. Practice treats a failed critical item as a failed inspection. That is the settled approach in GMP inspection, not a sentence in these four documents, and it should be attributed to practice rather than to the notice.

Preparing for an inspection under the new scale

A supervision inspection that arrives unannounced is the wrong moment to discover that the quality manual still cites a repealed on-site principle. Three artefacts are worth assembling before the inspection rather than during it.

The first is a clause map: for each critical item in the merged checklist, the internal procedure that satisfies it, its version date, and the person accountable. A map that cannot be produced within a day is not finished, because it is the document an inspector will ask for first.

The second is a change log for the two years before the inspection, covering process, supplier and equipment changes in the four families. A sterilisation parameter altered without revalidation reads as an unvalidated process, not as an administrative gap.

The third is the contract manufacturing chain. Where a foreign group uses a Chinese contract manufacturer, the group’s own quality agreement should already allocate responsibility for the merged items; if the agreement predates the merged checklist, it allocates responsibility for a document that no longer exists.

None of this is a legal requirement in the notice. It is the working order in which inspectors tend to ask, and preparing in that order shortens the inspection rather than the requirements.

Where the four lines differ

The four principles share a structure but not a weak point. For sterile devices the recurring failures cluster around cleanroom environment monitoring, sterilisation process validation and sterile barrier packaging validation. For implantable devices the pressure falls on traceability, from raw material to the finished device. For IVD reagents it falls on raw material and calibrator management, where a supplier change can move a result. For customised dentures it falls on the patient model and on material traceability, because each unit is made to an individual.

These are listed by product logic, not by clause number; the documents are the authority on which item sits in which grade.

A practical timetable

  • Complete a gap analysis now, not at renewal; the new scale already applies.
  • Convert the quality manual and any procedure citing the annex, then re-map to the merged items.
  • Run an internal audit using the three-grade logic, so that findings are ranked the way an inspector will rank them.
  • Re-evaluate suppliers whose materials feed a critical item, especially IVD raw and implantable materials.
  • Keep the annual self-inspection for products already licensed, and record it against the new item structure.

What this does not change

This is a production-end instrument. It does not alter registration or filing requirements, does not open a new channel and does not change how a device is cleared for the market. A registered device needs no new filing; what changes is how its factory is inspected.

Teams that read the four principles as a registration document will spend a quarter on the wrong file; teams that track registration only meet the risk on inspection day.

Outlook

Expect inspection reports to cite merged clauses rather than annex paragraphs, and expect internal document maps that still separate the GMP from its annexes to look dated within a year. The substantive requirements have not been rewritten; what changed is where they are written down and how findings are graded.

The practical test of readiness is simple: ask the quality head for the clause behind each critical item. If the answer is a page in an annex that no longer stands alone, the conversion has not been done.

Related reading

  • *Brain-Computer Interface Devices: Registration Pathways* (Article 454) — the registration side for an emerging device category.

Sources

  • 国家药监局·关于印发无菌医疗器械等四个检查指导原则的通知:https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjylqx/20261028170125118.html
  • 国家药品监督管理局:https://www.nmpa.gov.cn/
  • 中国政府网:https://www.gov.cn/
  • 国家市场监督管理总局:https://www.samr.gov.cn/

医疗器械 GMP:四个新检查指导原则如何判定符合性

概述

2026 年 10 月 23 日,国家药监局印发四个检查指导原则,配套新修订的《医疗器械生产质量管理规范》实施。规范自 2026 年 11 月 1 日起施行,四个指导原则同日施行。

四个指导原则分别对应无菌医疗器械、植入性医疗器械、体外诊断试剂和定制式义齿。通知同时废止了原国家食品药品监督管理总局印发的三个现场检查指导原则(食药监械监〔2015〕218 号),以及定制式义齿现场检查指导原则(食药监械监〔2016〕165 号)。废止与施行同日完成,中间没有并行期。

附录为什么被并了进去

编制方法在通知里写得很直白:把规范与相应附录融合衔接,转化形成检查项目。附录不再是放在规范旁边单独对照的文本,而成为检查表的一部分。

这会改变质量团队管理文件的方式。过去把程序文件对应到规范、再把附录当作第二层的体系,现在只剩一层,对应关系需要重建,而不是换个标签。做过一次完整映射的团队会发现,真正的工作量在条款对应,不在文字改写。

谁在被用新尺子量

四类产品:无菌医疗器械、植入性医疗器械、体外诊断试剂、定制式义齿。生产许可核查与上市后监督检查,都按新指导原则进行结果判定。

第二条渠道最容易被低估。多年前通过核查的持证企业并不豁免,下一次监督检查用的就是同一把新尺子。受托生产企业也在同一范围内,因为规则约束的是生产活动,而不是标签上的品牌;客户审核替代不了监管检查。

对外资集团而言,敞口集中在境内生产这四类产品的工厂,无论独资还是合资,也包括为集团产品线供货的本地基地。不生产这四类产品的工厂不受这四个指导原则约束,但仍受规范本身约束。

三个等级起什么作用

通知明确,检查项目按各条款在质量管理体系中的重要性以及不符合所带来的质量安全风险程度,划分为关键项目、主要项目、一般项目三个等级。分级是风险表述,不是打分制度:它告诉检查员哪些缺陷可以容忍,哪些不能。

写给董事会的材料里有一点要留神。实务中,关键项目不合格通常直接判定不通过。这是 GMP 检查的通行做法,不是这四份文件写明的条文,引用时应当归到实务,而不是归到通知。

按新尺子准备一次检查

等监督检查上门那天才发现质量手册还在引用已废止的现场检查指导原则,是最糟糕的时点。有三样东西值得在检查之前备好,而不是在检查当中去找。

第一份是条款对应表:合并后清单上的每一个关键项目,对应哪一份内部程序、版本日期、责任人是谁。一份一天之内拿不出来的对应表等于还没做完,因为这是检查员最先要的文件。

第二份是检查前两年的变更台账,覆盖这四类产品的工艺、供应商与设备变更。灭菌参数改了却没有再确认,在检查里读作”工艺未确认”,而不是”记录不全”。

第三份是受托生产链条。外资集团若使用境内受托生产企业,集团自身的质量协议里就应当已经就合并后的检查项目划分了责任;如果协议签署早于合并清单,它划分的是一份已经不存在的文件上的责任。

这些都不是通知里的法定要求。它们只是检查员通常的问询顺序,按这个顺序准备,缩短的是检查过程,而不是要求本身。

四条线的差别在哪里

四个指导原则结构相同,薄弱点不同。无菌器械的重复性问题集中在洁净区环境监测、灭菌过程确认和无菌屏障包装验证。植入性器械的压力落在可追溯性上,从原材料一直到成品。体外诊断试剂落在原料与校准品管理,供应商一换,结果就可能漂移。定制式义齿落在医患模型与材料溯源,因为每一件都是按个人定制。

这些是按产品逻辑列的,不是按条款号列的。哪一项属于哪个等级,以文件本身为准;把行业经验当成条文引用,是这类文章最常见的错误。

没有改变什么

这是生产端的文件。它不改变注册与备案要求,不新设申请通道,也不改变产品如何获准上市。产品已经注册的企业,不需要为此新交一份申请;改变的是工厂如何被检查。

把四个指导原则当成注册文件来读的团队,会把一个季度花在错误的材料上。反过来,只盯注册进度、不更新体系文件的团队,风险要到检查那天才显现。

一份可执行的时间表

  • 现在就对着四个指导原则做差距分析,不要等到换证;新尺子已经生效。
  • 换版质量手册,以及那些引用了附录的程序文件,再把它们重新对应到合并后的检查项目。
  • 用三个等级的逻辑做一次内审,让自查发现的问题按检查员的方式排序。
  • 对供应关键项目物料的上游做再评价,体外诊断原料与植入材料尤其如此。
  • 对已取证产品继续做年度自查,并按新的项目结构留痕。

展望

可以预期检查报告将引用合并后的条款,而不是附录段落;那些仍把规范与附录分开管理的内部文件地图,一年之内就会显得过时。实质性要求并没有重写,改变的是它们写在哪里、以及缺陷如何分级。

检验准备程度有一个很简单的办法:请质量负责人指出新清单上每一个关键项目背后的条款。如果答案仍然是某一页已经不再单独成立的附录,那么转化工作其实没有做。

延伸阅读

  • 《脑机接口医疗器械:注册路径》(第 454 篇)——新兴器械类别的注册一侧。

来源

  • 国家药监局·关于印发无菌医疗器械等四个检查指导原则的通知:https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjylqx/20261028170125118.html
  • 国家药品监督管理局:https://www.nmpa.gov.cn/
  • 中国政府网:https://www.gov.cn/
  • 国家市场监督管理总局:https://www.samr.gov.cn/

Green Power Trading for Foreign-Invested Enterprises: Power Purchase Agreement Routes, the Renewable Energy Certificate Question, and What a Zero-Carbon Factory Claim Needs

  • On 22 October 2026 an official of the Ministry of Commerce’s foreign investment administration said the ministry would support foreign-invested enterprises in participating in renewable energy trading on equal terms — a statement of direction, not a new set of trading rules.
    2026 年 10 月 22 日,商务部外国投资管理司负责人表示将支持外资企业平等参与可再生能源交易——这是方向性表态,不是新的交易规则。
  • The same briefing disclosed that inbound investment in the energy-saving, environmental-protection and clean-production sector grew 11.1 per cent year on year in the first nine months of 2026, and that several foreign-invested Zero-Carbon Factory projects have been commissioned using green electricity throughout.
    同场发布会披露,2026 年 1—9 月节能环保清洁产业引资同比增长 11.1%,一批外资零碳工厂相继落地,且全部使用绿色电力。
  • Nothing in the statement changes how a transaction is executed: purchases still run through the electricity trading institutions and local energy authorities under the medium- and long-term market rules, the green power trading pilot launched in 2021, and the certificate system.
    该表态不改变交易执行方式:采购仍按电力中长期交易规则、2021 年启动的绿电交易试点以及绿证制度,通过电力交易机构与地方能源主管部门办理。
  • Three routes exist and they are not interchangeable: a Power Purchase Agreement or monthly listing through a trading centre, purchase of certificates separately from physical power, and self-generation or distributed self-consumption.
    存在三条路径且不可互换:通过交易中心的长期购电协议或月度挂牌交易、与物理电量分离的绿证购买、以及自建或分布式自用。
  • The double-counting risk is the one that survives audit: buying a certificate does not mean buying green power, and a company that claims the same megawatt-hour in its electricity reporting and again in its certificate reporting will fail review.
    双重计算是审计中最容易被抓的问题:买证不等于买绿电,把同一兆瓦时既计入用电报告又计入绿证报告,复核时无法通过。
  • For exports, green procurement is worth only what the receiving regime will accept, so the evidence chain matters as much as the purchase itself.
    对出口而言,绿色采购的价值取决于接收方是否认可,因此凭证链的重要性不亚于采购本身。
  • Three contract terms deserve scrutiny before signature: the annual deviation assessment, curve matching against actual load, and mark-ups where power is passed through a landlord or park operator.
    签约前应重点审查三项条款:年度偏差考核、与实际负荷的曲线匹配、以及经由业主或园区转供时的加价。

Green Power Trading for Foreign-Invested Enterprises: Power Purchase Agreement Routes, the Renewable Energy Certificate Question, and What a Zero-Carbon Factory Claim Needs | 外资企业平等参与绿电交易:三条采购路径、绿证与绿电的双重计算,以及零碳工厂声明需要什么

Overview

At a State Council Information Office briefing on 22 October 2026, the official heading the foreign investment administration at the Ministry of Commerce said the ministry would support foreign-invested enterprises in participating in renewable energy trading on equal terms, alongside continued work on cross-border data flows. The same briefing disclosed that inbound investment in the energy-saving, environmental-protection and clean-production sector rose 11.1 per cent year on year in the first nine months of 2026, and that several foreign-invested zero-carbon factories have been commissioned, all running entirely on green electricity.

The two halves belong together. The numbers describe what has happened: foreign capital is putting money into clean production in China, and some of those plants are designed around renewable electricity from the day they switch on. The statement describes an intention about the next stage — that a foreign-invested user should not face a different door when it goes to buy that electricity.

What the statement is not is a rule. It creates no trading product, quota, preferential price or dedicated channel. Execution continues under the framework in force: the basic rules for medium- and long-term electricity trading, the pilot launched in 2021, the certificate system extended to full coverage of renewable generation in 2023, and the consumption responsibility weight system. A company that reads the sentence as a new entitlement will look for a form that does not exist.

What the statement does, and does not, do

It is a statement about equal treatment. The word used is “equal participation” (平等参与). For a manufacturer once told that a green power product was open to domestic users but not straightforwardly to it, this signals how such cases should be handled — to the executing bodies as much as to the market.

It confirms that no additional eligibility test is intended for foreign-invested users. That matters because green power products are often allocated through annual or monthly arrangements in which eligibility is settled locally. A statement at this level is useful in a conversation with a trading centre or a local energy authority; it is not a document those bodies must cite.

It does not create a purchase obligation, a renewable ratio for foreign-invested firms, or a new certificate category; companies should not infer a deadline. The consumption responsibility weight system, which does create obligations, is a separate instrument with its own addressees and measures.

No dedicated foreign-invested green power market has been announced.

Three routes, and how they differ

Route one: trading. A user buys electricity with renewable attributes attached through a trading centre, either as a longer-term agreement structured as a Power Purchase Agreement or through a monthly listing. It is the only route in which the attribute travels with the physical energy, and it produces the cleanest evidence: a trade record, a settlement statement and a certificate for the same volume.

Route two: certificates. A user buys renewable energy certificates separately from physical power — the unbundled model. It is faster, more liquid and available in small volumes, which suits a site whose load is unpredictable or whose meter the landlord controls. The trade-off is evidential: a certificate proves an attribute was bought, not that the electrons at that site came from a wind farm.

Route three: self-generation or distributed self-consumption. A factory with roof space or land installs capacity and consumes the output. This is the strongest claim, because generation and consumption coincide physically. It is also the route with the most friction: grid connection approval, limits on selling surplus power to a third party at the same site, and capital committed for years rather than for a contract term.

The double-counting problem

The failure that recurs in audit is arithmetic, not contractual. A company buys certificates for a volume, reports that volume as renewable in its electricity disclosure, and then also reports the certificates as an instrument holding — the same megawatt-hour in two ledgers.

The discipline is to decide, once, which ledger the attribute lives in. If the claim is made on a consumption basis, the certificate is retired against that consumption and does not reappear as an asset; if it is held as an instrument, it cannot simultaneously support a consumption claim. Retirement tracking exists for this reason, and a company running its own spreadsheet alongside it will eventually produce two numbers that do not reconcile.

The evidence chain for exports

For a manufacturer exporting to Europe, or supplying a brand committed to 100 per cent renewable electricity, procurement is only half the exercise; the other half is whether the receiving regime accepts the data.

Under the EU carbon border adjustment mechanism, importers must account for the embedded emissions of covered goods, and the question for a Chinese plant is whether actual data can displace default values. That depends on the rules for those goods and on the emissions scope — direct emissions from production, and indirect emissions from purchased electricity where counted. Green procurement affects the indirect side, and only as far as the rules permit an actual-data claim. That is a reason to keep records in the shape the receiving regime asks for, not a reason to delay.

Brand programmes impose their own tests. A 100 per cent renewable electricity commitment is normally assessed on market boundary and vintage: the certificate must come from the same market as the consumption, and from a matching generation period. The cheapest certificates available globally will not count, however defensible the spend looks.

Three contract terms to read closely

Annual deviation assessment. Contracts typically test whether actual consumption matched the contracted volume, with a tolerance band and a charge for the excess. For a plant ramping production or running seasonal campaigns, a band set for a steady-state factory produces a charge in year one. Model the load before agreeing the band, and negotiate the treatment of a shutdown in advance.

Curve matching. A contract may specify a curve rather than a flat volume. Where the contracted curve diverges from the site’s actual profile, the difference settles at spot or penalty prices, and the attribute may not attach to the diverging volume. Flat products are simpler; shaped products are cheaper only if the shape is right.

Pass-through mark-ups. Where the user is a tenant and the landlord buys wholesale and resells, the attribute can be marked up, diluted or lost. The lease and the energy supply agreement must state the volume passed through, the transfer mechanism and the price formula, or the tenant pays a premium for a claim it cannot substantiate.

Procurement checklist

Verify the account number and registered user name first; a mismatch between contracting entity and account holder blocks settlement. Confirm consumption history at monthly granularity, since contract shape and deviation band depend on it. Confirm the declaration timetable with the trading centre — a missed window may fall after the reporting year closes.

Set the retirement policy before the first purchase and write down which ledger the attribute sits in; keep the trade record, settlement statement and retirement certificate together for the same volume. Maintain an internal carbon ledger with one line per site per month: the audit question is never whether green power was bought, but whether the volume, the instrument and the retirement can be shown for that site in that year.

Outlook

The direction is clear enough: renewable electricity is being treated as a normal input rather than a special concession, and the investment data suggest some foreign-invested plants already buy it that way. What has not changed is the machinery — trading happens in the market that exists, certificates are retired in the system that exists, and obligations arise from the instruments that create them. The companies that benefit most will treat the statement as a reason to start now, using available routes, rather than to wait for a channel that has not been announced.

Related reading

  • Green power procurement and carbon compliance for foreign firms (No. 228) — the trading and certificate architecture in detail.
  • Renewable energy consumption responsibility weight mandates (No. 371) — the obligation side, including the implementing measures.

Sources

  • State Council Information Office, press conference on high-quality commerce development during the 15th Five-Year Plan period (22 October 2026): https://www.scio.gov.cn/live/2026/39833/index.html
  • Ministry of Commerce, policy releases and foreign investment data: https://www.mofcom.gov.cn/
  • National Development and Reform Commission: https://www.ndrc.gov.cn/
  • National Energy Administration, green power trading and certificate policy: https://www.nea.gov.cn/
  • The State Council, policy library: https://www.gov.cn/

外资企业平等参与绿电交易:三条采购路径、绿证与绿电的双重计算,以及零碳工厂声明需要什么

概述

2026 年 10 月 22 日,在国务院新闻办公室举行的一场发布会上,商务部外国投资管理司负责人表示,将做好支持外资企业平等参与可再生能源交易、持续提升数据跨境流动便利化水平等工作。同场发布会披露:2026 年 1—9 月,节能环保清洁产业引资同比增长 11.1%;一批外资零碳工厂相继落地,且全部使用绿色电力。

这两半内容本应放在一起读。数据描述已经发生的事:外资正在把钱投进中国的清洁生产环节,其中一些工厂从投产第一天起就围绕可再生能源电力设计。表态描述下一阶段的取向:一家外资用电企业去买这部分电时,不应面对一扇与境内企业不同的门。

需要说清的是,这个表态不是规则。它没有创设交易品种、配额、优惠电价,也没有开设专门通道。执行仍按现行框架:电力中长期交易基本规则、2021 年启动的试点、2023 年扩展到可再生能源发电全口径的绿证制度,以及消纳责任权重制度。把这句话读成”新权利落地”的企业,会去找一份并不存在的申请表。

这个表态做了什么、没做什么

它是关于平等对待的表态,用词是”平等参与”。对曾经被告知”这类产品对境内用户开放、对外资不太顺”的制造企业来说,这是指向个案处理方式的信号——既是给市场的,也是给执行机构的。

它确认了不打算对外资用电企业另设资格门槛。这一点重要,因为绿电产品往往通过年度或月度安排分配,资格认定在地方层面完成。这个层级的表态,在与交易中心或地方能源主管部门沟通时有用;但它不是这些机构必须援引的文件。

它没有创设绿电采购义务、没有对外资企业设定可再生能源比例、也没有新增绿证品类,企业不应据此推断出截止日期。真正创设义务的是可再生能源电力消纳责任权重制度,那是独立的一套工具,有自己的适用对象与实施办法。

也没有专门面向外资的绿电市场被宣布。

三条路径及其差别

路径一:交易。 用电企业通过交易机构购买附带可再生能源属性的电量,形式可以是结构上属于长期购电协议的多年期交易,也可以是月度挂牌。这是唯一让属性与物理电量同行的路径,凭证链也最干净:成交记录、结算单、以及就同一电量核发的绿证。

路径二:绿证。 在物理电量之外单独购买绿证,即证电分离。它更快、流动性更好、可小批量购买,适合负荷难以预测、或电表由业主掌控的场地。代价在证据上:绿证证明买到了属性,不证明这个场地用的电子来自某座风电场。

路径三:自建或分布式自用。 有屋顶或场地的工厂自建装机并消纳所发电力。这是最强的主张,因为发电与用电在物理上重合。摩擦也最多:并网审批、同一场地向第三方售电的限制、以及以年计而非以合同条款计的资金投入。

双重计算问题

审计中反复出现的失误是算术问题,不是合同问题。企业为某一电量购买了绿证,在用电披露中把这部分报为可再生能源,随后又把绿证作为持有工具再报一次——同一兆瓦时进了两本账。

纪律只有一条:一次性地确定属性记在哪本账上。如果主张建立在用电基础上,绿证就对应这部分用电核销,不再作为资产出现;如果绿证是作为工具持有,它就不能同时支撑用电主张。核销追踪系统的存在正是为此;企业若在系统之外另跑一张表,早晚会算出两个对不上的数字。

出口场景下的凭证链

对出口欧洲、或为已承诺百分之百使用可再生能源电力的品牌供货的制造商来说,采购只是事情的一半,另一半是接收方是否接受企业提供的数据。

按欧盟碳边境调节机制,进口商须就纳入范围货物的嵌入排放作出申报;对中国工厂而言,问题在于能否以实际数据替代默认值。这取决于该机制对具体货物的核算规则,也取决于排放口径——生产的直接排放,以及纳入计算时外购电力对应的间接排放。绿色采购只影响间接一侧,且只在规则允许以实际数据申报的范围内起作用。这是按接收方要求的形态留痕的理由,不是推迟采购的理由。

品牌方的要求有自己的口径。百分之百可再生能源电力的承诺,通常按市场边界与年份评估:凭证须来自与用电相同的市场,发电期与用电期对应。在全球范围挑最便宜的绿证,会发现它们不被计入,无论这笔支出在报告里多么说得通。

三个需要细读的合同条款

年度偏差考核。 合同通常考核实际用电量与合同电量是否匹配,设定允许区间,并对超出部分计收费用。对正在爬产或做季节性促销的工厂,按稳态工厂设定的区间会在第一年就产生费用。签约前先做负荷测算,并就停产的处理方式谈妥。

曲线匹配。 合同可能约定曲线而非平坦电量。当约定曲线与场地实际负荷形态不一致时,差额按现货价或违约价结算,绿色属性可能不附着于差额电量。平坦型产品更简单;分时型产品只有曲线对得上时才更便宜。

转供加价。 用电企业是租户、由业主批量购电再转售时,绿色属性可能被加价、被稀释、或者干脆丢失。租赁合同与供能协议必须写明转供电量、属性转移机制与价格公式;否则租户为一项自己无法举证的主张付了溢价。

采购落地清单

先核验用电户号与户名,签约主体与户名不一致会卡住结算。再按月度颗粒度确认用电历史,合同形态与偏差区间都取决于它。与交易中心确认申报时点:错过一个窗口,可能就落在报告年度结束之后。

在第一次采购之前确定核销政策,写清属性记在哪本账上;成交记录、结算单与核销凭证按同一电量放在同一处。维护一份内部碳台账,每场地每月一行:审计要问的从来不是有没有买绿电,而是这个场地这一年的电量、凭证与核销记录能否拿出来。

展望

方向足够清楚:可再生能源电力被当作常规投入品,而不是特殊照顾;投资数据也显示一部分外资工厂已经这么采购。没有变的是机制——交易在既有的市场里发生,绿证在既有的系统里核销,义务由创设义务的那套工具产生。受益最多的,是把这次表态当作”现在就用现有路径启动”的理由、而不是”等一个尚未宣布的通道”的理由的企业。

延伸阅读

  • 《外资企业的绿电采购与碳合规》(第 228 篇)——交易与绿证架构的详细展开。
  • 《可再生能源电力消纳责任权重》(第 371 篇)——义务一侧,含实施办法。

来源

  • 国务院新闻办公室·”十五五”商务高质量发展新闻发布会(2026-10-22):https://www.scio.gov.cn/live/2026/39833/index.html
  • 商务部·政策发布与外资数据:https://www.mofcom.gov.cn/
  • 国家发展和改革委员会:https://www.ndrc.gov.cn/
  • 国家能源局·绿电交易与绿证政策:https://www.nea.gov.cn/
  • 中国政府网·政策库:https://www.gov.cn/